Compositions and methods for controlling insect pests

Information

  • Patent Grant
  • 10378012
  • Patent Number
    10,378,012
  • Date Filed
    Tuesday, July 28, 2015
    10 years ago
  • Date Issued
    Tuesday, August 13, 2019
    6 years ago
Abstract
Disclosed herein are polynucleotides, compositions, and methods for controlling insect pests, especially flea beetles, such as Phyllotreta spp. and Psylliodes spp., particularly in plants. More specifically, polynucleotides such as double-stranded RNA triggers and methods of use thereof for modifying the expression of genes in flea beetles.
Description
FIELD

Disclosed herein are methods for controlling invertebrate pest infestations, particularly in plants, compositions and polynucleotides useful in such methods, and plants having improved resistance to the invertebrate pests. More specifically, polynucleotides and methods of use thereof for modifying the expression of genes in an insect pest, particularly through RNA interference are disclosed. Pest species of interest include flea beetles, such as Phyllotreta spp. and Psylliodes spp.


BACKGROUND

Commercial crops are often the targets of attack by invertebrate pests such as insects. Compositions for controlling insect infestations in plants have typically been in the form of chemical insecticides. However, there are several disadvantages to using chemical insecticides. For example, chemical insecticides are generally not selective, and applications of chemical insecticides intended to control insect pests in crop plants can exert their effects on non-target insects and other invertebrates as well. Chemical insecticides often persist in the environment and can be slow to degrade, thus potentially accumulating in the food chain. Furthermore the use of persistent chemical insecticides can result in the development of resistance in the target insect species. Thus there has been a long felt need for more environmentally friendly methods for controlling or eradicating insect infestation on or in plants, e. g., methods which are species-selective, environmentally inert, non-persistent, and biodegradable, and that fit well into pest resistance management schemes.


RNA interference (RNAi, RNA-mediated gene suppression) is an approach that shows promise for use in environmentally friendly pest control. In invertebrates, RNAi-based gene suppression was first demonstrated in nematodes (Fire et al., (1998) Nature, 391:806-811; Timmons & Fire (1998) Nature, 395:854). Subsequently, RNAi-based suppression of invertebrate genes using recombinant nucleic acid techniques has been reported in a number of species, including agriculturally or economically important pests from various insect and nematode taxa, such as: root-knot nematodes (Meloidogyne spp.), see Huang et al. (2006) Proc. Natl. Acad. Sci. USA, 103:14302-14306, doi:10.1073/pnas.0604698103); cotton bollworm (Helicoverpa armigera), see Mao et al. (2007) Nature Biotechnol., 25:1307-1313, doi:10.1038/nbt1352; Western corn rootworm (Diabrotica virgifera LeConte), see Baum et al. (2007) Nature Biotechnol., 25:1322-1326, doi:10.1038/nbt1359; sugar beet cyst nematode (Heterodera schachtii), see Sindhu et al. (2008) J. Exp. Botany, 60:315-324, doi:10.1093/jxb/ern289; mosquito (Aedes aegypti), see Pridgeon et al. (2008) J. Med. Entomol., 45:414-420, doi: full/10.1603/0022-2585%282008%2945%5B414%3ATAADRK %5D2.0.CO %3B2; fruit flies (Drosophila melanogaster), flour beetles (Tribolium castaneum), pea aphids (Acyrthosiphon pisum), and tobacco hornworms (Manduca sexta), see Whyard et al. (2009) Insect Biochem. Mol. Biol., 39:824-832, doi:10.1016/j.ibmb.2009.09.00; diamondback moth (Plutella xylostella), see Gong et al. (2011) Pest Manag. Sci., 67: 514-520, doi:10.1002/ps.2086; green peach aphid (Myzus persicae), see Pitino et al. (2011) PLoS ONE, 6:e25709, doi:10.1371/journal.pone.0025709; brown planthopper (Nilaparvata lugens), see Li et al. (2011) Pest Manag. Sci., 67:852-859, doi:10.1002/ps.2124; and whitefly (Bemisia tabaci), see Upadhyay et al. (2011) J. Biosci., 36:153-161, doi:10.1007/s12038-011-9009-1.


SUMMARY

The present embodiments relate to control of insect species, especially flea beetle species that are economically or agriculturally important pests. The compositions and methods disclosed herein include recombinant polynucleotide molecules, such as recombinant DNA constructs for making transgenic plants resistant to infestation by insect species and polynucleotide agents, such as RNA “triggers”, that are useful for controlling or preventing infestation by that insect species. Several embodiments described herein relate to a polynucleotide-containing composition (e. g., a composition containing a dsRNA trigger for suppressing a target gene) that is topically applied to an insect species or to a plant, plant part, or seed to be protected from infestation by an insect species. Other embodiments relate to methods for selecting preferred insect target genes that are more likely to be effective targets for RNAi-mediated control of an insect species.


Several embodiments relate to a method for controlling an insect infestation of a plant including contacting the insect with a dsRNA including at least one segment of 18 or more contiguous nucleotides with a sequence of about 95% to about 100% complementarity with a fragment of a target gene of the insect. In some embodiments, the dsRNA includes at least one segment of 21 contiguous nucleotides with a sequence of 100% complementarity with a fragment of a target gene of the insect. In some embodiments, the target gene is selected from the group consisting of Act5C, arginine kinase, COPI (coatomer subunit) alpha, COPI (coatomer subunit) beta, COPI (coatomer subunit) betaPrime, COPI (coatomer subunit) delta, COPI (coatomer subunit) epsilon, COPI (coatomer subunit) gamma, COPI (coatomer subunit) zeta, RpL07, RpL19, RpL3, RpL40, RpS21, RpS4, Rpn2, Rpn3, Rpt6, Rpn8, Rpn9, Rpn6-PB-like protein, Sar1, sec6, sec23, sec23A, shrb (snf7), Tubulin gamma chain, ProsAlpha2, ProsBeta5, Proteasome alpha 2, Proteasome beta 5, VATPase E, VATPase A, VATPase B, VATPase D, Vps2, Vps4, Vps16A, Vps20, Vps24, Vps27, Vps28, Vha26 (V-ATPase A), Vha68-2 (V-ATPase D/E), 40S ribosomal protein S14, and 60S ribosomal protein L13. In some embodiments, the target gene has a DNA sequence selected from the group consisting of SEQ ID NOs:1-859. In some embodiments, the dsRNA includes an RNA strand with a sequence of about 95% to about 100% identity or complementarity with a sequence selected from the group consisting of SEQ ID NOs:860-1718 and 1722-1724 or a fragment thereof. In some embodiments, the dsRNA includes an RNA strand with a sequence selected from the group consisting of SEQ ID NOs:860-1718 and 1722-1724. In various embodiments, the contacting of the insect is by oral delivery, or by non-oral contact, e. g., by absorption through the cuticle, or through a combination of oral and non-oral delivery. In some embodiments, the dsRNA trigger suppresses a target gene in the insect and stunts growth, development or reproduction by the insect, or kills the insect.


Several embodiments relate to a method of causing mortality or stunting in an insect, including providing in the diet of an insect at least one polynucleotide including at least one silencing element, wherein the at least one silencing element is essentially identical or essentially complementary to a fragment of a target gene sequence of the insect, and wherein ingestion of the polynucleotide by the insect results in mortality or stunting in the insect. In some embodiments, the target gene is selected from the group consisting of Act5C, arginine kinase, COPI (coatomer subunit) alpha, COPI (coatomer subunit) beta, COPI (coatomer subunit) betaPrime, COPI (coatomer subunit) delta, COPI (coatomer subunit) epsilon, COPI (coatomer subunit) gamma, COPI (coatomer subunit) zeta, RpL07, RpL19, RpL3, RpL40, RpS21, RpS4, Rpn2, Rpn3, Rpt6, Rpn8, Rpn9, Rpn6-PB-like protein, Sar1, sec6, sec23, sec23A, shrb (snf7), Tubulin gamma chain, ProsAlpha2, ProsBeta5, Proteasome alpha 2, Proteasome beta 5, VATPase E, VATPase A, VATPase B, VATPase D, Vps2, Vps4, Vps16A, Vps20, Vps24, Vps27, Vps28, Vha26 (V-ATPase A), Vha68-2 (V-ATPase D/E), 40S ribosomal protein S14, and 60S ribosomal protein L13. In some embodiments, the target gene sequence is selected from the group consisting of SEQ ID NOs:1-859. In some embodiments, the silencing element includes an RNA strand with a sequence of about 95% to about 100% identity or complementarity with a sequence selected from the group consisting of SEQ ID NOs:860-1718 and 1722-1724 or a fragment thereof. In some embodiments, the silencing element includes an RNA strand with a sequence selected from the group consisting of SEQ ID NOs:860-1718 and 1722-1724. In some embodiments, the polynucleotide is provided in the diet of the insect in the form of a plant or bacterial cell containing the polynucleotide, or as a synthetic polynucleotide molecule, or as a fermentation product (e. g., a hairpin form of a dsRNA, produced in a bacterium). In some embodiments, the polynucleotide is a recombinant RNA molecule. In some embodiments, the polynucleotide is a double-stranded RNA molecule.


Several embodiments relate to an insecticidal composition including an insecticidally effective amount of a polynucleotide, wherein the polynucleotide includes 18 or more contiguous nucleotides with about 95% to about 100% complementarity with a corresponding portion of a target gene of an insect that infests a plant. In some embodiments, the polynucleotide includes 21 contiguous nucleotides with a sequence of 100% complementarity with a corresponding portion of the target gene. In some embodiments, the target gene is selected from the group consisting of Act5C, arginine kinase, COPI (coatomer subunit) alpha, COPI (coatomer subunit) beta, COPI (coatomer subunit) betaPrime, COPI (coatomer subunit) delta, COPI (coatomer subunit) epsilon, COPI (coatomer subunit) gamma, COPI (coatomer subunit) zeta, RpL07, RpL19, RpL3, RpL40, RpS21, RpS4, Rpn2, Rpn3, Rpt6, Rpn8, Rpn9, Rpn6-PB-like protein, Sar1, sec6, sec23, sec23A, shrb (snf7), Tubulin gamma chain, ProsAlpha2, ProsBeta5, Proteasome alpha 2, Proteasome beta 5, VATPase E, VATPase A, VATPase B, VATPase D, Vps2, Vps4, Vps16A, Vps20, Vps24, Vps27, Vps28, Vha26 (V-ATPase A), Vha68-2 (V-ATPase D/E), 40S ribosomal protein S14, and 60S ribosomal protein L13. In some embodiments, the polynucleotide includes 18 or more contiguous nucleotides with about 95% to about 100% complementarity with a DNA sequence selected from the group consisting of SEQ ID NOs:1-859 or a fragment thereof. In some embodiments, the polynucleotide includes 21 contiguous nucleotides with a sequence of 100% complementarity with a DNA sequence selected from the group consisting of SEQ ID NOs:1-859 or a fragment thereof. In some embodiments, the polynucleotide is recombinant RNA. In some embodiments, the polynucleotide is molecule is dsRNA. In some embodiments, the polynucleotide includes at least one segment (e. g., an RNA strand or segment of an RNA strand) with a sequence of about 95% to about 100% identity or complementarity with a sequence selected from the group consisting of SEQ ID NOs:860-1718 and 1722-1724 or a fragment thereof. In some embodiments, polynucleotide includes at least one segment (e. g., an RNA strand or segment of an RNA strand) with a sequence selected from the group consisting of SEQ ID NOs:860-1718 and 1722-1724 or a fragment thereof. In some embodiments, the insecticidal composition further includes one or more of a carrier agent, a surfactant, an organosilicone, a cationic lipid, a polynucleotide herbicidal molecule, a non-polynucleotide herbicidal molecule, a non-polynucleotide pesticide, a fungicide, a safener, an insect attractant, and an insect growth regulator. Embodiments of the insecticidal compositions include non-polynucleotide insecticides, e. g., a bacterially produced insecticidal protein.


Several embodiments relate to a method of providing a plant having improved resistance to an insect, including expressing in the plant a recombinant DNA construct, wherein the recombinant DNA construct includes DNA encoding an RNA polynucleotide having a sequence essentially identical or essentially complementary to a fragment of at least one target gene of the insect, and wherein ingestion of the polynucleotide by the insect results in mortality or stunting in the insect. In some embodiments, the target gene is selected from the group consisting of Act5C, arginine kinase, COPI (coatomer subunit) alpha, COPI (coatomer subunit) beta, COPI (coatomer subunit) betaPrime, COPI (coatomer subunit) delta, COPI (coatomer subunit) epsilon, COPI (coatomer subunit) gamma, COPI (coatomer subunit) zeta, RpL07, RpL19, RpL3, RpL40, RpS21, RpS4, Rpn2, Rpn3, Rpt6, Rpn8, Rpn9, Rpn6-PB-like protein, Sar1, sec6, sec23, sec23A, shrb (snf7), Tubulin gamma chain, ProsAlpha2, ProsBeta5, Proteasome alpha 2, Proteasome beta 5, VATPase E, VATPase A, VATPase B, VATPase D, Vps2, Vps4, Vps16A, Vps20, Vps24, Vps27, Vps28, Vha26 (V-ATPase A), Vha68-2 (V-ATPase D/E), 40S ribosomal protein S14, and 60S ribosomal protein L13. In some embodiments, the target gene has a DNA sequence selected from the group consisting of SEQ ID NOs:1-859. In some embodiments, the polynucleotide is single-stranded RNA (ssRNA). In other embodiments, the polynucleotide is double-stranded RNA (dsRNA), which may include single-stranded portions, such as a loop in a stem-loop structure. In some embodiments, the polynucleotide is RNA (e. g., an RNA strand or segment of an RNA strand) with a sequence of about 95% to about 100% identity or complementarity with a sequence selected from the group consisting of SEQ ID NOs:860-1718 and 1722-1724 or a fragment thereof. In some embodiments, the polynucleotide is RNA (e. g., an RNA strand or segment of an RNA strand) with a sequence selected from the group consisting of SEQ ID NOs:860-1718 and 1722-1724 or a fragment thereof.


Several embodiments relate to a recombinant DNA construct including a heterologous promoter operably linked to DNA encoding an RNA transcript including a sequence of about 95% to about 100% identity or complementarity with a sequence selected from the group consisting of SEQ ID NOs:860-1718 and 1722-1724 or a fragment thereof. Several embodiments relate to a commercial unit of seed, such as a bag, in which all or substantially all of the seeds include a recombinant DNA construct including a heterologous promoter operably linked to DNA encoding an RNA transcript including a sequence of about 95% to about 100% identity or complementarity with a sequence selected from the group consisting of SEQ ID NOs:860-1718 and 1722-1724 or a fragment thereof. In some embodiments, the RNA transcript is single-stranded RNA (ssRNA). In other embodiments, the RNA transcript is double-stranded RNA (dsRNA), which may include single-stranded portions, such as a loop in a stem-loop structure. In some embodiments, the RNA transcript includes RNA (e. g., an RNA strand or segment of an RNA strand) with a sequence of about 95% to about 100% identity or complementarity with a sequence selected from the group consisting of SEQ ID NOs:860-1718 and 1722-1724 or a fragment thereof. In some embodiments, the RNA transcript includes RNA (e. g., an RNA strand or segment of an RNA strand) with a sequence selected from the group consisting of SEQ ID NOs:860-1718 and 1722-1724 or a fragment thereof.


In related aspects, provided herein are man-made compositions including a polynucleotide or trigger as described herein, such as dsRNA formulations useful for topical application to a plant or substance in need of protection from an insect infestation; recombinant constructs and vectors useful for making transgenic plant cells and transgenic plants; formulations and coatings useful for treating plants (including plant seeds or propagatable parts such as tubers); plant seeds or propagatable parts such as tubers treated with or containing a polynucleotide as described herein as well as commodity products and foodstuffs produced from such plants; seeds, or propagatable parts (especially commodity products and foodstuffs having a detectable amount of a polynucleotide disclosed herein). Several embodiments relate to polyclonal or monoclonal antibodies that bind a peptide or protein encoded by a sequence or a fragment of a sequence selected from the group consisting of SEQ ID NOs:1-859. Several embodiments relate to polyclonal or monoclonal antibodies that bind a peptide or protein encoded by a sequence or a fragment of a sequence selected from the group consisting of SEQ ID NOs:860-1718 and 1722-1724 or the complement thereof. Such antibodies are made by routine methods as known to one of ordinary skill in the art.


Other aspects and specific embodiments are disclosed in the following detailed description and working Examples.







DETAILED DESCRIPTION

The present embodiments relate to methods and compositions for controlling insect pests, in particular the group of coleopteran insects commonly known as “flea beetles”, of which there are several genera. Disclosed herein are target genes identified as useful for designing polynucleotide agents for preventing or treating flea beetle infestations, especially of commercially important plants. The methods and compositions are especially useful for preventing or treating flea beetle infestations of commercially important Brassica species including species commercially used as oilseed, food, or livestock feed (e. g., canola, rapeseed, turnips, and field mustard or turnip rape). Such Brassica species include B. napus, B. juncea, B. carinata, B. rapa, B. oleracea, B. rupestris, B. septiceps, B. nigra, B. narinosa, B. perviridus, B. tournefortii, and B. fructiculosa. Also disclosed are sequences for suppressing one or more flea beetle target genes. Several embodiments relate to polynucleotide agents, for example, in the form of dsRNA “triggers” that suppress flea beetle target genes. In some embodiments, polynucleotides and recombinant DNA molecules and constructs useful in methods of controlling insect pests, especially flea beetles are provided. Several embodiments relate to insecticidal compositions, as well as to transgenic plants resistant to infestation by insect pests. Several embodiments relate to methods of identifying efficacious polynucleotide agents, for example, double-stranded RNA molecules for controlling insect pests and methods for identifying target genes that are likely to represent essential functions, making these genes preferred targets for RNAi-mediated silencing and control of insect pests.


Several embodiments relate to methods and compositions for inhibiting or controlling flea beetle infestation of a plant by inhibiting in the flea beetle the expression of one or more target gene selected from the group consisting of Act5C, arginine kinase, COPI (coatomer subunit) alpha, COPI (coatomer subunit) beta, COPI (coatomer subunit) betaPrime, COPI (coatomer subunit) delta, COPI (coatomer subunit) epsilon, COPI (coatomer subunit) gamma, COPI (coatomer subunit) zeta, RpL07, RpL19, RpL3, RpL40, RpS21, RpS4, Rpn2, Rpn3, Rpt6, Rpn8, Rpn9, Rpn6-PB-like protein, Sar1, sec6, sec23, sec23A, shrb (snf7), Tubulin gamma chain, ProsAlpha2, ProsBeta5, Proteasome alpha 2, Proteasome beta 5, VATPase E, VATPase A, VATPase B, VATPase D, Vps2, Vps4, Vps16A, Vps20, Vps24, Vps27, Vps28, Vha26 (V-ATPase A), Vha68-2 (V-ATPase D/E), 40S ribosomal protein S14, and 60S ribosomal protein L13. In some embodiments, inhibiting the expression of one or more target gene in the flea beetle results in stunting or mortality.


Several embodiments relate to a polynucleotide molecule, such as a dsRNA, which includes one or more segments including 18 or more contiguous nucleotides, for example 21 or more contiguous nucleotides, having 95% to about 100% (e. g., about 95%, about 96%, about 97%, about 98%, about 99%, or about 100%) complementarity with a fragment of an insect target gene selected from the group consisting of Act5C, arginine kinase, COPI (coatomer subunit) alpha, COPI (coatomer subunit) beta, COPI (coatomer subunit) betaPrime, COPI (coatomer subunit) delta, COPI (coatomer subunit) epsilon, COPI (coatomer subunit) gamma, COPI (coatomer subunit) zeta, RpL07, RpL19, RpL3, RpL40, RpS21, RpS4, Rpn2, Rpn3, Rpt6, Rpn8, Rpn9, Rpn6-PB-like protein, Sar1, sec6, sec23, sec23A, shrb (snf7), Tubulin gamma chain, ProsAlpha2, ProsBeta5, Proteasome alpha 2, Proteasome beta 5, VATPase E, VATPase A, VATPase B, VATPase D, Vps2, Vps4, Vps16A, Vps20, Vps24, Vps27, Vps28, Vha26 (V-ATPase A), Vha68-2 (V-ATPase D/E), 40S ribosomal protein S14, and 60S ribosomal protein L13. In some embodiments, the polynucleotide, such as dsRNA, includes multiple segments each of 18 or more contiguous nucleotides with a sequence of about 95% to about 100% (e. g., about 95%, about 96%, about 97%, about 98%, about 99%, or about 100%) complementarity with a fragment of a DNA sequence selected from the group consisting of SEQ ID NOs:1-859. In some embodiments, the polynucleotide, such as dsRNA, includes 21 contiguous nucleotides having 100% complementarity with a fragment of a DNA sequence selected from the group consisting of SEQ ID NOs:1-859. For example, the polynucleotide, such as dsRNA, includes segments corresponding to different regions of the target gene, or can include multiple copies of a segment. In other embodiments, the polynucleotide, such as dsRNA, includes multiple segments, each of 18 or more contiguous nucleotides with a sequence of about 95% to about 100% (e. g., about 95%, about 96%, about 97%, about 98%, about 99%, or about 100%) complementarity with a fragment of a different target gene; in this way multiple target genes, or multiple insect species, can be suppressed.


Several embodiments relate to a dsRNA molecule, sometimes referred to herein as a “trigger”, which inhibits the expression of one or more insect target genes selected from the group consisting of Act5C, arginine kinase, COPI (coatomer subunit) alpha, COPI (coatomer subunit) beta, COPI (coatomer subunit) betaPrime, COPI (coatomer subunit) delta, COPI (coatomer subunit) epsilon, COPI (coatomer subunit) gamma, COPI (coatomer subunit) zeta, RpL07, RpL19, RpL3, RpL40, RpS21, RpS4, Rpn2, Rpn3, Rpt6, Rpn8, Rpn9, Rpn6-PB-like protein, Sar1, sec6, sec23, sec23A, shrb (snf7), Tubulin gamma chain, ProsAlpha2, ProsBeta5, Proteasome alpha 2, Proteasome beta 5, VATPase E, VATPase A, VATPase B, VATPase D, Vps2, Vps4, Vps16A, Vps20, Vps24, Vps27, Vps28, Vha26 (V-ATPase A), Vha68-2 (V-ATPase D/E), 40S ribosomal protein S14, and 60S ribosomal protein L13. Several embodiments relate to a dsRNA having a length greater than that which is typical of naturally occurring regulatory small RNAs (such as endogenously produced siRNAs and mature miRNAs), e. g, the dsRNA is at least about 30 contiguous base-pairs in length. In some embodiments, the dsRNA has a length of between about 50 to about 500 base-pairs. In some embodiments, the dsRNA is at least 50 base pairs in length. In some embodiments, the dsRNA is formed from two separate, essentially complementary strands (e. g., where each strand is separately provided, or where each strand is encoded on a separate DNA molecule, or where the two strands are encoded on separate sections of a DNA and are separately transcribed or made separate, for example, by the action of a recombinase or nuclease), wherein at least one RNA strand includes a sequence of about 95% to about 100% (e. g., about 95%, about 96%, about 97%, about 98%, about 99%, or about 100%) identity or complementarity with a sequence selected from the group consisting of SEQ ID NOs:860-1718 and 1722-1724 or a fragment thereof. In some embodiments, the dsRNA is blunt-ended, e. g., two separate, equal-length strands of RNA which form the dsRNA through intermolecular hybridisation. In some embodiments, the dsRNA has an overhang at one or both ends (termini), e. g., two separate, unequal-length strands of RNA which form the dsRNA through intermolecular hybridisation; the overhang can be a single nucleotide or 2, 3, 4, 5, 6, or more nucleotides, and can be located on the 5′ end or on the 3′ end of a strand. In some embodiments, the dsRNA includes at least one stem-loop, e. g., a single RNA molecule that forms a dsRNA with a “hairpin” secondary structure through intramolecular hybridization. In some embodiments, the dsRNA is formed from a single self-hybridizing hairpin transcript, wherein one “arm” of the hairpin includes a sequence of about 95% to about 100% (e. g., about 95%, about 96%, about 97%, about 98%, about 99%, or about 100%) identity or complementarity with a sequence selected from the group consisting of SEQ ID NOs:860-1718 and 1722-1724 or a fragment thereof. In embodiments, self-hybridizing transcripts which form hairpins (or partial hairpins) include dsRNA molecules that include “spacer” nucleotides or a single-stranded “loop region” between the dsRNA-forming complementary “arms” of sense sequence and anti-sense sequence. In embodiments, such spacers or loops include nucleotides having a sequence unrelated (not complementary or identical to) the target gene corresponding to the double-stranded portion of the hairpin. Examples of spacers or loops include those encoded by SEQ ID NOs:1719-1721. In embodiments, the dsRNA includes multiple stem-loops, with or without spacer nucleotides between each stem-loop. In embodiments, the dsRNA includes a modified stem-loop such as a “stabilized anti-sense” loop or a “stabilized sense” loop; see, e. g., U.S. Pat. Nos. 7,855,323 and 9,006,414, which are incorporated by reference in their entirety herein.


The dsRNA can be chemically synthesized (e. g., by in vitro transcription, such as transcription using a T7 polymerase or other polymerase), or can be produced by expression in a microorganism, by expression in a plant cell, or by microbial fermentation. The dsRNA can be chemically modified, e. g., to improve stability, ease of formulation, or efficacy. In some embodiments, the dsRNA molecule is provided in a microbial or plant cell that expresses dsRNA (such as a hairpin form of a dsRNA trigger), or in a microbial fermentation product.


A variety of methods for designing and producing a variety of forms of dsRNA are known in the art and are useful in the compositions and methods disclosed herein. See, for example, the following patents which are incorporated by reference in their entirety herein: (1) U.S. Pat. No. 8,598,332 to Waterhouse et al., which discloses recombinant DNA constructs including DNA encoding sense RNA and anti-sense RNA sequences in a single transcript that forms an artificial “hairpin” RNA structure with a double-stranded RNA stem by base-pairing between the sense and anti-sense nucleotide sequences; embodiments include hairpins with spacer nucleotides between the sense and anti-sense nucleotide sequences; (2) U.S. Pat. No. 8,158,414 to Rommens et al., which discloses recombinant DNA constructs including convergently oriented first and second promoters, which produce, e. g., an RNA duplex that is formed by annealing of two separate RNA transcripts; and (3) U.S. Pat. Nos. 7,855,323 and 9,006,414 to Huang et al., which disclose recombinant DNA constructs including DNA encoding “stabilized anti-sense” transcripts which form a loop of anti-sense-oriented RNA for suppressing one or more target genes; recombinant DNA constructs can be designed to similarly encode “stabilized sense” transcripts which form a loop of sense-oriented RNA for suppressing one or more target genes.


Embodiments of the compositions including polynucleotides such as the dsRNA triggers described herein further contain one or more additional components or adjuvants, e. g., a carrier agent, an encapsulation agent, an emulsifying agent, a surfactant, an organosilicone, a cationic lipid, a spreading agent, a photoprotective agent, a rainfastness agent, a polynucleotide herbicidal molecule, a non-polynucleotide herbicidal molecule, a non-polynucleotide pesticide, a non-polynucleotide fungicide, a safener, a bait, an insect attractant, an insect pheromone, and an insect growth regulator. In embodiments, these additional components or adjuvants are edible or digestible if ingested by a flea beetle.


In embodiments, the polynucleotides such as dsRNA triggers disclosed herein are used in combination with a non-nucleotide pesticidal agent such as a small-molecule pesticidal agent or a proteinaceous pesticidal agent, either concurrently or sequentially. Examples of non-nucleotide pesticidal agents include patatins, plant lectins, phytoecdy steroids, and bacterial insecticidal proteins (e. g., insecticidal proteins from Bacillus thuringiensis, Xenorhabdus sp., Photorhabdus sp., Brevibacillus laterosporus (previously Bacillus laterosporus), Lysinibacillus sphaericus (previously Bacillus sphaericus), Chromobacterium sp., Chromobacterium subtsugae, Paenibacillus sp., Paenibacillus lentimorbus, and Paenibacillus popilliae), a bacterium that produces an insecticidal protein, and an entomicidal bacterial species. In embodiments, the compositions including polynucleotides for flea beetle control such as the dsRNA triggers described herein can further include, or can be used concurrently or sequentially with, conventional pesticides such as Spiromesifen, Spirodiclofen, Spirotetramat, Pyridaben, Tebufenpyrad, Tolfenpyrad, Fenpyroximate, Flufenerim, Pyrimidifen, Fenazaquin, Rotenone, Cyenopyrafen, Hydramethylnon, Acequinocyl, Fluacrypyrim, Aluminium phosphide, Calcium phosphide, Phosphine, Zinc phosphide, Cyanide, Diafenthiuron, Azocyclotin, Cyhexatin, Fenbutatin oxide, Propargite, Tetradifon, Bensultap, Thiocyclam, Thiosultap-sodium, Flonicamid, Etoxazole, Clofentezine, Diflovidazin, Hexythiazox, Chlorfluazuron, Bistrifluron, Diflubenzuron, Flucycloxuron, Flufenoxuron, Hexaflumuron, Lufenuron, Novaluron, Noviflumuron, Teflubenzuron, Triflumuron, Buprofezin, Cyromazine, Hydroprene, Kinoprene, Methoprene, Fenoxycarb, Pyriproxyfen, Pymetrozine, Pyrifluquinazon, Chlorfenapyr, Tralopyril, B.t. (Bacillus thuringiensis) var. aizawai, B.t. var. israelensis, B.t. var. kurstaki, B.t. var. sphaericus, B.t. var. tenebrionensis, Bacillus thuringiensis crop proteins including Cry1Ab, Cry1Ac, Cry1Fa, Cry2Ab, mCry3A, Cry3Ab, Cry3Bb, Cry34/35Ab1, Methyl bromide and other alkyl halides, Chloropicrin, Sulfuryl fluoride, Benclothiaz, Chinomethionat, Cryolite, Methylneodecanamide, Benzoximate, Cymiazole, Fluensulfone, Azadirachtin, Bifenazate, Amidoflumet, Dicofol, Plifenate, Cyflumetofen, Pyridalyl, Beauveria bassiana GHA, Sulfoxaflor, Spinetoram, Spinosad, Spinosad, Emamectin benzoate, Lepimectin, Milbemectin, Abamectin, Methoxyfenozide, Chromafenozide, Halofenozide, Tebufenozide, Amitraz, Chlorantraniliprole, Cyantraniliprole, Flubendiamide, alpha-endosulfan, Chlordane, Endosulfan, Fipronil, Acetoprole, Ethiprole, Pyrafluprole, Pyriprole, Indoxacarb and Metaflumizone, Acrinathrin, Allethrin, Allethrin-cis-trans, Allethrin-trans, beta-Cyfluthrin, beta-Cypermethrin, Bifenthrin, Bioallethrin, Bioallethrin S-cyclopentenyl, Bioresmethrin, Cycloprothrin, Cyfluthrin, Cyhalothrin, Cypermethrin, Cyphenothrin [(1R)-trans-isomers], Dimefluthrin, Empenthrin [(EZ)-(1R)-isomers], Esfenvalerate, Etofenprox, Fenpropathrin, Fenvalerate, Flucythrinate, Flumethrin, Gamma-cyhalothryn, lambda-Cyhalothrin, Meperfluthrin, Metofluthrin, Permethrin, Phenothrin [(1R)-trans-isomer], Prallethrin, Profluthrin, Protrifenbute, Resmethrin, Silafluofen, tau-Fluvalinate, Tefluthrin, Tetramethrin, Tetramethrin [(1R)-isomers], Tetramethylfluthrin, theta-Cypermethrin, Tralomethrin, Transfluthrin, zeta-Cypermethrin, alpha-Cypermethrin, Deltamethrin, DDT, and Methoxychlor, Thiodicarb, Alanycarb, Aldicarb, Bendiocarb, Benfuracarb, Butoxycarboxim, Carbaryl, Carbofuran, Carbosulfan, Ethiofencarb, Fenobucarb, Formetanate, Furathiocarb, Isoprocarb, Methiocarb, Methomyl, Metolcarb, Oxamyl, Pirimicarb, Propoxur, Thiofanox, Triazamate, Trimethacarb, XMC, Xylylcarb, Chlorpyrifos, Malathion, Acephate, Azamethiphos, Azinphos-ethyl, Azinphos-methyl, Cadusafos, Chlorethoxyfos, Chlorfenvinphos, Chlormephos, Chlorpyrifos-methyl, Coumaphos, Cyanophos, Demeton-S-methyl, Diazinon, Dichlorvos/DDVP, Dicrotophos, Dimethoate, Dimethylvinphos, Disulfoton, EPN, Ethion, Ethoprophos, Famphur, Fenamiphos, Fenitrothion, Fenthion, Fonofos, Fosthiazate, Imicyafos, Isofenphos-methyl, Mecarbam, Methamidophos, Methidathion, Mevinphos, Monocrotophos, Naled, Omethoate, Oxydemeton-methyl, Parathion, Parathion-methyl, Phenthoate, Phorate, Phosalone, Phosmet, Phosphamidon, Phoxim, Pirimiphos-ethyl, Profenofos, Propaphos, Propetamphos, Prothiofos, Pyraclofos, Pyridaphenthion, Quinalphos, Sulfotep, Tebupirimfos, Temephos, Terbufos, Tetrachlorvinphos, Thiometon, Triazophos, Trichlorfon, Vamidothion Imidacloprid, Thiamethoxam, Acetamiprid, Clothianidin, Dinotefuran, Nitenpyram, Nithiozine, Nicotine, Thiacloprid, chlorantraniliprole, and cyantraniliprole. In embodiments, the compositions including polynucleotides for flea beetle control in Brassica species including canola further include, or are used concurrently or sequentially with, foliar sprays including one or more pesticides selected from the group consisting of Deltamethrin, Cypermethrin, Lambda-cyhalothrin, Permethrin, Carbaryl, Carbofuran, and Malathion, or seed treatments including one or more pesticides selected from the group consisting of Thiamethoxam, Imidacloprid, and Clothianadin.


In embodiments, the compositions including polynucleotides for flea beetle control such as the dsRNA triggers described herein can further include, or can be used concurrently or sequentially with, conventional fungicides such as bupirimate, dimethirimol, ethirimol, cyprodinil, pyrimethanil, mepanipyrim, fenpiclonil, fludioxonil; phenylamides, benalaxyl, furalaxyl, metalaxyl, R-metalaxyl, ofurace, oxadixyl, benomyl, carbendazim, debacarb, fuberidazole, thiabendazole, chlozolinate, dichlozoline, iprodine, myclozoline, procymidone, vinclozolin, carboxin, fenfuram, flutolanil, mepronil, oxycarboxin, thifluzamide, guazatine, dodine, iminoctadine, azoxystrobin, kresoxim-methyl, metominostrobin, or trifloxystrobin, ferbam, mancozeb, maneb, metiram, propineb, thiram, zineb, ziram, captafol, captan, dichlofluanid, fluoromide, folpet, tolyfluanid, copper hydroxide, copper oxychloride, copper sulfate, cuprous oxide, mancopper, oxine-copper, dinocap, nitrothal-isopropyl, edifenphos, iprobenphos, isoprothiolane, phosdiphen, pyrazopho, toclofos-methyl, acibenzolar-S-methyl, harpin, anilazine, blasticidin-S, chinomethionat, chloroneb, chlorothalonil, cymoxanil, dichione, diclomezine, dicloran, diethofencarb, dimethomorph, dithianon, etridiazole, famoxadone, fenamidone, fentin, fenpyrazamine, ferimzone, fluazinam, flusulfamide, fosetyl-aluminium, hymexazol, kasugamycin, methasulfocarb, pencycuron, phthalide, polyoxins, probenazole, propamocarb, pyroquilon, quinoxyfen, quintozene, sulfur, triazoxide, tricyclazole, validamycin, azaconazole, bitertanol, propiconazole, difenoconazole, diniconazole, cyproconazole, epoxiconazole, fluquinconazole, flusilazole, flutriafol, hexaconazole, imazalil, imibenconazole, ipconazole, tebuconazole, tetraconazole, fenbuconazole, metconazole, myclobutanil, perfurazoate, penconazole, bromuconazole, pyrifenox, prochloraz, triadimefon, triadimenol, triflumizol, triticonazole, triforine, ancymidol, fenarimol or nuarimol, dodemorph, fenpropidin, fenpropimorph, spiroxamine, tridemorph, and fenhexamid. In embodiments, the compositions including polynucleotides for flea beetle control in Brassica species including canola further include, or are used concurrently or sequentially with, foliar sprays including one or more fungicides selected from the group consisting of Azoxystrobin, Bacillus subtilis strain QST 2808, Boscalid, Fluxopyroxad, Pyraclostrobin, Metconazole, Prothioconazole, Penthiopyrad, Picoxystrobin, and Thiophanate Methyl, or seed treatments including one or more fungicides selected from the group consisting of Azoxystrobin, Metalaxyl, Trifloxystrobin, Pyraclostrobin, Sedaxane, Penflufen, Fludioxonil, and Mefenoxam.


In embodiments, the compositions including polynucleotides for flea beetle control such as the dsRNA triggers described herein can further include, or can be used concurrently or sequentially with, conventional herbicides such as glyphosate, auxin-like herbicides such as dicamba, phosphinothricin, glufosinate, 2,2-dichloropropionic acid (Dalapon), acetolactate synthase inhibitors such as sulfonylurea, imidazolinone, triazolopyrimidine, pyrimidyloxybenzoates, and phthalide, bromoxynil, cyclohexanedione (sethoxydim) and aryloxyphenoxypropionate (haloxyfop), sulfonamide herbicides, triazine herbicides, 5-methyltryptophan, aminoethyl cysteine, pyridazinone herbicides such as norflurazon, cyclopropylisoxazole herbicides such as isoxaflutole, protoporphyrinogen oxidase inhibitors, herbicidea containing an aryloxyalkanoate moiety, phenoxy auxins such as 2,4-D and dichlorprop, pyridyloxy auxins such as fluroxypyr and triclopyr, aryloxyphenoxypropionates (AOPP) acetyl-coenzyme A carboxylase (ACCase) inhibitors such as haloxyfop, quizalofop, and diclofop, and 5-substituted phenoxyacetate protoporphyrinogen oxidase IX inhibitors such as pyraflufen and flumiclorac. In embodiments, the compositions including polynucleotides for flea beetle control in Brassica species including canola further include, or are used concurrently or sequentially with, one or more post-emergence herbicides selected from the group consisting of Quizalofop, Sethoxydim, Clethodim, and Clopyralid. In embodiments, the compositions including polynucleotides for flea beetle control in herbicide-resistant Brassica species including herbicide-resistant canola further include, or are used concurrently or sequentially with, one or more herbicides selected from the group consisting of Imazamox, Glyphosate, and Glufosinate.


The compositions and methods disclosed are useful for inhibiting or controlling flea beetle infestation of a plant, such as a Brassica species. In embodiments, the compositions and methods are used to treat a growing plant, such as a field of Brassica plants. Embodiments include compositions including polynucleotides disclosed herein in a composition in the form of a solid, liquid, powder, suspension, emulsion, spray, encapsulation, microbeads, carrier particulates, film, matrix, soil drench, or seed treatment composition. In embodiments, such compositions are applied to a surface of the plant in need of protection from or treatment for flea beetle infestations, or applied directly to the flea beetles, or provided in an ingestible form to the flea beetles. In embodiments, a composition including polynucleotides disclosed herein is applied directly to ungerminated seeds (such as ungerminated Brassica species seeds), providing plants germinated from the treated seeds increased resistance to flea beetle infestations; examples of seed treatment methods are disclosed in U.S. patent application Ser. No. 14/143,836, which is incorporated by reference in its entirety herein. An embodiment includes a Brassica seed that is treated by directly contacting the seed with a polynucleotide (such as a dsRNA trigger) disclosed herein, followed by germination into a Brassica plant that exhibits increased resistance to flea beetle infestations.


Unless defined otherwise, all technical and scientific terms used have the same meaning as commonly understood by one of ordinary skill in the art. The terms “to comprise” or “to include” are understood to mean “to include, but not to be limited to”. Generally, the nomenclature used and the manufacturing or laboratory procedures described below are well known and commonly employed in the art. Conventional methods are used for these procedures, such as those provided in the art and various general references. Where a term is provided in the singular, the inventors also contemplate aspects described by the plural of that term. Where there are discrepancies in terms and definitions used in references that are incorporated by reference, the terms used in this application shall have the definitions given. Other technical terms used have their ordinary meaning in the art in which they are used, as exemplified by various art-specific dictionaries, for example, “The American Heritage® Science Dictionary” (Editors of the American Heritage Dictionaries, 2011, Houghton Mifflin Harcourt, Boston and New York), the “McGraw-Hill Dictionary of Scientific and Technical Terms” (6th edition, 2002, McGraw-Hill, New York), or the “Oxford Dictionary of Biology” (6th edition, 2008, Oxford University Press, Oxford and New York). The inventors do not intend to be limited to a mechanism or mode of action. Reference thereto is provided for illustrative purposes only.


Unless otherwise stated, nucleic acid sequences in the text of this specification are given, when read from left to right, in the 5′ to 3′ direction. One of skill in the art would be aware that a given DNA sequence is understood to define a corresponding RNA sequence which is identical to the DNA sequence except for replacement of the thymine (T) nucleotides of the DNA with uracil (U) nucleotides. Thus, providing a specific DNA sequence is understood to define the exact RNA equivalent. A given first polynucleotide sequence, whether DNA or RNA, further defines the sequence of its exact complement (which can be DNA or RNA), i. e., a second polynucleotide that hybridizes perfectly to the first polynucleotide by forming Watson-Crick base-pairs. By “essentially identical” or “essentially complementary” to a target gene or a fragment of a target gene is meant that a polynucleotide strand (or at least one strand of a double-stranded polynucleotide) is designed to hybridize (generally under physiological conditions such as those found in a living plant or animal cell) to a target gene or to a fragment of a target gene or to the transcript of the target gene or the fragment of a target gene; one of skill in the art would understand that such hybridization does not necessarily require 100% sequence identity or complementarity. A first nucleic acid sequence is “operably” connected or “linked” with a second nucleic acid sequence when the first nucleic acid sequence is placed in a functional relationship with the second nucleic acid sequence. For example, a promoter sequence is “operably linked” to DNA if the promoter provides for transcription or expression of the DNA. Generally, operably linked DNA sequences are contiguous.


The term “polynucleotide” commonly refers to a DNA or RNA molecule containing multiple nucleotides and generally refers both to “oligonucleotides” (a polynucleotide molecule of 18-25 nucleotides in length) and longer polynucleotides of 26 or more nucleotides. Polynucleotides also include molecules containing multiple nucleotides including non-canonical nucleotides or chemically modified nucleotides as commonly practiced in the art; see, e. g., chemical modifications disclosed in the technical manual “RNA Interference (RNAi) and DsiRNAs”, 2011 (Integrated DNA Technologies Coralville, Iowa). Generally, polynucleotide as described herein, whether DNA or RNA or both, and whether single- or double-stranded, include at least one segment of 18 or more contiguous nucleotides (or, in the case of double-stranded polynucleotides, at least 18 contiguous base-pairs) that are essentially identical or complementary to a fragment of equivalent size of the DNA of a target gene or the target gene's RNA transcript. Throughout this disclosure, “at least 18 contiguous” means “from about 18 to about 10,000, including every whole number point in between”. Thus, embodiments include compositions including oligonucleotides having a length of 18-25 nucleotides (18-mers, 19-mers, 20-mers, 21-mers, 22-mers, 23-mers, 24-mers, or 25-mers), or medium-length polynucleotides having a length of 26 or more nucleotides (polynucleotides of 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, about 65, about 70, about 75, about 80, about 85, about 90, about 95, about 100, about 110, about 120, about 130, about 140, about 150, about 160, about 170, about 180, about 190, about 200, about 210, about 220, about 230, about 240, about 250, about 260, about 270, about 280, about 290, or about 300 nucleotides), or long polynucleotides having a length greater than about 300 nucleotides (e. g., polynucleotides of between about 300 to about 400 nucleotides, between about 400 to about 500 nucleotides, between about 500 to about 600 nucleotides, between about 600 to about 700 nucleotides, between about 700 to about 800 nucleotides, between about 800 to about 900 nucleotides, between about 900 to about 1000 nucleotides, between about 300 to about 500 nucleotides, between about 300 to about 600 nucleotides, between about 300 to about 700 nucleotides, between about 300 to about 800 nucleotides, between about 300 to about 900 nucleotides, or about 1000 nucleotides in length, or even greater than about 1000 nucleotides in length, for example up to the entire length of a target gene including coding or non-coding or both coding and non-coding portions of the target gene). Where a polynucleotide is double-stranded, such as the dsRNA triggers described in the working Examples, its length can be similarly described in terms of base pairs. Double-stranded polynucleotides, such as the dsRNA triggers described in the working examples, can further be described in terms of one or more of the single-stranded components.


The polynucleotides described herein can be single-stranded (ss) or double-stranded (ds). “Double-stranded” refers to the base-pairing that occurs between sufficiently complementary, anti-parallel nucleic acid strands to form a double-stranded nucleic acid structure, generally under physiologically relevant conditions. Embodiments include those wherein the polynucleotide is selected from the group consisting of sense single-stranded DNA (ssDNA), sense single-stranded RNA (ssRNA), double-stranded RNA (dsRNA), double-stranded DNA (dsDNA), a double-stranded DNA/RNA hybrid, anti-sense ssDNA, or anti-sense ssRNA; a mixture of polynucleotides of any of these types can be used. In some embodiments, the polynucleotide is double-stranded RNA of a length greater than that which is typical of naturally occurring regulatory small RNAs (such as endogenously produced siRNAs and mature miRNAs). In some embodiments, the polynucleotide is double-stranded RNA of at least about 30 contiguous base-pairs in length. In some embodiments, the polynucleotide is double-stranded RNA with a length of between about 50 to about 500 base-pairs. In some embodiments, the polynucleotide can include components other than standard ribonucleotides, e. g., an embodiment is an RNA that includes terminal deoxyribonucleotides.


Effective polynucleotides of any size can be used, alone or in combination, in the various methods and compositions described herein. In some embodiments, a single polynucleotide trigger is used to make a composition (e. g., a composition for topical application, or a recombinant DNA construct useful for making a transgenic plant). In other embodiments, a mixture or pool of different polynucleotide triggers is used; in such cases the polynucleotide triggers can be for a single target gene or for multiple target genes.


In various embodiments, the polynucleotide described herein includes naturally occurring nucleotides, such as those which occur in DNA and RNA. In certain embodiments, the polynucleotide is a combination of ribonucleotides and deoxyribonucleotides, for example, synthetic polynucleotides consisting mainly of ribonucleotides but with one or more terminal deoxyribonucleotides or one or more terminal dideoxyribonucleotides or synthetic polynucleotides consisting mainly of deoxyribonucleotides but with one or more terminal dideoxyribonucleotides. In certain embodiments, the polynucleotide includes non-canonical nucleotides such as inosine, thiouridine, or pseudouridine. In certain embodiments, the polynucleotide includes chemically modified nucleotides. Examples of chemically modified oligonucleotides or polynucleotides are well known in the art; see, for example, U.S. Patent Publication 2011/0171287, U.S. Patent Publication 2011/0171176, U.S. Patent Publication 2011/0152353, U.S. Patent Publication 2011/0152346, and U.S. Patent Publication 2011/0160082, which are herein incorporated by reference. Illustrative examples include, but are not limited to, the naturally occurring phosphodiester backbone of an oligonucleotide or polynucleotide which can be partially or completely modified with phosphorothioate, phosphorodithioate, or methylphosphonate internucleotide linkage modifications, modified nucleoside bases or modified sugars can be used in oligonucleotide or polynucleotide synthesis, and oligonucleotides or polynucleotides can be labeled with a fluorescent moiety (e. g., fluorescein or rhodamine) or other label (e. g., biotin).


The term “recombinant”, as used to refer to a polynucleotide (such as the recombinant RNA molecules or recombinant DNA constructs described herein), means that the polynucleotide is not a naturally occurring molecule, i. e., that human intervention is required for the polynucleotide to exist. A recombinant polynucleotide is produced using recombinant nucleic acid techniques, or by chemical synthesis, and can include combinations of sequences that do not occur in nature (e. g., combinations of a heterologous promoter and a DNA encoding an RNA to be expressed, or an RNA molecule that includes concatenated segments of a target gene that do not in nature occur adjacent to one another). A recombinant polynucleotide can be biologically produced in a cell (such as a bacterial or plant or animal cell), for example, when that cell is transfected or transformed with a vector encoding the recombinant polynucleotide (e. g., a vector encoding a hairpin form of a dsRNA, produced in a bacterium). A recombinant polynucleotide can include sequences of nucleotides designed in silico using appropriate algorithms.


The polynucleotides or triggers disclosed herein are generally designed to suppress or silence one or more genes (“target genes”). The term “gene” refers to any portion of a nucleic acid that provides for expression of a transcript or encodes a transcript, or that is a hereditable nucleic acid sequence. A “gene” can include, but is not limited to, a promoter region, 5′ untranslated regions, transcript encoding regions that can include intronic regions, 3′ untranslated regions, or combinations of these regions. In embodiments, the target genes can include coding or non-coding sequence or both. In other embodiments, the target gene has a sequence identical to or complementary to a messenger RNA, e. g., in embodiments the target gene is a cDNA.


As used herein, the term “isolated” refers to separating a molecule from other molecules normally associated with it in its native or natural state. The term “isolated” thus may refer to a DNA molecule that has been separated from other DNA molecule(s) which normally are associated with it in its native or natural state. Such a DNA molecule may be present in a recombined state, such as a recombinant DNA molecule. Thus, DNA molecules fused to regulatory or coding sequences with which they are not normally associated, for example as the result of recombinant techniques, are considered isolated, even when integrated as a transgene into the chromosome of a cell or present with other DNA molecules.


By “insecticidally effective” is meant effective in inducing a physiological or behavioural change in an insect (e. g., adult or larval flea beetles) that infests a plant such as, but not limited to, growth stunting, increased mortality, decrease in reproductive capacity or decreased fecundity, decrease in or cessation of feeding behavior or movement, or decrease in or cessation of metamorphosis stage development. In some embodiments, application of an insecticidally effective amount of the polynucleotide, such as a dsRNA molecule, to a plant improves the plant's resistance to infestation by the insect. In some embodiments, application of an insecticidally effective amount of the polynucleotide, such as a dsRNA molecule, to a crop plant improves yield (e. g., increased biomass, increased seed or fruit production, or increased oil, starch, sugar, or protein content) of that crop plant, in comparison to a crop plant not treated with the polynucleotide. While there is no upper limit on the concentrations and dosages of a polynucleotide as described herein that can be useful in the methods and compositions provided herein, lower effective concentrations and dosages will generally be sought for efficiency and economy. Non-limiting embodiments of effective amounts of a polynucleotide include a range from about 10 nanograms per milliliter to about 100 micrograms per milliliter of a polynucleotide in a liquid form sprayed on a plant, or from about 10 milligrams per acre to about 100 grams per acre of polynucleotide applied to a field of plants, or from about 0.001 to about 0.1 microgram per milliliter of polynucleotide in an artificial diet for feeding the insect. Where compositions as described herein are topically applied to a plant, the concentrations can be adjusted in consideration of the volume of spray or treatment applied to plant leaves or other plant part surfaces, such as flower petals, stems, tubers, fruit, anthers, pollen, leaves, roots, or seeds. In one embodiment, a useful treatment for herbaceous plants using 25-mer polynucleotides as described herein is about 1 nanomole (nmol) of polynucleotides per plant, for example, from about 0.05 to 1 nmol polynucleotides per plant. Other embodiments for herbaceous plants include useful ranges of about 0.05 to about 100 nmol, or about 0.1 to about 20 nmol, or about 1 nmol to about 10 nmol of polynucleotides per plant. In certain embodiments, about 40 to about 50 nmol of a single-stranded polynucleotide as described herein are applied. In certain embodiments, about 0.5 nmol to about 2 nmol of a dsRNA as described herein is applied. In certain embodiments, a composition containing about 0.5 to about 2.0 milligrams per milliliter, or about 0.14 milligrams per milliliter of a dsRNA (or a single-stranded 21-mer) as described herein is applied. In certain embodiments, a composition of about 0.5 to about 1.5 milligrams per milliliter of a dsRNA polynucleotide as described herein of about 50 to about 200 or more nucleotides is applied. In certain embodiments, about 1 nmol to about 5 nmol of a dsRNA as described herein is applied to a plant. In certain embodiments, the polynucleotide composition as topically applied to the plant contains at least one polynucleotide as described herein at a concentration of about 0.01 to about 10 milligrams per milliliter, or about 0.05 to about 2 milligrams per milliliter, or about 0.1 to about 2 milligrams per milliliter. Very large plants, trees, or vines can require correspondingly larger amounts of polynucleotides. When using long dsRNA molecules that can be processed into multiple oligonucleotides (e. g., multiple triggers encoded by a single recombinant DNA molecule as disclosed herein, lower concentrations can be used. Non-limiting examples of effective polynucleotide treatment regimes include a treatment of between about 0.1 to about 1 nmol of polynucleotide molecule per plant, or between about 1 nmol to about 10 nmol of polynucleotide molecule per plant, or between about 10 nmol to about 100 nmol of polynucleotide molecule per plant.


Methods of Causing Insect Mortality and of Controlling Insect Infestations


Several embodiments relate to a method of causing mortality or stunting in an insect, including providing in the diet of an insect at least one recombinant RNA including at least one silencing element essentially identical or essentially complementary to a fragment of a target gene sequence of the insect, wherein the target gene sequence is selected from the group consisting of SEQ ID NOs:1-859, and wherein ingestion of the recombinant RNA by the insect results in mortality or stunting in the insect. These methods are useful for controlling insect infestations of a plant, for example for prevention or treatment of a flea beetle infestation of a crop plant, particularly commercially important Brassica species.


In embodiments, the at least one silencing element includes an RNA strand including a sequence of about 95% to about 100% identity or complementarity with a sequence selected from the group consisting of SEQ ID NOs:860-1718 and 1722-1724 or a fragment thereof. In embodiments, the at least one silencing element includes an RNA strand including at least one segment of 18 or more contiguous nucleotides with a sequence of 100% complementarity with a fragment of the target gene of the insect, wherein the target gene has a DNA sequence selected from the group consisting of SEQ ID NOs:1-859. In embodiments, the at least one silencing element includes an RNA strand including at least one segment of 18 or more contiguous nucleotides of an RNA sequence selected from the group consisting of SEQ ID NOs:860-1718 and 1722-1724 or a fragment thereof. In embodiments, the at least one silencing element includes an RNA strand including a sequence selected from the group consisting of SEQ ID NOs:860-1718 and 1722-1724 or a fragment thereof. In embodiments the at least one silencing element includes dsRNA including at least one RNA strand including a sequence of about 95% to about 100% identity or complementarity with a sequence selected from the group consisting of SEQ ID NOs:860-1718 and 1722-1724 or a fragment thereof.


In embodiments, the recombinant RNA is provided in a microbial or plant cell that expresses the recombinant RNA, or in a microbial fermentation product, or is chemically synthesized. In embodiments, the at least one silencing element includes dsRNA. In embodiments, the dsRNA is blunt-ended, or has an overhang at at least one terminus, or includes at least one stem-loop. The dsRNA is provided by convenient techniques commonly used. In embodiments, the dsRNA is chemically synthesized, produced by expression in a microorganism, produced by expression in a plant cell, or produced by microbial fermentation. In embodiments, the dsRNA is made from naturally occurring ribonucleotides; in other embodiments the dsRNA is chemically modified.


In embodiments, the method is useful for causing mortality or stunting in insects that are pests of commercially important crop plants, such as an insect pest of a Brassica species. In embodiments, the insect is a flea beetle. In embodiments, the insect is a species of a genus selected from the group consisting of the genera Alfica, Anthobiodes, Aphthona, Aphthonaltica, Aphthonoides, Apteopeda, Argopistes, Argopus, Arrhenocoela, Batophila, Blepharida, Chaetocnema, Clitea, Crepidodera, Derocrepis, Dibolia, Disonycha, Epitrix, Hermipyxis, Hermaeophaga, Hespera, Hippuriphila, Horaia, Hyphasis, Lipromima, Liprus, Longitarsus, Luperomorpha, Lythraria, Manobia, Mantura, Meishania, Minota, Mniophila, Neicrepidodera, Nonarthra, Novofoudrasia, Ochrosis, Oedionychis, Oglobinia, Omeisphaera, Ophrida, Orestia, Paragopus, Pentamesa, Philopona, Phygasia, Phyllotreta, Podagrica, Podagricomela, Podontia, Pseudodera, Psylliodes, Sangariola, Sinaltica, Sphaeroderma, Systena, Trachyaphthona, Xuthea, and Zipangia. In embodiments, the insect is a species selected from the group consisting of Altica ambiens (alder flea beetle), Altica canadensis (prairie flea beetle), Altica chalybaea (grape flea beetle), Altica prasina (poplar flea beetle), Altica rosae (rose flea beetle), Altica sylvia (blueberry flea beetle), Altica ulmi (elm flea beetle), Chaetocnema pulicaria (corn flea beele), Chaetocnema conofinis (sweet potato flea beetle), Epitrix cucumeris (potato flea beetle), Systena blanda (palestripped fleabeetle), and Systena frontalis (redheaded flea beetle). In embodiments, the insect is a species selected from the group consisting of Phyllotreta armoraciae (horseradish flea beetle), Phyllotreta cruciferae (canola flea beetle), Phyllotreta pusilla (western black flea beetle), Phyllotreta nemorum (striped turnip flea beetle), Phyllotreta atra (turnip flea beetle), Phyllotreta robusta (garden flea beetle), Phyllotreta striolata (striped flea beetle), Phyllotreta undulata, Psylliodes chrysocephala, and Psylliodes punctulata (hop flea beetle).


Embodiments of the method include those in which the recombinant RNA is designed to silence a target gene in a genus- or species-specific manner, for example, wherein (a) the insect is a Phyllotreta species and the target gene has a DNA sequence selected from the group consisting of SEQ ID NOs:1-551; (b) the insect is Phyllotreta atra (turnip flea beetle) and the target gene has a DNA sequence selected from the group consisting of SEQ ID NOs:1-296; (c) the insect is Phyllotreta cruciferae (canola flea beetle) and the target gene has a DNA sequence selected from the group consisting of SEQ ID NOs:297-532; (d) the insect is Phyllotreta striolata (striped flea beetle) and the target gene has a DNA sequence selected from the group consisting of SEQ ID NOs:533-551; (e) the insect is a Psylliodes species and the target gene has a DNA sequence selected from the group consisting of SEQ ID NOs:552-859; or (f) the insect is Psylliodes chrysocephala and the target gene has a DNA sequence selected from the group consisting of SEQ ID NOs:552-859. Embodiments of the method also include those wherein (a) the insect is a Phyllotreta species and the silencing element includes an RNA strand including a sequence selected from the group consisting of SEQ ID NOs:860-1410 or a fragment thereof; (b) the insect is Phyllotreta atra (turnip flea beetle) and the silencing element includes an RNA strand including a sequence selected from the group consisting of SEQ ID NOs:860-1155 or a fragment thereof; (c) the insect is Phyllotreta cruciferae (canola flea beetle) the silencing element includes an RNA strand including a sequence selected from the group consisting of SEQ ID NOs:1156-1391 or a fragment thereof; (d) the insect is Phyllotreta striolata (striped flea beetle) and the silencing element includes an RNA strand including a sequence selected from the group consisting of SEQ ID NOs:1392-1410 or a fragment thereof; (e) the insect is a Psylliodes species and the silencing element includes an RNA strand including a sequence selected from the group consisting of SEQ ID NOs:1411-1718 or a fragment thereof; or (f) the insect is Psylliodes chrysocephala and the silencing element includes an RNA strand including a sequence selected from the group consisting of SEQ ID NOs:1411-1718 or a fragment thereof.


Embodiments of the method include those wherein the at least one recombinant RNA is provided in a composition including the at least one recombinant RNA, wherein the composition is applied to a surface of the insect or to a surface of a seed or plant in need of protection from infestation by the insect. Embodiments of such compositions include those where the composition includes a solid, liquid, powder, suspension, emulsion, spray, encapsulation, microbeads, carrier particulates, film, matrix, soil drench, or seed treatment. In many embodiments, the composition is formulated in a form that is ingested by the insect. In embodiments, the composition further includes one or more components selected from the group consisting of a carrier agent, a surfactant, an organosilicone, a polynucleotide herbicidal molecule, a non-polynucleotide herbicidal molecule, a non-polynucleotide pesticide, a fungicide, a safener, a fertilizer, a micronutrient, an insect attractant, and an insect growth regulator. In embodiments, the composition further includes at least one pesticidal agent selected from the group consisting of a patatin, a plant lectin, a phytoecdy steroid, a Bacillus thuringiensis insecticidal protein, a Xenorhabdus insecticidal protein, a Photorhabdus insecticidal protein, a Bacillus laterosporous insecticidal protein, a Bacillus sphaericus insecticidal protein, a bacterium that produces an insecticidal protein, an entomicidal bacterial species, Lysinibacillus sphaericus (Bacillus sphaericus), Brevibacillus laterosporus (Bacillus laterosporus), Chromobacterium species, Chromobacterium subtsugae, Paenibacillus species, Paenibacillus lentimorbus, and Paenibacillus popilliae.


Several embodiments relate to a method for controlling an insect infestation of a plant including contacting the plant and/or an insect that infests a plant with a double-stranded RNA (dsRNA), wherein the dsRNA includes at least one segment of 18 or more contiguous nucleotides with a sequence of about 95% to about 100% (e. g., about 95%, about 96%, about 97%, about 98%, about 99%, or about 100%) complementarity with a fragment of a target gene of the insect selected from the group consisting of Act5C, arginine kinase, COPI (coatomer subunit) alpha, COPI (coatomer subunit) beta, COPI (coatomer subunit) betaPrime, COPI (coatomer subunit) delta, COPI (coatomer subunit) epsilon, COPI (coatomer subunit) gamma, COPI (coatomer subunit) zeta, RpL07, RpL19, RpL3, RpL40, RpS21, RpS4, Rpn2, Rpn3, Rpt6, Rpn8, Rpn9, Rpn6-PB-like protein, Sar1, sec6, sec23, sec23A, shrb (snf7), Tubulin gamma chain, ProsAlpha2, ProsBeta5, Proteasome alpha 2, Proteasome beta 5, VATPase E, VATPase A, VATPase B, VATPase D, Vps2, Vps4, Vps16A, Vps20, Vps24, Vps27, Vps28, Vha26 (V-ATPase A), Vha68-2 (V-ATPase D/E), 40S ribosomal protein S14, and 60S ribosomal protein L13. In some embodiments, the dsRNA includes at least one segment of 18 or more contiguous nucleotides with a sequence of about 95% to about 100% complementarity with a fragment of a DNA sequence selected from the group consisting of SEQ ID NOs:1-859. In some embodiments, the dsRNA includes at least one segment of 21 contiguous nucleotides with a sequence of 100% complementarity with a fragment of a DNA sequence selected from the group consisting of SEQ ID NOs:1-859. In this context “controlling” includes inducement of a physiological or behavioural change in an insect (adult or larvae or nymphs) such as, but not limited to, growth stunting, increased mortality, decrease in reproductive capacity, decrease in or cessation of feeding behavior or movement, or decrease in or cessation of metamorphosis stage development. In some embodiments, the dsRNA includes a sequence selected from the group consisting of SEQ ID NOs:860-1155 or a fragment thereof, or the complement thereof.


In various embodiments, the insect is a flea beetle, e. g., a species of a genus selected from the group consisting of the genera Altica, Anthobiodes, Aphthona, Aphthonaltica, Aphthonoides, Apteopeda, Argopistes, Argopus, Arrhenocoela, Batophila, Blepharida, Chaetocnema, Clitea, Crepidodera, Derocrepis, Dibolia, Disonycha, Epitrix, Hermipyxis, Hermaeophaga, Hespera, Hippuriphila, Horaia, Hyphasis, Lipromima, Liprus, Longitarsus, Luperomorpha, Lythraria, Manobia, Mantura, Meishania, Minota, Mniophila, Neicrepidodera, Nonarthra, Novofoudrasia, Ochrosis, Oedionychis, Oglobinia, Omeisphaera, Ophrida, Orestia, Paragopus, Pentamesa, Philopona, Phygasia, Phyllotreta, Podagrica, Podagricomela, Podontia, Pseudodera, Psylliodes, Sangariola, Sinaltica, Sphaeroderma, Systena, Trachyaphthona, Xuthea, and Zipangia. In some embodiments, the insect is selected from the group consisting of Altica ambiens (alder flea beetle), Altica canadensis (prairie flea beetle), Altica chalybaea (grape flea beetle), Altica prasina (poplar flea beetle), Altica rosae (rose flea beetle), Altica sylvia (blueberry flea beetle), Altica ulmi (elm flea beetle), Chaetocnema pulicaria (corn flea beele), Chaetocnema conofinis (sweet potato flea beetle), Epitrix cucumeris (potato flea beetle), Systena blanda (palestripped fleabeetle), and Systena frontalis (redheaded flea beetle). In some embodiments, the insect is selected from the group consisting of Phyllotreta armoraciae (horseradish flea beetle), Phyllotreta cruciferae (canola flea beetle), Phyllotreta pusilla (western black flea beetle), Phyllotreta nemorum (striped turnip flea beetle), Phyllotreta atra (turnip flea beetle), Phyllotreta robusta (garden flea beetle), Phyllotreta striolata (striped flea beetle), Phyllotreta undulata, Psylliodes chrysocephala, and Psylliodes punctulata (hop flea beetle).


The plant can be any plant that is subject to infestation by an insect that can be controlled by the polynucleotides disclosed herein. Plants of particular interest include commercially important plants, including row crop plants, vegetables, and fruits, and other plants of agricultural or decorative use. Examples of suitable plants are provided under the heading “Plants”. The method is especially useful for controlling an insect infestation of an ornamental plant or a crop plant. Various embodiments of the method include those wherein the plant is a plant in the family Brassicaceae, including a Brassica species selected from the group consisting of B. napus, B. juncea, B. carinata, B. rapa, B. oleracea, B. rupestris, B. septiceps, B. nigra, B. narinosa, B. perviridus, B. tournefortii, and B. fructiculosa. In other embodiments, the plant is selected from the group consisting of Glycine max, Linum usitatissimum, Zea mays, Carthamus tinctorius, Helianthus annuus, Nicotiana tabacum, Arabidopsis thaliana, Betholettia excelsa, Ricinus communis, Cocus nucifera, Coriandrum sativum, Gossypium spp., Arachis hypogaea, Simmondsia chinensis, Solanum tuberosum, Elaeis guineensis, Olea europaea, Oryza sativa, Cucurbita maxim, Hordeum vulgare, and Triticum aestivum.


Methods include those developed for specific flea beetle pests for a given plant, e. g., wherein the plant is a potato plant and the insect is Epitrix cucumeris (potato flea beetle). In some embodiments, specific target genes are identified as targets for RNAi-mediated control in a given insect species. Various embodiments of the method include those wherein (a) the insect is Phyllotreta atra (turnip flea beetle) and the target gene has a DNA sequence selected from the group consisting of SEQ ID NOs:1-296; (b) the insect is Phyllotreta cruciferae (canola flea beetle) and the target gene has a DNA sequence selected from the group consisting of SEQ ID NOs:297-532; (c) the insect is Phyllotreta striolata (striped flea beetle) and the target gene has a DNA sequence selected from the group consisting of SEQ ID NOs:533-551; or (d) the insect is Psylliodes chrysocephala and the target gene has a DNA sequence selected from the group consisting of SEQ ID NOs:552-859.


In some embodiments, specific dsRNA “triggers” are developed for specific target genes in a given insect species. Embodiments of the method include those wherein (a) the insect is Phyllotreta atra (turnip flea beetle) and the dsRNA includes at least one RNA sequence selected from the group consisting of SEQ ID NOs:860-1155 or a fragment thereof; (b) the insect is Phyllotreta cruciferae (canola flea beetle) and the dsRNA includes at least one RNA sequence selected from the group consisting of SEQ ID NOs:1156-1391 or a fragment thereof; (c) the insect is Phyllotreta striolata (striped flea beetle) and the dsRNA includes at least one RNA sequence selected from the group consisting of SEQ ID NOs:1392-1410 or a fragment thereof; or (d) the insect is Psylliodes chrysocephala and the dsRNA includes at least one RNA sequence selected from the group consisting of SEQ ID NOs:1411-1718 or a fragment thereof.


The method includes contacting an insect, such as a flea beetle, with a double-stranded RNA (dsRNA). Embodiments include contacting via oral delivery to the insect, or non-oral delivery to the insect, or a combination of oral and non-oral delivery to the insect. Embodiments include contacting insects in the adult stage, or in larval stages, or in the egg stage. In some embodiments, contacting results in mortality (death) or stunting (growth stunting or decrease in or cessation of metamorphosis stage development) of the insect, thereby preventing or treating infestation of the plant by the insect. In some embodiments, contacting results in inducement of a physiological or behavioural change in an insect (adult or larvae or nymphs) that results in a decreased ability of the insect to infest or damage a plant, for example, a decrease in reproductive capacity, or a decrease in or cessation of feeding behavior or movement.


In some embodiments of the method, the contacting includes application of a composition including the dsRNA to a surface of the insect or to a surface of the plant infested by the insect. The composition can include or be in the form of a solid, liquid, powder, suspension, emulsion, spray, encapsulation, microbeads, carrier particulates, film, matrix, soil drench, or seed treatment. In some embodiments, the contacting includes providing the dsRNA in a composition that further includes one or more components selected from the group consisting of a carrier agent, a surfactant, an organosilicone, a polynucleotide herbicidal molecule, a non-polynucleotide herbicidal molecule, a non-polynucleotide pesticide, a fungicide, a safener, an insect attractant, and an insect growth regulator. In some embodiments, the contacting includes providing the dsRNA in a composition that further includes at least one pesticidal agent selected from the group consisting of a patatin, a plant lectin, a phytoecdysteroid, a Bacillus thuringiensis insecticidal protein, a Xenorhabdus insecticidal protein, a Photorhabdus insecticidal protein, a Bacillus laterosporous insecticidal protein, a Bacillus sphaericus insecticidal protein, a bacterium that produces an insecticidal protein, an entomicidal bacterial species, Lysinibacillus sphaericus (Bacillus sphaericus), Brevibacillus laterosporus (Bacillus laterosporus), Chromobacterium species, Chromobacterium subtsugae, Paenibacillus species, Paenibacillus lentimorbus, and Paenibacillus popilliae.


In some embodiments of the method, the contacting includes providing the dsRNA in a composition that is ingested by the insect, such as in a liquid, emulsion, or powder applied to a plant on which the insect feeds, or in the form of bait. Such compositions can further includes one or more components selected from the group consisting of a carrier agent, a surfactant, an organosilicone, a polynucleotide herbicidal molecule, a non-polynucleotide herbicidal molecule, a non-polynucleotide pesticide, a fungicide, a safener, an insect attractant, and an insect growth regulator. Such compositions can further include at least one pesticidal agent selected from the group consisting of a patatin, a plant lectin, a phytoecdysteroid, a Bacillus thuringiensis insecticidal protein, a Xenorhabdus insecticidal protein, a Photorhabdus insecticidal protein, a Bacillus laterosporous insecticidal protein, a Bacillus sphaericus insecticidal protein, a bacterium that produces an insecticidal protein, an entomicidal bacterial species, Lysinibacillus sphaericus (Bacillus sphaericus), Brevibacillus laterosporus (Bacillus laterosporus), Chromobacterium species, Chromobacterium subtsugae, Paenibacillus species, Paenibacillus lentimorbus, and Paenibacillus popilliae. In embodiments, the combination of the dsRNA and the pesticidal agent provides a level of insect control that is greater than the sum of the effects of the dsRNA and the pesticidal agent components if tested separately.


Insecticidal Compositions


Several embodiments relate to an insecticidal composition including an insecticidally effective amount of a polynucleotide, such as a dsRNA molecule, wherein the polynucleotide includes at least 18 or more contiguous nucleotides with a sequence of about 95% to about 100% (e. g., about 95%, about 96%, about 97%, about 98%, about 99%, or about 100%) complementarity with a fragment of an insect target gene selected from the group consisting of Act5C, arginine kinase, COPI (coatomer subunit) alpha, COPI (coatomer subunit) beta, COPI (coatomer subunit) betaPrime, COPI (coatomer subunit) delta, COPI (coatomer subunit) epsilon, COPI (coatomer subunit) gamma, COPI (coatomer subunit) zeta, RpL07, RpL19, RpL3, RpL40, RpS21, RpS4, Rpn2, Rpn3, Rpt6, Rpn8, Rpn9, Rpn6-PB-like protein, Sar1, sec6, sec23, sec23A, shrb (snf7), Tubulin gamma chain, ProsAlpha2, ProsBeta5, Proteasome alpha 2, Proteasome beta 5, VATPase E, VATPase A, VATPase B, VATPase D, Vps2, Vps4, Vps16A, Vps20, Vps24, Vps27, Vps28, Vha26 (V-ATPase A), Vha68-2 (V-ATPase D/E), 40S ribosomal protein S14, and 60S ribosomal protein L13. In some embodiments the polynucleotide includes at least 18 or more contiguous nucleotides having about 95% to about 100% complementarity with a fragment of a DNA sequence selected from the group consisting of SEQ ID NOs:1-859. In some embodiments the polynucleotide includes 21 contiguous nucleotides having 100% complementarity with a fragment of a DNA sequence selected from the group consisting of SEQ ID NOs:1-859. In embodiments, the polynucleotide includes a sequence selected from the group consisting of SEQ ID NOs:860-1718 and 1722-1724 or a fragment thereof.


In various embodiments of the insecticidal composition, the insect is a flea beetle, e. g., a species of a genus selected from the group consisting of the genera Altica, Anthobiodes, Aphthona, Aphthonaltica, Aphthonoides, Apteopeda, Argopistes, Argopus, Arrhenocoela, Batophila, Blepharida, Chaetocnema, Clitea, Crepidodera, Derocrepis, Dibolia, Disonycha, Epitrix, Hermipyxis, Hermaeophaga, Hespera, Hippuriphila, Horaia, Hyphasis, Lipromima, Liprus, Longitarsus, Luperomorpha, Lythraria, Manobia, Mantura, Meishania, Minota, Mniophila, Neicrepidodera, Nonarthra, Novofoudrasia, Ochrosis, Oedionychis, Oglobinia, Omeisphaera, Ophrida, Orestia, Paragopus, Pentamesa, Philopona, Phygasia, Phyllotreta, Podagrica, Podagricomela, Podontia, Pseudodera, Psylliodes, Sangariola, Sinaltica, Sphaeroderma, Systena, Trachyaphthona, Xuthea, and Zipangia. In some embodiments, the insect is selected from the group consisting of Altica ambiens (alder flea beetle), Altica canadensis (prairie flea beetle), Altica chalybaea (grape flea beetle), Altica prasina (poplar flea beetle), Altica rosae (rose flea beetle), Altica sylvia (blueberry flea beetle), Altica ulmi (elm flea beetle), Chaetocnema pulicaria (corn flea beele), Chaetocnema conofinis (sweet potato flea beetle), Epitrix cucumeris (potato flea beetle), Systena blanda (palestripped fleabeetle), and Systena frontalis (redheaded flea beetle). In some embodiments, the insect is selected from the group consisting of Phyllotreta armoraciae (horseradish flea beetle), Phyllotreta cruciferae (canola flea beetle), Phyllotreta pusilla (western black flea beetle), Phyllotreta nemorum (striped turnip flea beetle), Phyllotreta atra (turnip flea beetle), Phyllotreta robusta (garden flea beetle), Phyllotreta striolata (striped flea beetle), Phyllotreta undulata, Psylliodes chrysocephala, and Psylliodes punctulata (hop flea beetle).


The insecticidal composition is useful for treating a plant or area in the vicinity of a plant to provide protection or treatment from insects, especially flea beetles. A related aspect is a plant treated with an insecticidal composition as described herein, or a seed of the treated plant, wherein the plant exhibits improved resistance to the insect (e. g., improved resistance to flea beetles). In some embodiments, the plant exhibiting improved resistance to the insect is characterized by improved yield, when compared to a plant not treated with the insecticidal composition. In an embodiment, yield (oilseed biomass or oil content) in canola or oilseed rape plants is improved by application of an insecticidally effective amount of a polynucleotide, such as a dsRNA molecule, targetting one or more genes identified from Phyllotreta cruciferae (canola flea beetle); in particular embodiments, the target gene has a DNA sequence selected from the group consisting of SEQ ID NOs:297-532. The plant can be any plant that is subject to infestation by an insect that can be controlled by the insecticidal composition. Plants of particular interest include commercially important plants, including row crop plants, vegetables, and fruits, and other plants of agricultural or decorative use. Examples of suitable plants are provided under the heading “Plants”. The method is especially useful for controlling an insect infestation of an ornamental plant or a crop plant. Various embodiments include those wherein the plant is a plant in the family Brassicaceae, including a Brassica species selected from the group consisting of B. napus, B. juncea, B. carinata, B. rapa, B. oleracea, B. rupestris, B. septiceps, B. nigra, B. narinosa, B. perviridus, B. tournefortii, and B. fructiculosa. In other embodiments, the plant is selected from the group consisting of Glycine max, Linum usitatissimum, Zea mays, Carthamus tinctorius, Helianthus annuus, Nicotiana tabacum, Arabidopsis thaliana, Betholettia excelsa, Ricinus communis, Cocus nucifera, Coriandrum sativum, Gossypium spp., Arachis hypogaea, Simmondsia chinensis, Solanum tuberosum, Elaeis guineensis, Olea europaea, Oryza sativa, Cucurbita maxim, Hordeum vulgare, and Triticum aestivum.


In some embodiments, the insecticidal composition is developed for specific flea beetle pests for a given plant, e. g., where the plant is a potato plant and the insect is Epitrix cucumeris (potato flea beetle). In some embodiments, the insecticidal composition is developed for specific target genes in a given insect species. Specific embodiments of the insecticidal composition include those wherein (a) the insect is Phyllotreta atra (turnip flea beetle) and the target gene has a DNA sequence selected from the group consisting of SEQ ID NOs:1-296; (b) the insect is Phyllotreta cruciferae (canola flea beetle) and the target gene has a DNA sequence selected from the group consisting of SEQ ID NOs:297-532; (c) the insect is Phyllotreta striolata (striped flea beetle) and the target gene has a DNA sequence selected from the group consisting of SEQ ID NOs:533-551; or (d) the insect is Psylliodes chrysocephala and the target gene has a DNA sequence selected from the group consisting of SEQ ID NOs:552-859.


In some embodiments the dsRNA molecule of use in this method is provided as an isolated dsRNA molecule (not part of an expression construct, e. g., lacking additional elements such as a promoter or terminator sequences). Such dsRNA molecules can be relatively short, such as single- or double-stranded RNA molecules of between about 18 to about 300 or between about 50 to about 500 nucleotides (for single-stranded polynucleotides) or between about 18 to about 300 or between about 50 to about 500 base-pairs (for double-stranded polynucleotides). In embodiments the polynucleotide is a dsRNA including a segment including a sequence selected from the group consisting of SEQ ID NOs:860-1718 and 1722-1724 or a fragment thereof.


In some embodiments, the insecticidal composition is in a form selected from the group consisting of a solid, liquid, powder, suspension, emulsion, spray, encapsulation, microbeads, carrier particulates, film, matrix, soil drench, insect diet or insect bait, and seed treatment. In some embodiments, the insecticidal composition is provided in a form that is ingested by the insect, such as in a liquid, emulsion, or powder applied to a plant on which the insect feeds, or in the form of bait. The insecticidal compositions can further include one or more components selected from the group consisting of a carrier agent, a surfactant, an organosilicone, a polynucleotide herbicidal molecule, a non-polynucleotide herbicidal molecule, a non-polynucleotide pesticide, a fungicide, a safener, an insect attractant, and an insect growth regulator. The insecticidal compositions can further include at least one pesticidal agent selected from the group consisting of a patatin, a plant lectin, a phytoecdysteroid, a Bacillus thuringiensis insecticidal protein, a Xenorhabdus insecticidal protein, a Photorhabdus insecticidal protein, a Bacillus laterosporous insecticidal protein, a Bacillus sphaericus insecticidal protein, a bacterium that produces an insecticidal protein, an entomicidal bacterial species, Lysinibacillus sphaericus (Bacillus sphaericus), Brevibacillus laterosporus (Bacillus laterosporus), Chromobacterium species, Chromobacterium subtsugae, Paenibacillus species, Paenibacillus lentimorbus, and Paenibacillus popilliae. In some embodiments, the combination of the recombinant RNA molecule and the pesticidal agent provides a level of insect control that is greater than the sum of the effects of the recombinant RNA molecule and the pesticidal agent components if tested separately.


Embodiments of the compositions optionally include the appropriate stickers and wetters required for efficient foliar coverage as well as UV protectants to protect polynucleotides such as dsRNAs from UV damage. Such additives are commonly used in the bioinsecticide industry and are known to those skilled in the art. Compositions for soil application can include granular formulations that serve as bait for insect larvae. Embodiments include a carrier agent, a surfactant, an organosilicone, a polynucleotide herbicidal molecule, a non-polynucleotide herbicidal molecule, a non-polynucleotide pesticide, a fungicide, a safener, an insect attractant, and an insect growth regulator.


Embodiments of compositions may include a “transfer agent”, an agent that, when combined with a composition including a polynucleotide as disclosed herein that is topically applied to the surface of an organism, enables the polynucleotide to enter the cells of that organism. Such transfer agents can be incorporated as part of the composition including a polynucleotide as disclosed herein, or can be applied prior to, contemporaneously with, or following application of the composition including a polynucleotide as described herein. In some embodiments, a transfer agent is an agent that improves the uptake of a polynucleotide by an insect. In some embodiments, a transfer agent is an agent that conditions the surface of plant tissue, e. g., seeds, leaves, stems, roots, flowers, or fruits, to permeation by a polynucleotide into plant cells. In some embodiments, the transfer agent enables a pathway for a polynucleotide through cuticle wax barriers, stomata, and/or cell wall or membrane barriers into plant cells.


Suitable transfer agents include agents that increase permeability of the exterior of the organism or that increase permeability of cells of the organism to polynucleotides. Suitable transfer agents include a chemical agent, or a physical agent, or combinations thereof. Chemical agents for conditioning or transfer include (a) surfactants, (b) an organic solvent or an aqueous solution or aqueous mixtures of organic solvents, (c) oxidizing agents, (d) acids, (e) bases, (f) oils, (g) enzymes, or combinations thereof. In some embodiments, application of a polynucleotide and a transfer agent optionally includes an incubation step, a neutralization step (e. g., to neutralize an acid, base, or oxidizing agent, or to inactivate an enzyme), a rinsing step, or combinations thereof. Suitable transfer agents can be in the form of an emulsion, a reverse emulsion, a liposome, or other micellar-like composition, or can cause the polynucleotide composition to take the form of an emulsion, a reverse emulsion, a liposome, or other micellar-like composition. Embodiments of transfer agents include counter-ions or other molecules that are known to associate with nucleic acid molecules, e. g., cationic lipids, inorganic ammonium ions, alkyl ammonium ions, lithium ions, polyamines such as spermine, spermidine, or putrescine, and other cations. Embodiments of transfer agents include organic solvents such as DMSO, DMF, pyridine, N-pyrrolidine, hexamethylphosphoramide, acetonitrile, dioxane, polypropylene glycol, or other solvents miscible with water or that dissolve phosphonucleotides in non-aqueous systems (such as is used in synthetic reactions). Embodiments of transfer agents include naturally derived or synthetic oils with or without surfactants or emulsifiers, e. g., plant-sourced oils, crop oils (such as those listed in the 9th Compendium of Herbicide Adjuvants, publicly available on-line at herbicide.adjuvants.com), paraffinic oils, polyol fatty acid esters, or oils with short-chain molecules modified with amides or polyamines such as polyethyleneimine or N-pyrrolidine.


Embodiments of transfer agents include organosilicone preparations. For example, a suitable transfer agent is an organosilicone preparation that is commercially available as SILWET L-77® brand surfactant having CAS Number 27306-78-1 and EPA Number: CAL.REG.NO. 5905-50073-AA, and currently available from Momentive Performance Materials, Albany, N.Y. In embodiments where a SILWET L-77® brand surfactant organosilicone preparation is used as transfer agent in the form of a spray treatment (applied prior to, contemporaneously with, or following application of the composition including a polynucleotide as disclosed herein) of plant leaves or other plant surfaces, freshly made concentrations in the range of about 0.015 to about 2 percent by weight (wt percent) (e. g., about 0.01, 0.015, 0.02, 0.025, 0.03, 0.035, 0.04, 0.045, 0.05, 0.055, 0.06, 0.065, 0.07, 0.075, 0.08, 0.085, 0.09, 0.095, 0.1, 0.2, 0.3, 0.4, 0.5, 0.6, 0.7, 0.8, 0.9, 1.0, 1.1, 1.2, 1.3, 1.4, 1.5, 1.6, 1.7, 1.8, 1.9, 2.0, 2.1, 2.2, 2.3, 2.5 wt percent) are efficacious in preparing a leaf or other plant surface for transfer of a polynucleotide as disclosed herein into plant cells from a topical application on the surface. One embodiment includes a composition that includes a polynucleotide and a transfer agent including an organosilicone preparation such as Silwet L-77 in the range of about 0.015 to about 2 percent by weight (wt percent) (e. g., about 0.01, 0.015, 0.02, 0.025, 0.03, 0.035, 0.04, 0.045, 0.05, 0.055, 0.06, 0.065, 0.07, 0.075, 0.08, 0.085, 0.09, 0.095, 0.1, 0.2, 0.3, 0.4, 0.5, 0.6, 0.7, 0.8, 0.9, 1.0, 1.1, 1.2, 1.3, 1.4, 1.5, 1.6, 1.7, 1.8, 1.9, 2.0, 2.1, 2.2, 2.3, 2.5 wt percent). One embodiment includes a composition that includes a polynucleotide and a transfer agent including SILWET L-77® brand surfactant in the range of about 0.3 to about 1 percent by weight (wt percent) or about 0.5 to about 1%, by weight (wt percent).


Organosilicone compounds useful as transfer agents for use in compositions and methods disclosed herein include, but are not limited to, compounds that include: (a) a trisiloxane head group that is covalently linked to, (b) an alkyl linker including, but not limited to, an n-propyl linker, that is covalently linked to, (c) a polyglycol chain, that is covalently linked to, (d) a terminal group. Trisiloxane head groups of such organosilicone compounds include, but are not limited to, heptamethyltrisiloxane. Alkyl linkers can include, but are not limited to, an n-propyl linker. Polyglycol chains include, but are not limited to, polyethylene glycol or polypropylene glycol. Polyglycol chains can include a mixture that provides an average chain length “n” of about “7.5”. In certain embodiments, the average chain length “n” can vary from about 5 to about 14. Terminal groups can include, but are not limited to, alkyl groups such as a methyl group. Organosilicone compounds useful as transfer agents for use in compositions and methods disclosed herein include, but are not limited to, trisiloxane ethoxylate surfactants or polyalkylene oxide modified heptamethyl trisiloxane. An example of a transfer agent for use in compositions and methods disclosed herein is Compound I:




embedded image


Organosilicone compounds useful as transfer agents for use in compositions and methods disclosed herein are used, e. g., as freshly made concentrations in the range of about 0.015 to about 2 percent by weight (wt percent) (e. g., about 0.01, 0.015, 0.02, 0.025, 0.03, 0.035, 0.04, 0.045, 0.05, 0.055, 0.06, 0.065, 0.07, 0.075, 0.08, 0.085, 0.09, 0.095, 0.1, 0.2, 0.3, 0.4, 0.5, 0.6, 0.7, 0.8, 0.9, 1.0, 1.1, 1.2, 1.3, 1.4, 1.5, 1.6, 1.7, 1.8, 1.9, 2.0, 2.1, 2.2, 2.3, 2.5 wt percent).


Embodiments of transfer agents include one or more salts such as ammonium chloride, tetrabutylphosphonium bromide, and ammonium sulfate, provided in or used with a composition including a polynucleotide disclosed herein. In some embodiments, ammonium chloride, tetrabutylphosphonium bromide, and/or ammonium sulfate are used at a concentration of about 0.5% to about 5% (w/v), or about 1% to about 3% (w/v), or about 2% (w/v). In certain embodiments, the composition including a polynucleotide includes an ammonium salt at a concentration greater or equal to 300 millimolar. In certain embodiments, the composition including a polynucleotide includes an organosilicone transfer agent in a concentration of about 0.015 to about 2 percent by weight (wt percent) as well as ammonium sulfate at concentrations from about 80 to about 1200 millimolar or about 150 millimolar to about 600 millimolar.


Embodiments of transfer agents include a phosphate salt. Phosphate salts useful in a composition including a polynucleotide include, but are not limited to, calcium, magnesium, potassium, or sodium phosphate salts. In certain embodiments, the composition including a polynucleotide includes a phosphate salt at a concentration of at least about 5 millimolar, at least about 10 millimolar, or at least about 20 millimolar. In certain embodiments, the composition including a polynucleotide includes a phosphate salt in a range of about 1 millimolar to about 25 millimolar or in a range of about 5 millimolar to about 25 millimolar. In certain embodiments, the composition including a polynucleotide includes sodium phosphate at a concentration of at least about 5 millimolar, at least about 10 millimolar, or at least about 20 millimolar. In certain embodiments, the composition including a polynucleotide includes sodium phosphate at a concentration of about 5 millimolar, about 10 millimolar, or about 20 millimolar. In certain embodiments, the composition including a polynucleotide includes a sodium phosphate salt in a range of about 1 millimolar to about 25 millimolar or in a range of about 5 millimolar to about 25 millimolar. In certain embodiments, the composition including a polynucleotide includes a sodium phosphate salt in a range of about 10 millimolar to about 160 millimolar or in a range of about 20 millimolar to about 40 millimolar. In certain embodiments, the composition including a polynucleotide includes a sodium phosphate buffer at a pH of about 6.8.


Embodiments of transfer agents include surfactants and/or effective molecules contained therein. Surfactants and/or effective molecules contained therein include, but are not limited to, sodium or lithium salts of fatty acids (such as tallow or tallowamines or phospholipids) and organosilicone surfactants. In certain embodiments, the composition including a polynucleotide is formulated with counter-ions or other molecules that are known to associate with nucleic acid molecules. Non-limiting examples include, tetraalkyl ammonium ions, trialkyl ammonium ions, sulfonium ions, lithium ions, and polyamines such as spermine, spermidine, or putrescine. In certain embodiments, the composition including a polynucleotide is formulated with a non-polynucleotide herbicide e. g., glyphosate, auxin-like benzoic acid herbicides including dicamba, chloramben, and TBA, glufosinate, auxin-like herbicides including phenoxy carboxylic acid herbicide, pyridine carboxylic acid herbicide, quinoline carboxylic acid herbicide, pyrimidine carboxylic acid herbicide, and benazolin-ethyl herbicide, sulfonylureas, imidazolinones, bromoxynil, delapon, cyclohezanedione, protoporphyrinogen oxidase inhibitors, and 4-hydroxyphenyl-pyruvate-dioxygenase inhibiting herbicides. In certain embodiments, the composition including a polynucleotide is formulated with a non-polynucleotide pesticide, e. g., a patatin, a plant lectin, a phytoecdysteroid, a Bacillus thuringiensis insecticidal protein, a Xenorhabdus insecticidal protein, a Photorhabdus insecticidal protein, a Bacillus laterosporous insecticidal protein, and a Bacillus sphaericus insecticidal protein.


Methods of Providing Plants with Improved Insect Resistance


Several embodiments relate to a method of providing a plant having improved resistance to an insect, including expressing in the plant a recombinant DNA construct, wherein the recombinant DNA construct includes DNA encoding an RNA having a sequence essentially identical or essentially complementary to a fragment of at least one insect target gene selected from the group consisting of Act5C, arginine kinase, COPI (coatomer subunit) alpha, COPI (coatomer subunit) beta, COPI (coatomer subunit) betaPrime, COPI (coatomer subunit) delta, COPI (coatomer subunit) epsilon, COPI (coatomer subunit) gamma, COPI (coatomer subunit) zeta, RpL07, RpL19, RpL3, RpL40, RpS21, RpS4, Rpn2, Rpn3, Rpt6, Rpn8, Rpn9, Rpn6-PB-like protein, Sar1, sec6, sec23, sec23A, shrb (snf7), Tubulin gamma chain, ProsAlpha2, ProsBeta5, Proteasome alpha 2, Proteasome beta 5, VATPase E, VATPase A, VATPase B, VATPase D, Vps2, Vps4, Vps16A, Vps20, Vps24, Vps27, Vps28, Vha26 (V-ATPase A), Vha68-2 (V-ATPase D/E), 40S ribosomal protein S14, and 60S ribosomal protein L13. In some embodiments, the DNA construct includes DNA encoding an RNA including a sequence essentially identical or essentially complementary to a fragment of a DNA sequence selected from the group consisting of SEQ ID NOs:1-859. Several embodiments relate to a plant produced by such method. In some embodiments, the DNA construct includes DNA encoding an RNA having about 95% to about 100% (e. g., about 95%, about 96%, about 97%, about 98%, about 99%, or about 100%) identity or complementarity with a sequence selected from the group consisting of SEQ ID NOs:860-1718 and 1722-1724 or a fragment thereof.


In some embodiments, the recombinant DNA construct further includes a heterologous promoter operably linked to the DNA encoding an RNA, wherein the heterologous promoter is functional in a plant cell. “Heterologous” refers to nucleic acid sequences that are not usually operably linked in a native or naturally occurring genome; by “heterologous promoter” is meant that the promoter is not natively operably linked with the DNA encoding an RNA. Promoters functional in a plant cell include those listed under the heading “Promoters”.


In some embodiments, the recombinant DNA construct is expressed in the plant by means of transgenic expression or transient expression. In some embodiments, the method further includes expression in the plant of at least one pesticidal agent selected from the group consisting of a patatin, a plant lectin, a phytoecdysteroid, a Bacillus thuringiensis insecticidal protein, a Xenorhabdus insecticidal protein, a Photorhabdus insecticidal protein, a Bacillus laterosporous insecticidal protein, a Bacillus sphaericus insecticidal protein, a bacterium that produces an insecticidal protein, an entomicidal bacterial species, Lysinibacillus sphaericus (Bacillus sphaericus), Brevibacillus laterosporus (Bacillus laterosporus), Chromobacterium species, Chromobacterium subtsugae, Paenibacillus species, Paenibacillus lentimorbus, and Paenibacillus popilliae. The pesticidal agent can be expressed from the same recombinant DNA construct that includes the DNA encoding an RNA, or from a different recombinant DNA construct.


A related aspect is a plant having improved resistance to an insect (e. g., improved resistance to flea beetles), or the seed of such a plant, wherein the plant is provided by the method including expressing in the plant a recombinant DNA construct, wherein the recombinant DNA construct includes DNA encoding an RNA having a sequence essentially identical or essentially complementary to a fragment of at least one target gene of the insect, wherein the target gene is selected from the group consisting of Act5C, arginine kinase, COPI (coatomer subunit) alpha, COPI (coatomer subunit) beta, COPI (coatomer subunit) betaPrime, COPI (coatomer subunit) delta, COPI (coatomer subunit) epsilon, COPI (coatomer subunit) gamma, COPI (coatomer subunit) zeta, RpL07, RpL19, RpL3, RpL40, RpS21, RpS4, Rpn2, Rpn3, Rpt6, Rpn8, Rpn9, Rpn6-PB-like protein, Sar1, sec6, sec23, sec23A, shrb (snf7), Tubulin gamma chain, ProsAlpha2, ProsBeta5, Proteasome alpha 2, Proteasome beta 5, VATPase E, VATPase A, VATPase B, VATPase D, Vps2, Vps4, Vps16A, Vps20, Vps24, Vps27, Vps28, Vha26 (V-ATPase A), Vha68-2 (V-ATPase D/E), 40S ribosomal protein S14, and 60S ribosomal protein L13. In some embodiments, the recombinant DNA construct includes DNA encoding an RNA including a sequence essentially identical or essentially complementary to a fragment of a DNA sequence selected from the group consisting of SEQ ID NOs:1-859. In some embodiments, the plant exhibiting improved resistance to the insect is characterized by improved yield, when compared to a plant not expressing the recombinant DNA construct. In an embodiment, yield (oilseed biomass or oil content) in canola or oilseed rape plants is improved by expressing in the canola or oilseed rape plants a polynucleotide, such as a dsRNA molecule, targetting one or more genes of Phyllotreta cruciferae (canola flea beetle), e. g., wherein the target gene has a DNA sequence selected from the group consisting of SEQ ID NOs:297-532. Several embodiments relate to fruit, seed, or propagatable parts of the plant provided by this method and exhibiting improved resistance to the insect. The plant can be any plant that is subject to infestation by an insect that can be controlled by expressing in the plant the recombinant DNA construct according to this method. Plants of particular interest include commercially important plants, including row crop plants, vegetables, and fruits, and other plants of agricultural or decorative use. Examples of suitable plants are provided under the heading “Plants”. The method is especially useful for providing an ornamental plant or a crop plant with improved resistance to flea beetles. Various embodiments of the method include those wherein the plant is a plant in the family Brassicaceae, including a Brassica species selected from the group consisting of B. napus, B. juncea, B. carinata, B. rapa, B. oleracea, B. rupestris, B. septiceps, B. nigra, B. narinosa, B. perviridus, B. tournefortii, and B. fructiculosa. In other embodiments, the plant is selected from the group consisting of Glycine max, Linum usitatissimum, Zea mays, Carthamus tinctorius, Helianthus annuus, Nicotiana tabacum, Arabidopsis thaliana, Betholettia excelsa, Ricinus communis, Cocus nucifera, Coriandrum sativum, Gossypium spp., Arachis hypogaea, Simmondsia chinensis, Solanum tuberosum, Elaeis guineensis, Olea europaea, Oryza sativa, Cucurbita maxim, Hordeum vulgare, and Triticum aestivum. In an embodiment, the method provides a potato plant with improved resistance to Epitrix cucumeris (potato flea beetle).


Embodiments of the method provide a plant having improved resistance to one or more flea beetle species, e. g., a species of a genus selected from the group consisting of the genera Altica, Anthobiodes, Aphthona, Aphthonaltica, Aphthonoides, Apteopeda, Argopistes, Argopus, Arrhenocoela, Batophila, Blepharida, Chaetocnema, Clitea, Crepidodera, Derocrepis, Dibolia, Disonycha, Epitrix, Hermipyxis, Hermaeophaga, Hespera, Hippuriphila, Horaia, Hyphasis, Lipromima, Liprus, Longitarsus, Luperomorpha, Lythraria, Manobia, Mantura, Meishania, Minota, Mniophila, Neicrepidodera, Nonarthra, Novofoudrasia, Ochrosis, Oedionychis, Oglobinia, Omeisphaera, Ophrida, Orestia, Paragopus, Pentamesa, Philopona, Phygasia, Phyllotreta, Podagrica, Podagricomela, Podontia, Pseudodera, Psylliodes, Sangariola, Sinaltica, Sphaeroderma, Systena, Trachyaphthona, Xuthea, and Zipangia. In embodiments, the insect is selected from the group consisting of Altica ambiens (alder flea beetle), Altica canadensis (prairie flea beetle), Altica chalybaea (grape flea beetle), Altica prasina (poplar flea beetle), Altica rosae (rose flea beetle), Altica sylvia (blueberry flea beetle), Altica ulmi (elm flea beetle), Chaetocnema pulicaria (corn flea beele), Chaetocnema conofinis (sweet potato flea beetle), Epitrix cucumeris (potato flea beetle), Systena blanda (palestripped fleabeetle), and Systena frontalis (redheaded flea beetle). In embodiments, the method provides a plant having improved resistance to an insect selected from the group consisting of Phyllotreta armoraciae (horseradish flea beetle), Phyllotreta cruciferae (canola flea beetle), Phyllotreta pusilla (western black flea beetle), Phyllotreta nemorum (striped turnip flea beetle), Phyllotreta atra (turnip flea beetle), Phyllotreta robusta (garden flea beetle), Phyllotreta striolata (striped flea beetle), Phyllotreta undulata, Psylliodes chrysocephala, and Psylliodes punctulata (hop flea beetle).


In some embodiments, the method is developed for specific target genes in a given insect species. In some embodiments, a plant having improved resistance to Phyllotreta atra (turnip flea beetle), wherein the target gene has a DNA sequence selected from the group consisting of SEQ ID NOs:1-296, is provided. In some embodiments, a plant having improved resistance to Phyllotreta cruciferae (canola flea beetle), wherein the target gene has a DNA sequence selected from the group consisting of SEQ ID NOs:297-532, is provided. In some embodiments, a plant having improved resistance to Phyllotreta striolata (striped flea beetle), wherein the target gene has a DNA sequence selected from the group consisting of SEQ ID NOs:533-551, is provided. In some embodiments, a plant having improved resistance to Psylliodes chrysocephala, wherein the target gene has a DNA sequence selected from the group consisting of SEQ ID NOs:552-859, is provided. In some embodiments, a plant having improved resistance to Phyllotreta atra (turnip flea beetle) that expresses from a recombinant DNA construct a dsRNA strand including a sequence of about 95% to about 100% identity with a sequence selected from the group consisting of SEQ ID NOs:860-1155 or a fragment thereof is provided. In some embodiments, a plant having improved resistance to Phyllotreta cruciferae (canola flea beetle) that expresses from a recombinant DNA construct a dsRNA including a strand including a sequence of about 95% to about 100% identity with a sequence selected from the group consisting of SEQ ID NOs:1156-1391 or a fragment thereof is provided. In some embodiments, a plant having improved resistance to Phyllotreta striolata (striped flea beetle) that expresses from a recombinant DNA construct a dsRNA including a strand including a sequence of about 95% to about 100% identity with a sequence selected from the group consisting of SEQ ID NOs:1392-1410 or a fragment thereof is provided. In some embodiments, a plant having improved resistance to Psylliodes chrysocephala that expresses from a recombinant DNA construct a dsRNA including a strand including a sequence of about 95% to about 100% identity with a sequence selected from the group consisting of SEQ ID NOs:1411-1718 or a fragment thereof is provided.


Recombinant DNA Constructs Encoding RNA for Insect Control


Several embodiments relate to a recombinant DNA construct including a heterologous promoter operably linked to DNA encoding an RNA transcript including a sequence of about 95% to about 100% (e. g., about 95%, about 96%, about 97%, about 98%, about 99%, or about 100%) identity or complementarity with a sequence selected from the group consisting of SEQ ID NOs:860-1718 and 1722-1724 or a fragment thereof.


In some embodiments of the recombinant DNA construct, the RNA transcript includes at least one RNA strand including a sequence of about 95% to about 100% (e. g., about 95%, about 96%, about 97%, about 98%, about 99%, or about 100%) identity or complementarity with a sequence selected from the group consisting of SEQ ID NOs:860-1718 and 1722-1724 or a fragment thereof. In some embodiments, the RNA transcript forms dsRNA. In some embodiments, the RNA transcript is a dsRNA including an RNA strand including at least one segment of 18 or more contiguous nucleotides of an RNA sequence selected from the group consisting of SEQ ID NOs:860-1718 and 1722-1724 or a fragment thereof. In some embodiments, the RNA transcript is a dsRNA including an RNA strand including at least one segment of 21 contiguous nucleotides of an RNA sequence selected from the group consisting of SEQ ID NOs:860-1718 and 1722-1724 or a fragment thereof. In some embodiments, the RNA transcript is a dsRNA including at least one RNA strand including a sequence of about 95% to about 100% identity or complementarity with a sequence selected from the group consisting of SEQ ID NOs:860-1718 and 1722-1724 or a fragment thereof. In some embodiments, the RNA transcript is a dsRNA including an RNA strand including a sequence selected from the group consisting of SEQ ID NOs:860-1718 and 1722-1724 or a fragment thereof.


In some embodiments of the recombinant DNA construct, the heterologous promoter is functional for expression of the RNA transcript in a bacterium. In some embodiments where the recombinant DNA construct is to be expressed in a bacterium, the bacterium is selected from the group consisting of Escherichia coli, Bacillus species, Pseudomonas species, Xenorhabdus species, or Photorhabdus species. In other embodiments, the recombinant DNA construct includes a heterologous promoter that is functional in a plant cell.


In some embodiments, the recombinant DNA construct is contained in a recombinant vector, such as a recombinant plant virus vector or a recombinant baculovirus vector. In embodiments, the recombinant DNA construct is integrated into a plant chromosome or plastid, e. g., by stable transformation.


Related aspects include a transgenic plant cell including in its genome the recombinant DNA construct, and a transgenic plant including such a transgenic plant cell. Transgenic plant cells and plants are made by methods known in the art, such as those described under the heading “Making and Using Transgenic Plant Cells and Transgenic Plants”. Further aspects include a commodity product produced from such a transgenic plant, and transgenic progeny seed or propagatable plant part of the transgenic plant.


Related Information and Techniques


Plants


The methods and compositions described herein for treating and protecting plants from insect infestations are useful across a broad range of plants. Suitable plants in which the methods and compositions disclosed herein can be used include, but are not limited to, cereals and forage grasses (rice, maize, wheat, barley, oat, sorghum, pearl millet, finger millet, cool-season forage grasses, and bahiagrass), oilseed crops (soybean, oilseed brassicas including canola and oilseed rape, sunflower, peanut, flax, sesame, and safflower), legume grains and forages (common bean, cowpea, pea, fava bean, lentil, tepary bean, Asiatic beans, pigeonpea, vetch, chickpea, lupine, alfalfa, and clovers), temperate fruits and nuts (apple, pear, peach, plums, berry crops, cherries, grapes, olive, almond, and Persian walnut), tropical and subtropical fruits and nuts (citrus including limes, oranges, and grapefruit; banana and plantain, pineapple, papaya, mango, avocado, kiwifruit, passionfruit, and persimmon), vegetable crops (solanaceous plants including tomato, eggplant, and peppers; vegetable brassicas; radish, carrot, cucurbits, alliums, asparagus, and leafy vegetables), sugar, tuber, and fiber crops (sugarcane, sugar beet, stevia, potato, sweet potato, cassava, and cotton), plantation crops, ornamentals, and turf grasses (tobacco, coffee, cocoa, tea, rubber tree, medicinal plants, ornamentals, and turf grasses), and forest tree species. Specific plant species of interest are plants in the family Brassicaceae, including the Brassica species B. napus, B. juncea, B. carinata, B. rapa, B. oleracea, B. rupestris, B. septiceps, B. nigra, B. narinosa, B. perviridus, B. tournefortii, and B. fructiculosa. Additional plant species of interest are Glycine max, Linum usitatissimum, Zea mays, Carthamus tinctorius, Helianthus annuus, Nicotiana tabacum, Arabidopsis thaliana, Betholettia excelsa, Ricinus communis, Cocos nucifera, Coriandrum sativum, Gossypium spp., Arachis hypogaea, Simmondsia chinensis, Solanum tuberosum, Elaeis guineensis, Olea europaea, Oryza sativa, Cucurbita maxim, Hordeum vulgare, and Triticum aestivum.


Additional Construct Elements


Embodiments of the polynucleotides and nucleic acid molecules disclosed herein can include additional elements, such as promoters, small RNA recognition sites, aptamers or ribozymes, additional and additional expression cassettes for expressing coding sequences (e. g., to express a transgene such as an insecticidal protein or selectable marker) or non-coding sequences (e. g., to express additional suppression elements). For example, an aspect provides a recombinant DNA construct including a heterologous promoter operably linked to DNA encoding an RNA transcript including a sequence of about 95% to about 100% identity or complementarity with a sequence selected from the group consisting of SEQ ID NOs:860-1718 and 1722-1724 or a fragment thereof. In another embodiment, a recombinant DNA construct including a promoter operably linked to DNA encoding: (a) an RNA transcript including a sequence of about 95% to about 100% identity or complementarity with a sequence selected from the group consisting of SEQ ID NOs:860-1718 and 1722-1724 or a fragment thereof, and (b) an aptamer, is stably integrated into the plant's genome from where RNA transcripts including the RNA aptamer and the RNA silencing element are expressed in cells of the plant; the aptamer serves to guide the RNA silencing element to a desired location in the cell. In another embodiment, inclusion of one or more recognition sites for binding and cleavage by a small RNA (e. g., by a miRNA or an siRNA that is expressed only in a particular cell or tissue) allows for more precise expression patterns in a plant, wherein the expression of the recombinant DNA construct is suppressed where the small RNA is expressed. Such additional elements are described below.


Promoters


Promoters of use in the compositions and methods disclosed herein are functional in the cell in which the construct is intended to be transcribed. Generally these promoters are heterologous promoters, as used in recombinant constructs, i. e., they are not in nature found to be operably linked to the other nucleic elements used in the constructs. In various embodiments, the promoter is selected from the group consisting of a constitutive promoter, a spatially specific promoter, a temporally specific promoter, a developmentally specific promoter, and an inducible promoter. In many embodiments the promoter is a promoter functional in a plant, for example, a pol II promoter, a pol III promoter, a pol IV promoter, or a pol V promoter.


Non-constitutive promoters suitable for use with the recombinant DNA constructs disclosed herein include spatially specific promoters, temporally specific promoters, and inducible promoters. Spatially specific promoters can include organelle-, cell-, tissue-, or organ-specific promoters (e. g., a plastid-specific, a root-specific, a pollen-specific, or a seed-specific promoter for expression in plastids, roots, pollen, or seeds, respectively). In many cases a seed-specific, embryo-specific, aleurone-specific, or endosperm-specific promoter is especially useful. Temporally specific promoters can include promoters that tend to promote expression during certain developmental stages in a plant's growth cycle, or during different times of day or night, or at different seasons in a year. Inducible promoters include promoters induced by chemicals or by environmental conditions such as, but not limited to, biotic or abiotic stress (e. g., water deficit or drought, heat, cold, high or low nutrient or salt levels, high or low light levels, or pest or pathogen infection). MicroRNA promoters are useful, especially those having a temporally specific, spatially specific, or inducible expression pattern; examples of miRNA promoters, as well as methods for identifying miRNA promoters having specific expression patterns, are provided in U. S. Patent Application Publications 2006/0200878, 2007/0199095, and 2007/0300329, which are specifically incorporated herein by reference. An expression-specific promoter can also include promoters that are generally constitutively expressed but at differing degrees or “strengths” of expression, including promoters commonly regarded as “strong promoters” or as “weak promoters”.


Promoters of particular interest include the following examples: an opaline synthase promoter isolated from T-DNA of Agrobacterium; a cauliflower mosaic virus 35S promoter; enhanced promoter elements or chimeric promoter elements such as an enhanced cauliflower mosaic virus (CaMV) 35S promoter linked to an enhancer element (an intron from heat shock protein 70 of Zea mays); root specific promoters such as those disclosed in U.S. Pat. Nos. 5,837,848; 6,437,217 and 6,426,446; a maize L3 oleosin promoter disclosed in U.S. Pat. No. 6,433,252; a promoter for a plant nuclear gene encoding a plastid-localized aldolase disclosed in U. S. Patent Application Publication 2004/0216189; cold-inducible promoters disclosed in U.S. Pat. No. 6,084,089; salt-inducible promoters disclosed in U.S. Pat. No. 6,140,078; light-inducible promoters disclosed in U.S. Pat. No. 6,294,714; pathogen-inducible promoters disclosed in U.S. Pat. No. 6,252,138; and water deficit-inducible promoters disclosed in U.S. Patent Application Publication 2004/0123347 A1. All of the above-described patents and patent publications disclosing promoters and their use, especially in recombinant DNA constructs functional in plants are incorporated herein by reference.


Plant vascular- or phloem-specific promoters of interest include a rolC or rolA promoter of Agrobacterium rhizogenes, a promoter of a Agrobacterium tumefaciens T-DNA gene 5, the rice sucrose synthase RSs 1 gene promoter, a Commelina yellow mottle badnavirus promoter, a coconut foliar decay virus promoter, a rice tungro bacilliform virus promoter, the promoter of a pea glutamine synthase GS3A gene, a invCD 111 and invCD 141 promoters of a potato invertase genes, a promoter isolated from Arabidopsis shown to have phloem-specific expression in tobacco by Kertbundit et al. (1991) Proc. Natl. Acad Sci. USA., 88:5212-5216, a VAHOX1 promoter region, a pea cell wall invertase gene promoter, an acid invertase gene promoter from carrot, a promoter of a sulfate transporter gene Sultr1;3, a promoter of a plant sucrose synthase gene, and a promoter of a plant sucrose transporter gene.


Promoters suitable for use with a recombinant DNA construct or polynucleotide disclosed herein include polymerase II (“pol II”) promoters and polymerase III (“pol III”) promoters. RNA polymerase II transcribes structural or catalytic RNAs that are usually shorter than 400 nucleotides in length, and recognizes a simple run of T residues as a termination signal; it has been used to transcribe siRNA duplexes (see, e. g., Lu et al. (2004) Nucleic Acids Res., 32:e171). Pol II promoters are therefore preferred in certain embodiments where a short RNA transcript is to be produced from a recombinant DNA construct. In one embodiment, the recombinant DNA construct includes a pol II promoter to express an RNA transcript flanked by self-cleaving ribozyme sequences (e. g., self-cleaving hammerhead ribozymes), resulting in a processed RNA, such as a single-stranded RNA that binds to the transcript of the flea beetle target gene, with defined 5′ and 3′ ends, free of potentially interfering flanking sequences. An alternative approach uses pol III promoters to generate transcripts with relatively defined 5′ and 3′ ends, i. e., to transcribe an RNA with minimal 5′ and 3′ flanking sequences. In some embodiments, Pol III promoters (e. g., U6 or H1 promoters) are preferred for adding a short AT-rich transcription termination site that results in 2 base-pair overhangs (UU) in the transcribed RNA; this is useful, e. g., for expression of siRNA-type constructs. Use of pol III promoters for driving expression of siRNA constructs has been reported; see van de Wetering et al. (2003) EMBO Rep., 4: 609-615, and Tuschl (2002) Nature Biotechnol., 20: 446-448. Baculovirus promoters such as baculovirus polyhedrin and p10 promoters are known in the art and commercially available; see, e. g., Invitrogen's “Guide to Baculovirus Expression Vector Systems (BEVS) and Insect Cell Culture Techniques”, 2002 (Life Technologies, Carlsbad, Calif.) and F. J. Haines et al. “Baculovirus Expression Vectors”, undated (Oxford Expression Technologies, Oxford, UK).


The promoter element can include nucleic acid sequences that are not naturally occurring promoters or promoter elements or homologues thereof but that can regulate expression of a gene. Examples of such “gene independent” regulatory sequences include naturally occurring or artificially designed RNA sequences that include a ligand-binding region or aptamer (see “Aptamers”, below) and a regulatory region (which can be cis-acting). See, for example, Isaacs et al. (2004) Nat. Biotechnol., 22:841-847, Bayer and Smolke (2005) Nature Biotechnol., 23:337-343, Mandal and Breaker (2004) Nature Rev. Mol. Cell Biol., 5:451-463, Davidson and Ellington (2005) Trends Biotechnol., 23:109-112, Winkler et al. (2002) Nature, 419:952-956, Sudarsan et al. (2003) RNA, 9:644-647, and Mandal and Breaker (2004) Nature Struct. Mol. Biol., 11:29-35. Such “riboregulators” could be selected or designed for specific spatial or temporal specificity, for example, to regulate translation of DNA that encodes a silencing element for suppressing a target gene only in the presence (or absence) of a given concentration of the appropriate ligand. One example is a riboregulator that is responsive to an endogenous ligand (e. g., jasmonic acid or salicylic acid) produced by the plant when under stress (e. g., abiotic stress such as water, temperature, or nutrient stress, or biotic stress such as attach by pests or pathogens); under stress, the level of endogenous ligand increases to a level sufficient for the riboregulator to begin transcription of the DNA that encodes a silencing element for suppressing a target gene.


Recombinase Sites


In some embodiments, the recombinant DNA construct or polynucleotide includes DNA encoding one or more site-specific recombinase recognition sites. In one embodiment, the recombinant DNA construct includes at least a pair of loxP sites, wherein site-specific recombination of DNA between the loxP sites is mediated by a Cre recombinase. The position and relative orientation of the loxP sites is selected to achieve the desired recombination; for example, when the loxP sites are in the same orientation, the DNA between the loxP sites is excised in circular form. In another embodiment, the recombinant DNA construct includes DNA encoding one loxP site; in the presence of Cre recombinase and another DNA with a loxP site, the two DNAs are recombined.


Aptamers


In some embodiments, the recombinant DNA construct or polynucleotide includes DNA that is processed to an RNA aptamer, that is, an RNA that binds to a ligand through binding mechanism that is not primarily based on Watson-Crick base-pairing (in contrast, for example, to the base-pairing that occurs between complementary, anti-parallel nucleic acid strands to form a double-stranded nucleic acid structure). See, for example, Ellington and Szostak (1990) Nature, 346:818-822. Examples of aptamers can be found, for example, in the public Aptamer Database, available on line at aptamer.icmb.utexas.edu (Lee et al. (2004) Nucleic Acids Res., 32(1):D95-100). Aptamers can, however, be monovalent (binding a single ligand) or multivalent (binding more than one individual ligand, e. g., binding one unit of two or more different ligands).


Ligands include any molecule (or part of a molecule) that can be recognized and be bound by a nucleic acid secondary structure by a mechanism not primarily based on Watson-Crick base pairing. In this way, the recognition and binding of ligand and aptamer is analogous to that of antigen and antibody, or of biological effector and receptor. Ligands can include single molecules (or part of a molecule), or a combination of two or more molecules (or parts of a molecule), and can include one or more macromolecular complexes (e. g., polymers, lipid bilayers, liposomes, cellular membranes or other cellular structures, or cell surfaces). Examples of specific ligands include vitamins such as coenzyme B12 and thiamine pyrophosphate, flavin mononucleotide, guanine, adenosine, S-adenosylmethionine, S-adenosylhomocysteine, coenzyme A, lysine, tyrosine, dopamine, glucosamine-6-phosphate, caffeine, theophylline, antibiotics such as chloramphenicol and neomycin, herbicides such as glyphosate and dicamba, proteins including viral or phage coat proteins and invertebrate epidermal or digestive tract surface proteins, and RNAs including viral RNA, transfer-RNAs (t-RNAs), ribosomal RNA (rRNA), and RNA polymerases such as RNA-dependent RNA polymerase (RdRP). One class of RNA aptamers are “thermoswitches” that do not bind a ligand but are thermally responsive, that is to say, the aptamer's conformation is determined by temperature; see, for example, Box 3 in Mandal and Breaker (2004) Nature Rev. Mol. Cell Biol., 5:451-463.


Transgene Transcription Units


In some embodiments, the recombinant DNA construct or polynucleotide disclosed herein includes a transgene transcription unit. A transgene transcription unit includes DNA sequence encoding a gene of interest, e. g., a natural protein or a heterologous protein. A gene of interest can be any coding or non-coding sequence from any species (including, but not limited to, non-eukaryotes such as bacteria, and viruses; fungi, protists, plants, invertebrates, and vertebrates. Particular genes of interest are genes encoding one or more proteins conferring resistance to an herbicide and genes encoding at least one pesticidal agent selected from the group consisting of a patatin, a plant lectin, a phytoecdysteroid, a Bacillus thuringiensis insecticidal protein, a Xenorhabdus insecticidal protein, a Photorhabdus insecticidal protein, a Bacillus laterosporous insecticidal protein, a Bacillus sphaericus insecticidal protein, and an insecticidal protein produced by any of Lysinibacillus sphaericus (Bacillus sphaericus), Brevibacillus laterosporus (Bacillus laterosporus), Chromobacterium species, Chromobacterium subtsugae, Paenibacillus species, Paenibacillus lentimorbus, and Paenibacillus popilliae. The transgene transcription unit can further include 5′ or 3′ sequence or both as required for transcription of the transgene.


Introns


In some embodiments, the recombinant DNA construct or polynucleotide includes DNA encoding a spliceable intron. By “intron” is generally meant a segment of DNA (or the RNA transcribed from such a segment) that is located between exons (protein-encoding segments of the DNA or corresponding transcribed RNA), wherein, during maturation of the messenger RNA, the intron present is enzymatically “spliced out” or removed from the RNA strand by a cleavage/ligation process that occurs in the nucleus in eukaryotes. The term “intron” is also applied to non-coding DNA sequences that are transcribed to RNA segments that can be spliced out of a maturing RNA transcript, but are not introns found between protein-coding exons. One example of these are spliceable sequences that that have the ability to enhance expression in plants (in some cases, especially in monocots) of a downstream coding sequence; these spliceable sequences are naturally located in the 5′ untranslated region of some plant genes, as well as in some viral genes (e. g., the tobacco mosaic virus 5′ leader sequence or “omega” leader described as enhancing expression in plant genes by Gallie and Walbot (1992) Nucleic Acids Res., 20:4631-4638). These spliceable sequences or “expression-enhancing introns” can be artificially inserted in the 5′ untranslated region of a plant gene between the promoter but before any protein-coding exons. Examples of such expression-enhancing introns include, but are not limited to, a maize alcohol dehydrogenase (Zm-Adh1), a maize Bronze-1 expression-enhancing intron, a rice actin 1 (Os-Act1) intron, a Shrunken-1 (Sh-1) intron, a maize sucrose synthase intron, a heat shock protein 18 (hsp18) intron, and an 82 kilodalton heat shock protein (hsp82) intron. U.S. Pat. Nos. 5,593,874 and 5,859,347, specifically incorporated by reference herein, describe methods of improving recombinant DNA constructs for use in plants by inclusion of an expression-enhancing intron derived from the 70 kilodalton maize heat shock protein (hsp70) in the non-translated leader positioned 3′ from the gene promoter and 5′ from the first protein-coding exon.


Ribozymes


In some embodiments, the recombinant DNA construct or polynucleotide includes DNA encoding one or more ribozymes. Ribozymes of particular interest include a self-cleaving ribozyme, a hammerhead ribozyme, or a hairpin ribozyme. In one embodiment, the recombinant DNA construct includes DNA encoding one or more ribozymes that serve to cleave the transcribed RNA to provide defined segments of RNA, such as separate sense or anti-sense single-stranded RNA segments (which in embodiments hybridise to form dsRNA), or an RNA segment having self-complementary nucleotide sequences that form at least partially dsRNA (e. g., in a stem-loop structure) for suppressing a flea beetle target gene.


Gene Suppression Elements


In some embodiments, the recombinant DNA construct or polynucleotide includes DNA encoding additional gene suppression element for suppressing a target gene other than a flea beetle target gene. The target gene to be suppressed can include coding or non-coding sequence or both.


Suitable gene suppression elements are described in detail in U. S. Patent Application Publication 2006/0200878, which disclosure is specifically incorporated herein by reference, and include one or more of:

    • (a) DNA that includes at least one anti-sense DNA segment that is anti-sense to at least one segment of the gene to be suppressed;
    • (b) DNA that includes multiple copies of at least one anti-sense DNA segment that is anti-sense to at least one segment of the gene to be suppressed;
    • (c) DNA that includes at least one sense DNA segment that is at least one segment of the gene to be suppressed;
    • (d) DNA that includes multiple copies of at least one sense DNA segment that is at least one segment of the gene to be suppressed;
    • (e) DNA that transcribes to RNA for suppressing the gene to be suppressed by forming double-stranded RNA and includes at least one anti-sense DNA segment that is anti-sense to at least one segment of the gene to be suppressed and at least one sense DNA segment that is at least one segment of the gene to be suppressed;
    • (f) DNA that transcribes to RNA for suppressing the gene to be suppressed by forming a single double-stranded RNA and includes multiple serial anti-sense DNA segments that are anti-sense to at least one segment of the gene to be suppressed and multiple serial sense DNA segments that are at least one segment of the gene to be suppressed;
    • (g) DNA that transcribes to RNA for suppressing the gene to be suppressed by forming multiple double strands of RNA and includes multiple anti-sense DNA segments that are anti-sense to at least one segment of the gene to be suppressed and multiple sense DNA segments that are at least one segment of the gene to be suppressed, and wherein the multiple anti-sense DNA segments and the multiple sense DNA segments are arranged in a series of inverted repeats;
    • (h) DNA that includes nucleotides derived from a plant miRNA;
    • (i) DNA that includes nucleotides of a siRNA;
    • (j) DNA that transcribes to an RNA aptamer capable of binding to a ligand; and
    • (k) DNA that transcribes to an RNA aptamer capable of binding to a ligand, and DNA that transcribes to regulatory RNA capable of regulating expression of the gene to be suppressed, wherein the regulation is dependent on the conformation of the regulatory RNA, and the conformation of the regulatory RNA is allosterically affected by the binding state of the RNA aptamer.


In some embodiments, an intron is used to deliver a gene suppression element in the absence of any protein-coding exons (coding sequence). In one example, an intron, such as an expression-enhancing intron (preferred in certain embodiments), is interrupted by embedding within the intron a gene suppression element, wherein, upon transcription, the gene suppression element is excised from the intron. Thus, protein-coding exons are not required to provide the gene suppressing function of the recombinant DNA constructs disclosed herein.


Transcription Regulatory Elements


In some embodiments, the recombinant DNA construct or polynucleotide includes DNA encoding a transcription regulatory element. Transcription regulatory elements include elements that regulate the expression level of the recombinant DNA construct (relative to its expression in the absence of such regulatory elements). Examples of suitable transcription regulatory elements include riboswitches (cis- or trans-acting), transcript stabilizing sequences, and miRNA recognition sites, as described in detail in U. S. Patent Application Publication 2006/0200878, specifically incorporated herein by reference.


Transgenic Plant Cells and Transgenic Plants


The recombinant DNA constructs disclosed herein can be stacked with other recombinant DNA for imparting additional traits (e. g., in the case of transformed plants, traits including herbicide resistance, pest resistance, cold germination tolerance, water deficit tolerance, and the like) for example, by expressing or suppressing other genes. Constructs for coordinated decrease and increase of gene expression are disclosed in U.S. Patent Application Publication 2004/0126845 A1, specifically incorporated by reference.


In certain transgenic plant cells and transgenic plants, it is sometimes desirable to concurrently express a gene of interest while also modulating expression of a flea beetle target gene. Thus, in some embodiments, the transgenic plant contains recombinant DNA further including a gene expression element for expressing at least one gene of interest, and transcription of the recombinant DNA construct for flea beetle control is preferably effected with concurrent transcription of the gene expression element. In embodiments, the transgenic plant expresses DNA encoding a recombinant RNA transcript as disclosed herein for suppression of a flea beetle target gene, and also expresses DNA encoding a non-nucleotide pesticidal agent such as a small-molecule pesticidal agent or a proteinaceous pesticidal agent; such DNAs can be stacked in a single recombinant construct or expression cassette, or alternatively can be expressed from discrete recombinant constructs or expression cassettes. Examples of non-nucleotide pesticidal agents include patatins, plant lectins, phytoecdysteroids, and bacterial insecticidal proteins (e. g., insecticidal proteins from Bacillus thuringiensis, Xenorhabdus sp., Photorhabdus sp., Brevibacillus laterosporus (Bacillus laterosporus), Lysinibacillus sphaericus (Bacillus sphaericus), Chromobacterium sp., Chromobacterium subtsugae, Paenibacillus sp., Paenibacillus lentimorbus, and Paenibacillus popilliae). In embodiments, the transgenic plant expresses DNA encoding a recombinant RNA transcript as disclosed herein for suppression of a flea beetle target gene, and also expresses DNA encoding one or more proteins conferring tolerance to an herbicide. Examples of proteins conferring tolerance to an herbicide include 5-enolpyruvylshikimate-3-phosphate synthases (EPSPS; see, e. g., U.S. Pat. Nos. 5,627,061, 5,633,435 RE39247, 6,040,497, and 5,094,945, and PCT International Application Publications WO04074443 and WO04009761), glyphosate oxidoreductase (GOX; U.S. Pat. No. 5,463,175), glyphosate decarboxylase (PCT International Application Publication WO05003362, U.S. Pat. No. 7,405,347, and U. S. Patent Application Publication 2004/0177399), glyphosate-N-acetyl transferase (GAT; U.S. Pat. No. 7,714,188) conferring tolerance to glyphosate; dicamba monooxygenase conferring tolerance to auxin-like herbicides such as dicamba (U.S. Pat. No. 7,105,724); phosphinothricin acetyltransferase (pat or bar) conferring tolerance to phosphinothricin or glufosinate (U.S. Pat. No. 5,646,024); 2,2-dichloropropionic acid dehalogenase conferring tolerance to 2,2-dichloropropionic acid (Dalapon) (PCT International Application Publication WO9927116); acetohydroxyacid synthase or acetolactate synthase conferring tolerance to acetolactate synthase inhibitors such as sulfonylurea, imidazolinone, triazolopyrimidine, pyrimidyloxybenzoates and phthalide (U.S. Pat. No. 6,225,105); haloarylnitrilase (Bxn) for conferring tolerance to bromoxynil (U.S. Pat. No. 4,810,648); modified acetyl-coenzyme A carboxylase for conferring tolerance to cyclohexanedione (sethoxydim) and aryloxyphenoxypropionate (haloxyfop) (U.S. Pat. No. 6,414,222); dihydropteroate synthase (sul I) for conferring tolerance to sulfonamide herbicides (U.S. Pat. No. 5,719,046); 32 kDa photosystem II polypeptide (psbA) for conferring tolerance to triazine herbicides (Hirschberg et al., 1983, Science, 222:1346-1349); anthranilate synthase for conferring tolerance to 5-methyltryptophan (U.S. Pat. No. 4,581,847); dihydrodipicolinic acid synthase (dap A) for conferring to tolerance to aminoethyl cysteine (PCT International Application Publication WO8911789); phytoene desaturase (crtl) for conferring tolerance to pyridazinone herbicides such as norflurazon (Japan Patent JP06343473); hydroxyphenylpyruvate dioxygenase, a 4-hydroxyphenylacetic acid oxidase and a 4-hydroxyphenylacetic 1-hydrolase (U.S. Pat. No. 7,304,209) for conferring tolerance to cyclopropylisoxazole herbicides such as isoxaflutole (U.S. Pat. No. 6,268,549); modified protoporphyrinogen oxidase I (protox) for conferring tolerance to protoporphyrinogen oxidase inhibitors (U.S. Pat. No. 5,939,602); aryloxyalkanoate dioxygenase (AAD-1) for conferring tolerance to an herbicide containing an aryloxyalkanoate moiety (WO05107437); a serine hydroxymethyltransferase (US Patent Application Publication 2008/0155716), a glufosinate-tolerant glutamine synthase (US Patent Application Publication 2009/0018016). Examples of such herbicides include phenoxy auxins (such as 2,4-D and dichlorprop), pyridyloxy auxins (such as fluroxypyr and triclopyr), aryloxyphenoxypropionates (AOPP) acetylcoenzyme A carboxylase (ACCase) inhibitors (such as haloxyfop, quizalofop, and diclofop), and 5-substituted phenoxyacetate protoporphyrinogen oxidase IX inhibitors (such as pyraflufen and flumiclorac). The nucleotide sequences of the nucleic acids encoding herbicide-tolerance proteins and the sequences of the herbicide-tolerance proteins, as disclosed in the U. S. patent and patent application publications cited in this paragraph are incorporated herein by reference.


In some embodiments, the recombinant DNA constructs disclosed herein can be transcribed in any plant cell or tissue or in a whole plant of any developmental stage. Transgenic plants can be derived from any monocot or dicot plant, such as, but not limited to, plants of commercial or agricultural interest, such as crop plants (especially crop plants used for human food or animal feed), wood- or pulp-producing trees, vegetable plants, fruit plants, and ornamental plants. Examples of plants of interest include grain crop plants (such as wheat, oat, barley, maize, rye, triticale, rice, millet, sorghum, quinoa, amaranth, and buckwheat); forage crop plants (such as forage grasses and forage dicots including alfalfa, vetch, clover, and the like); oilseed crop plants (such as cotton, safflower, sunflower, soybean, canola, rapeseed, flax, peanuts, and oil palm); tree nuts (such as walnut, cashew, hazelnut, pecan, almond, and the like); sugarcane, coconut, date palm, olive, sugarbeet, tea, and coffee; wood- or pulp-producing trees; vegetable crop plants such as legumes (for example, beans, peas, lentils, alfalfa, peanut), lettuce, asparagus, artichoke, celery, carrot, radish, the brassicas (for example, cabbages, kales, mustards, and other leafy brassicas, broccoli, cauliflower, Brussels sprouts, turnip, kohlrabi), edible cucurbits (for example, cucumbers, melons, summer squashes, winter squashes), edible alliums (for example, onions, garlic, leeks, shallots, chives), edible members of the Solanaceae (for example, tomatoes, eggplants, potatoes, peppers, groundcherries), and edible members of the Chenopodiaceae (for example, beet, chard, spinach, quinoa, amaranth); fruit crop plants such as apple, pear, citrus fruits (for example, orange, lime, lemon, grapefruit, and others), stone fruits (for example, apricot, peach, plum, nectarine), banana, pineapple, grape, kiwifruit, papaya, avocado, and berries; plants grown for biomass or biofuel (for example, Miscanthus grasses, switchgrass, jatropha, oil palm, eukaryotic microalgae such as Botryococcus braunii, Chlorella spp., and Dunaliella spp., and eukaryotic macroalgae such as Gracilaria spp., and Sargassum spp.); and ornamental plants including ornamental flowering plants, ornamental trees and shrubs, ornamental groundcovers, and ornamental grasses. Specific plant species of interest in which a recombinant DNA construct is transcribed to provide resistance to flea beetles are plants in the family Brassicaceae, including the Brassica species B. napus, B. juncea, B. carinata, B. rapa, B. oleracea, B. rupestris, B. septiceps, B. nigra, B. narinosa, B. perviridus, B. tournefortii, and B. fructiculosa. Additional plant species of interest in which a recombinant DNA construct is transcribed to provide resistance to flea beetles are Glycine max, Linum usitatissimum, Zea mays, Carthamus tinctorius, Helianthus annuus, Nicotiana tabacum, Arabidopsis thaliana, Betholettia excelsa, Ricinus communis, Cocos nucifera, Coriandrum sativum, Gossypium spp., Arachis hypogaea, Simmondsia chinensis, Solanum tuberosum, Elaeis guineensis, Olea europaea, Oryza sativa, Cucurbita maxim, Hordeum vulgare, and Triticum aestivum.


Also disclosed herein are commodity products produced from a transgenic plant cell, plant, or seed expressing a recombinant DNA construct imparting improved resistance to flea beetles as disclosed herein, including, but not limited to, harvested leaves, roots, shoots, tubers, stems, fruits, seeds, or other parts of a plant, meals, oils, extracts, fermentation or digestion products, crushed or whole grains or seeds of a plant, or any food or non-food product including such commodity products produced from a transgenic plant cell, plant, or seed as disclosed herein. The detection of one or more of nucleic acid sequences of the recombinant DNA constructs for flea beetle control as disclosed herein in one or more commodity or commodity products contemplated herein is de facto evidence that the commodity or commodity product contains or is derived from a transgenic plant cell, plant, or seed expressing such a recombinant DNA construct.


Generally a transgenic plant having in its genome a recombinant DNA construct as disclosed herein exhibits increased resistance to an insect infestation, specifically increased resistance to a flea beetle infestation. In various embodiments, for example, where the transgenic plant expresses a recombinant DNA construct for flea beetle control that is stacked with other recombinant DNA for imparting additional traits, the transgenic plant has at least one additional altered trait, relative to a plant lacking the recombinant DNA construct, selected from the group of traits consisting of: (a) improved abiotic stress tolerance;

    • (b) improved biotic stress tolerance;
    • (c) modified primary metabolite composition;
    • (d) modified secondary metabolite composition;
    • (e) modified trace element, carotenoid, or vitamin composition;
    • (f) improved yield;
    • (g) improved ability to use nitrogen, phosphate, or other nutrients;
    • (h) modified agronomic characteristics;
    • (i) modified growth or reproductive characteristics; and
    • (j) improved harvest, storage, or processing quality.


In some embodiments, the transgenic plant is characterized by: improved tolerance of abiotic stress (e. g., tolerance of water deficit or drought, heat, cold, non-optimal nutrient or salt levels, non-optimal light levels) or of biotic stress (e. g., crowding, allelopathy, or wounding); by a modified primary metabolite (e. g., fatty acid, oil, amino acid, protein, sugar, or carbohydrate) composition; a modified secondary metabolite (e. g., alkaloids, terpenoids, polyketides, non-ribosomal peptides, and secondary metabolites of mixed biosynthetic origin) composition; a modified trace element (e. g., iron, zinc), carotenoid (e. g., beta-carotene, lycopene, lutein, zeaxanthin, or other carotenoids and xanthophylls), or vitamin (e. g., tocopherols) composition; improved yield (e. g., improved yield under non-stress conditions or improved yield under biotic or abiotic stress); improved ability to use nitrogen, phosphate, or other nutrients; modified agronomic characteristics (e. g., delayed ripening; delayed senescence; earlier or later maturity; improved shade tolerance; improved resistance to root or stalk lodging; improved resistance to “green snap” of stems; modified photoperiod response); modified growth or reproductive characteristics (e. g., intentional dwarfing; intentional male sterility, useful, e. g., in improved hybridization procedures; improved vegetative growth rate; improved germination; improved male or female fertility); improved harvest, storage, or processing quality (e. g., improved resistance to pests during storage, improved resistance to breakage, improved appeal to consumers); or any combination of these traits.


In another embodiment, transgenic seed, or seed produced by the transgenic plant, has modified primary metabolite (e. g., fatty acid, oil, amino acid, protein, sugar, or carbohydrate) composition, a modified secondary metabolite composition, a modified trace element, carotenoid, or vitamin composition, an improved harvest, storage, or processing quality, or a combination of these. In another embodiment, it can be desirable to change levels of native components of the transgenic plant or seed of a transgenic plant, for example, to decrease levels of an allergenic protein or glycoprotein or of a toxic metabolite.


EXAMPLES
Example 1

This example illustrates non-limiting embodiments of coding DNA sequences useful as target genes for controlling insect species and for making compositions for controlling insects and insect-resistant transgenic plants, and identifies dsRNA trigger sequences useful for controlling insect species. More specifically, embodiments of target genes identified by name (annotation) and sequence identifier (SEQ ID NO.) for controlling flea beetles are provided in SEQ ID NOs:1-859, and embodiments of dsRNA trigger sequences ranging in size from 135 to 352 base pairs and designed to suppress these target genes are provided in SEQ ID NOs.:860-1718.
















TABLE 1





Target
Trigger
Target
Trigger
Target
Trigger
Target
Trigger


Gene
SEQ
Gene
SEQ
Gene
SEQ
Gene
SEQ


SEQ ID
ID
SEQ ID
ID
SEQ ID
ID
SEQ ID
ID


NO.
NO.*
NO.
NO.*
NO.
NO.*
NO.
NO.*






















1
860
216
1075
431
1290
646
1505


2
861
217
1076
432
1291
647
1506


3
862
218
1077
433
1292
648
1507


4
863
219
1078
434
1293
649
1508


5
864
220
1079
435
1294
650
1509


6
865
221
1080
436
1295
651
1510


7
866
222
1081
437
1296
652
1511


8
867
223
1082
438
1297
653
1512


9
868
224
1083
439
1298
654
1513


10
869
225
1084
440
1299
655
1514


11
870
226
1085
441
1300
656
1515


12
871
227
1086
442
1301
657
1516


13
872
228
1087
443
1302
658
1517


14
873
229
1088
444
1303
659
1518


15
874
230
1089
445
1304
660
1519


16
875
231
1090
446
1305
661
1520


17
876
232
1091
447
1306
662
1521


18
877
233
1092
448
1307
663
1522


19
878
234
1093
449
1308
664
1523


20
879
235
1094
450
1309
665
1524


21
880
236
1095
451
1310
666
1525


22
881
237
1096
452
1311
667
1526


23
882
238
1097
453
1312
668
1527


24
883
239
1098
454
1313
669
1528


25
884
240
1099
455
1314
670
1529


26
885
241
1100
456
1315
671
1530


27
886
242
1101
457
1316
672
1531


28
887
243
1102
458
1317
673
1532


29
888
244
1103
459
1318
674
1533


30
889
245
1104
460
1319
675
1534


31
890
246
1105
461
1320
676
1535


32
891
247
1106
462
1321
677
1536


33
892
248
1107
463
1322
678
1537


34
893
249
1108
464
1323
679
1538


35
894
250
1109
465
1324
680
1539


36
895
251
1110
466
1325
681
1540


37
896
252
1111
467
1326
682
1541


38
897
253
1112
468
1327
683
1542


39
898
254
1113
469
1328
684
1543


40
899
255
1114
470
1329
685
1544


41
900
256
1115
471
1330
686
1545


42
901
257
1116
472
1331
687
1546


43
902
258
1117
473
1332
688
1547


44
903
259
1118
474
1333
689
1548


45
904
260
1119
475
1334
690
1549


46
905
261
1120
476
1335
691
1550


47
906
262
1121
477
1336
692
1551


48
907
263
1122
478
1337
693
1552


49
908
264
1123
479
1338
694
1553


50
909
265
1124
480
1339
695
1554


51
910
266
1125
481
1340
696
1555


52
911
267
1126
482
1341
697
1556


53
912
268
1127
483
1342
698
1557


54
913
269
1128
484
1343
699
1558


55
914
270
1129
485
1344
700
1559


56
915
271
1130
486
1345
701
1560


57
916
272
1131
487
1346
702
1561


58
917
273
1132
488
1347
703
1562


59
918
274
1133
489
1348
704
1563


60
919
275
1134
490
1349
705
1564


61
920
276
1135
491
1350
706
1565


62
921
277
1136
492
1351
707
1566


63
922
278
1137
493
1352
708
1567


64
923
279
1138
494
1353
709
1568


65
924
280
1139
495
1354
710
1569


66
925
281
1140
496
1355
711
1570


67
926
282
1141
497
1356
712
1571


68
927
283
1142
498
1357
713
1572


69
928
284
1143
499
1358
714
1573


70
929
285
1144
500
1359
715
1574


71
930
286
1145
501
1360
716
1575


72
931
287
1146
502
1361
717
1576


73
932
288
1147
503
1362
718
1577


74
933
289
1148
504
1363
719
1578


75
934
290
1149
505
1364
720
1579


76
935
291
1150
506
1365
721
1580


77
936
292
1151
507
1366
722
1581


78
937
293
1152
508
1367
723
1582


79
938
294
1153
509
1368
724
1583


80
939
295
1154
510
1369
725
1584


81
940
296
1155
511
1370
726
1585


82
941
297
1156
512
1371
727
1586


83
942
298
1157
513
1372
728
1587


84
943
299
1158
514
1373
729
1588


85
944
300
1159
515
1374
730
1589


86
945
301
1160
516
1375
731
1590


87
946
302
1161
517
1376
732
1591


88
947
303
1162
518
1377
733
1592


89
948
304
1163
519
1378
734
1593


90
949
305
1164
520
1379
735
1594


91
950
306
1165
521
1380
736
1595


92
951
307
1166
522
1381
737
1596


93
952
308
1167
523
1382
738
1597


94
953
309
1168
524
1383
739
1598


95
954
310
1169
525
1384
740
1599


96
955
311
1170
526
1385
741
1600


97
956
312
1171
527
1386
742
1601


98
957
313
1172
528
1387
743
1602


99
958
314
1173
529
1388
744
1603


100
959
315
1174
530
1389
745
1604


101
960
316
1175
531
1390
746
1605


102
961
317
1176
532
1391
747
1606


103
962
318
1177
533
1392
748
1607


104
963
319
1178
534
1393
749
1608


105
964
320
1179
535
1394
750
1609


106
965
321
1180
536
1395
751
1610


107
966
322
1181
537
1396
752
1611


108
967
323
1182
538
1397
753
1612


109
968
324
1183
539
1398
754
1613


110
969
325
1184
540
1399
755
1614


111
970
326
1185
541
1400
756
1615


112
971
327
1186
542
1401
757
1616


113
972
328
1187
543
1402
758
1617


114
973
329
1188
544
1403
759
1618


115
974
330
1189
545
1404
760
1619


116
975
331
1190
546
1405
761
1620


117
976
332
1191
547
1406
762
1621


118
977
333
1192
548
1407
763
1622


119
978
334
1193
549
1408
764
1623


120
979
335
1194
550
1409
765
1624


121
980
336
1195
551
1410
766
1625


122
981
337
1196
552
1411
767
1626


123
982
338
1197
553
1412
768
1627


124
983
339
1198
554
1413
769
1628


125
984
340
1199
555
1414
770
1629


126
985
341
1200
556
1415
771
1630


127
986
342
1201
557
1416
772
1631


128
987
343
1202
558
1417
773
1632


129
988
344
1203
559
1418
774
1633


130
989
345
1204
560
1419
775
1634


131
990
346
1205
561
1420
776
1635


132
991
347
1206
562
1421
777
1636


133
992
348
1207
563
1422
778
1637


134
993
349
1208
564
1423
779
1638


135
994
350
1209
565
1424
780
1639


136
995
351
1210
566
1425
781
1640


137
996
352
1211
567
1426
782
1641


138
997
353
1212
568
1427
783
1642


139
998
354
1213
569
1428
784
1643


140
999
355
1214
570
1429
785
1644


141
1000
356
1215
571
1430
786
1645


142
1001
357
1216
572
1431
787
1646


143
1002
358
1217
573
1432
788
1647


144
1003
359
1218
574
1433
789
1648


145
1004
360
1219
575
1434
790
1649


146
1005
361
1220
576
1435
791
1650


147
1006
362
1221
577
1436
792
1651


148
1007
363
1222
578
1437
793
1652


149
1008
364
1223
579
1438
794
1653


150
1009
365
1224
580
1439
795
1654


151
1010
366
1225
581
1440
796
1655


152
1011
367
1226
582
1441
797
1656


153
1012
368
1227
583
1442
798
1657


154
1013
369
1228
584
1443
799
1658


155
1014
370
1229
585
1444
800
1659


156
1015
371
1230
586
1445
801
1660


157
1016
372
1231
587
1446
802
1661


158
1017
373
1232
588
1447
803
1662


159
1018
374
1233
589
1448
804
1663


160
1019
375
1234
590
1449
805
1664


161
1020
376
1235
591
1450
806
1665


162
1021
377
1236
592
1451
807
1666


163
1022
378
1237
593
1452
808
1667


164
1023
379
1238
594
1453
809
1668


165
1024
380
1239
595
1454
810
1669


166
1025
381
1240
596
1455
811
1670


167
1026
382
1241
597
1456
812
1671


168
1027
383
1242
598
1457
813
1672


169
1028
384
1243
599
1458
814
1673


170
1029
385
1244
600
1459
815
1674


171
1030
386
1245
601
1460
816
1675


172
1031
387
1246
602
1461
817
1676


173
1032
388
1247
603
1462
818
1677


174
1033
389
1248
604
1463
819
1678


175
1034
390
1249
605
1464
820
1679


176
1035
391
1250
606
1465
821
1680


177
1036
392
1251
607
1466
822
1681


178
1037
393
1252
608
1467
823
1682


179
1038
394
1253
609
1468
824
1683


180
1039
395
1254
610
1469
825
1684


181
1040
396
1255
611
1470
826
1685


182
1041
397
1256
612
1471
827
1686


183
1042
398
1257
613
1472
828
1687


184
1043
399
1258
614
1473
829
1688


185
1044
400
1259
615
1474
830
1689


186
1045
401
1260
616
1475
831
1690


187
1046
402
1261
617
1476
832
1691


188
1047
403
1262
618
1477
833
1692


189
1048
404
1263
619
1478
834
1693


190
1049
405
1264
620
1479
835
1694


191
1050
406
1265
621
1480
836
1695


192
1051
407
1266
622
1481
837
1696


193
1052
408
1267
623
1482
838
1697


194
1053
409
1268
624
1483
839
1698


195
1054
410
1269
625
1484
840
1699


196
1055
411
1270
626
1485
841
1700


197
1056
412
1271
627
1486
842
1701


198
1057
413
1272
628
1487
843
1702


199
1058
414
1273
629
1488
844
1703


200
1059
415
1274
630
1489
845
1704


201
1060
416
1275
631
1490
846
1705


202
1061
417
1276
632
1491
847
1706


203
1062
418
1277
633
1492
848
1707


204
1063
419
1278
634
1493
849
1708


205
1064
420
1279
635
1494
850
1709


206
1065
421
1280
636
1495
851
1710


207
1066
422
1281
637
1496
852
1711


208
1067
423
1282
638
1497
853
1712


209
1068
424
1283
639
1498
854
1713


210
1069
425
1284
640
1499
855
1714


211
1070
426
1285
641
1500
856
1715


212
1071
427
1286
642
1501
857
1716


213
1072
428
1287
643
1502
858
1717


214
1073
429
1288
644
1503
859
1718


215
1074
430
1289
645
1504





*Trigger sequences are provided for the anti-sense strand of the dsRNA trigger in 5′ to 3′ direction.


** T44966 and T44967 are positive controls based on a Phyllotretastriolata arginine kinase mRNA disclosed in Zhao et al. (2008), Eur. J. Entomol., 5:815.






The embodiments of dsRNA trigger sequences provided in Table 1 are generally useful for RNA-mediated suppression of the corresponding target gene identified in Table 1. These dsRNA triggers are useful for controlling insects, especially flea beetles, including the source species from which the target genes in Table 1 were identified. RNA-mediated suppression of one or more of the target genes provided in Table 1, or use of one or more of the dsRNA triggers provided in Table 1, is useful for causing mortality or stunting, or otherwise controlling, target insect species in the following genera: Altica, Anthobiodes, Aphthona, Aphthonaltica, Aphthonoides, Apteopeda, Argopistes, Argopus, Arrhenocoela, Batophila, Blepharida, Chaetocnema, Clitea, Crepidodera, Derocrepis, Dibolia, Disonycha, Epitrix, Hermipyxis, Hermaeophaga, Hespera, Hippuriphila, Horaia, Hyphasis, Lipromima, Liprus, Longitarsus, Luperomorpha, Lythraria, Manobia, Mantura, Meishania, Minota, Mniophila, Neicrepidodera, Nonarthra, Novofoudrasia, Ochrosis, Oedionychis, Oglobinia, Omeisphaera, Ophrida, Orestia, Paragopus, Pentamesa, Philopona, Phygasia, Phyllotreta, Podagrica, Podagricomela, Podontia, Pseudodera, Psylliodes, Sangariola, Sinaltica, Sphaeroderma, Systena, Trachyaphthona, Xuthea, and Zipangia. In embodiments, compositions including a dsRNA trigger for suppression of one or more of the target genes provided in Table 1 (e. g., a composition including an effective amount of one or more of the dsRNA triggers provided in Table 1) are useful for controlling at least one of Altica ambiens (alder flea beetle), Altica canadensis (prairie flea beetle), Altica chalybaea (grape flea beetle), Altica prasina (poplar flea beetle), Altica rosae (rose flea beetle), Altica sylvia (blueberry flea beetle), Altica ulmi (elm flea beetle), Chaetocnema pulicaria (corn flea beele), Chaetocnema conofinis (sweet potato flea beetle), Epitrix cucumeris (potato flea beetle), Systena blanda (palestripped fleabeetle), and Systena frontalis (redheaded flea beetle), thus preventing or treating plant infestation by these species. For example, a composition including an effective amount of one or more of the dsRNA triggers provided in Table 1 is useful for preventing or treating infestation of potato plants by Epitrix cucumeris (potato flea beetle).


In embodiments, RNA-mediated suppression of one or more of the target genes provided in Table 1, or use of one or more of the dsRNA triggers provided in Table 1, is useful for causing mortality or stunting in flea beetle species in the genera Phyllotreta and Psylliodes, thus preventing or treating plant infestation by these species. In specific embodiments, RNA-mediated suppression of one or more of the target genes provided in Table 1, or use of one or more of the dsRNA triggers provided in Table 1, is useful for causing mortality or stunting in at least one flea beetle species selected from the group consisting of Phyllotreta armoraciae (horseradish flea beetle), Phyllotreta cruciferae (canola flea beetle), Phyllotreta pusilla (western black flea beetle), Phyllotreta nemorum (striped turnip flea beetle), Phyllotreta atra (turnip flea beetle), Phyllotreta robusta (garden flea beetle), Phyllotreta striolata (striped flea beetle), Phyllotreta undulata, Psylliodes chrysocephala, and Psylliodes punctulata (hop flea beetle). In embodiments, RNA-mediated suppression of one or more of the target genes having a sequence selected from the group consisting of SEQ ID NOs:1-296 is used to cause mortality or stunting in Phyllotreta atra (turnip flea beetle) adults or larvae, for example, by contacting Phyllotreta atra adults, larvae, or eggs with an effective amount of a dsRNA trigger including a sequence selected from the group consisting of SEQ ID NOs:860-1155. In embodiments, RNA-mediated suppression of one or more of the target genes having a sequence selected from the group consisting of SEQ ID NOs:297-532 is used to cause mortality or stunting in Phyllotreta cruciferae (canola flea beetle) adults or larvae, for example, by contacting Phyllotreta cruciferae adults, larvae, or eggs with an effective amount of a dsRNA trigger including a sequence selected from the group consisting of SEQ ID NOs:1156-1391. In embodiments, RNA-mediated suppression of one or more of the target genes having a sequence selected from the group consisting of SEQ ID NOs:533-551 is used to cause mortality or stunting in Phyllotreta striolata (striped flea beetle) adults or larvae, for example, by contacting Phyllotreta striolata adults, larvae, or eggs with an effective amount of a dsRNA trigger including a sequence selected from the group consisting of SEQ ID NOs:1392-1410. In embodiments, RNA-mediated suppression of one or more of the target genes having a sequence selected from the group consisting of SEQ ID NOs:552-859 is used to cause mortality or stunting in Psylliodes chrysocephala adults or larvae, for example, by contacting Psylliodes chrysocephala adults, larvae, or eggs with an effective amount of a dsRNA trigger including a sequence selected from the group consisting of SEQ ID NOs:1411-1718.


Plants which can be protected by such infestation by transgenic expression or topical application of one or more of the dsRNA triggers provided in Table 1 include any plant species or variety that is subject to infestation by flea beetles, especially plants of economic importance, including ornamental plants and crop plants. Embodiments of such plants include plants in the family Brassicaceae (mustard family), such as a plant in the genus Brassica including, for example, one of the following: B. napus (rapeseed, including cultivars such as canola and rutabaga), B. juncea (Indian mustard), B. carinata (Abyssinian mustard), B. rapa (turnip), B. oleracea (wild cabbage, including domesticated cultivars such as, kale, cabbage, broccoli, cauliflower, brussels sprouts, etc.) B. rupestris (brown mustard), B. septiceps (seventop mustard), B. nigra (black mustard), B. narinosa (broadbeaked mustard), B. perviridus (mustard spinach), B. tournefortii (asian mustard), and B. fructiculosa (Mediterranean cabbage). In additional embodiments, the target plants may include, but not limited to, one of the following: Glycine max (soybean), Linum usitatissimum (linseed/flax), Zea mays (maize), Carthamus tinctorius (safflower), Helianthus annuus (sunflower), Nicotiana tabacum (tobacco), Arabidopsis thaliana, Betholettia excelsa (Brazil nut), Ricinus communis (castor bean), Cocos nucifera (coconut), Coriandrum sativum (coriander), Gossypium spp. (cotton), Arachis hypogaea (groundnut or peanut), Simmondsia chinensis (jojoba), Solanum tuberosum (potato) Elaeis guineensis (oil palm), Olea europaea (olive), Oryza sativa (rice), Cucurbita maxima (squash), Hordeum vulgare (barley), and Triticum aestivum (wheat).


An aspect includes compositions including an effective amount of one or more of the dsRNA triggers provided in Table 1 for topical treatment of a plant to be treated for, or be protected from, flea beetle infestation. Another aspect includes a recombinant DNA construct encoding at least one strand of at least one the dsRNA triggers provided in Table 1 for transgenic expression in a plant that has improved resistance to flea beetle infestation, in comparison to a plant not expressing such a construct.


Example 2

This example illustrates non-limiting embodiments of testing the efficacy of dsRNA trigger sequences and validating the triggers' utility for suppressing coding DNA sequences useful as target genes for controlling insect species. More specifically this example illustrates a method including contacting an insect, such as a flea beetle adult or larva, with one or more dsRNA triggers designed to cause stunting or mortality in the insect. Other embodiments include methods where the dsRNA trigger is delivered to the insect by oral delivery (e. g., on or in a food material ingested by the insect), or through non-oral delivery (e. g., delivery through the insect's cuticle, or delivery by contacting an egg of the insect).


In one embodiment, a feeding assay is used to determine efficacy of a dsRNA trigger in causing stunting or mortality in insects, such as flea beetles. To test the efficacy of the dsRNA triggers to kill or stunt flea beetles, a single discriminating dose (for example, 100 nanograms/milliliter) is used to identify dsRNA triggers with measurable ability to kill or stunt flea beetles at that dose. A negative control dsRNA trigger, such as a dsRNA targetting green fluorescent protein (GFP), is also included in the assay. Each dsRNA trigger is coated evenly onto 1.0 centimeter diameter canola leaf discs and placed in multiwell trays, with 2 male and 2 female adult flea beetles or 4 flea beetle larvae per well. Every 24 hours for a set period (e. g., 2 weeks), new, freshly-coated leaves are provided. Stunting and mortality are scored periodically (e. g., daily, or every 2 or 3 days).


The dsRNA triggers that show efficacy in this single-dose assay are tested further. Using a similar protocol, varying doses of dsRNA triggers are tested, as described above, to determine the LC50 dose for each of the active dsRNAs. Bioassays include 12-24 insects per dose, performed in triplicate. Stunting and mortality is assessed over a 2 week period, scored on every third day.


The dsRNA trigger sequences that are confirmed to be effective in suppressing a target gene in a sequence-specific manner are useful for identifying efficacious RNA delivery agents and formulations. The insecticidal activity of formulations containing the dsRNA triggers can be optimized by various techniques, such as modifying the chemical entities in the formulation or modifying the ratio of the chemical components in the formulation. Non-limiting examples of delivery agents and formulations are provided in Example 5.


Example 3

This example illustrates non-limiting embodiments of methods for validating dsRNA trigger efficacy for suppressing or silencing a target gene in an insect cell or causing stunting or mortality in an insect. More specifically this example illustrates methods for testing dsRNA triggers for efficacy in preventing or treating flea beetle infestations in whole plants.


Polynucleotides (such as the dsRNA trigger sequences described in Examples 1 and 2) that have been confirmed to be effective in suppressing a target gene in a sequence-specific manner are further evaluated in whole plant assays. In one method, the polynucleotides (e. g., dsRNA triggers) are applied directly to the insect surface (e. g. by spraying or dusting). In another method, the polynucleotides are provided to the insect in an insect diet (e. g., in a bacterial or plant cell expressing a dsRNA trigger such as a hairpin form of a dsRNA trigger, or in an artificial bait containing RNA). Stunting and mortality are scored periodically, as described in Example 2.


In various methods that are also appropriate for large-scale application (e. g., to fields of crop plants), the polynucleotide is applied in a foliar application through aerial or terrestrial spraying or dusting or chemigation on the leaf surface to control early season damage from the adult stage of the life cycle, or applied as a seed treatment to control larval or adult stages of the insect life cycle, or applied as a soil in-furrow or drench application to control larval or adult stages of the insect life cycle. An example of a foliar testing regime includes treating the plant immediately after emergence from the ground and evaluating foliar damage caused by adult flea beetles 1-2 weeks after plant emergence. For in-furrow or seed treatment similar timing for damage evaluation is followed.


Example 4

The polynucleotides are generally designed to modulate expression by inducing regulation or suppression of an insect target gene and are designed to have a nucleotide sequence essentially identical or essentially complementary to the nucleotide sequence an insect target gene or cDNA (e. g., SEQ ID NOs:1-859) or to the sequence of RNA transcribed from an insect target gene, which can be coding sequence or non-coding sequence. These effective polynucleotide molecules that modulate expression are referred to herein as a “trigger”, or “triggers”. This example describes non-limiting techniques useful in the design and selection of polynucleotides as “triggers” to modulate expression of an insect target gene.


Selection of Polynucleotide Triggers by “Tiling”


Polynucleotides of use in the compositions and methods disclosed herein need not be of the full length of a target gene, and in many embodiments are of much shorter length in comparison to the target gene. An example of a technique that is useful for selecting effective triggers is “tiling”, or evaluation of polynucleotides corresponding to adjacent or partially overlapping segments of a target gene.


Effective polynucleotide “triggers” can be identified by “tiling” gene targets in selected length fragments, e. g., fragments of 200-300 nucleotides in length, with partially overlapping regions, e. g., of about 25 nucleotides, along the length of the target gene. To suppress a single gene, trigger sequences are designed to correspond to (have a nucleotide identity or complementarity with) regions that are unique to the target gene; the selected region of the target gene can include coding sequence or non-coding sequence (e. g., promoter regions, 3′ untranslated regions, introns and the like) or a combination of both.


Where it is of interest to design a target effective in suppressing multiple target genes, the multiple target gene sequences are aligned and polynucleotide triggers designed to correspond to regions with high sequence homology in common among the multiple targets. Conversely, where it is of interest to design a target effective in selectively suppressing one among multiple target sequences, the multiple target gene sequences are aligned and polynucleotide triggers designed to correspond to regions with no or low sequence homology in common among the multiple targets.


In a non-limiting example, anti-sense single-stranded RNA triggers are designed for each of the target genes listed in Table 1 as follows. Multiple anti-sense single-stranded RNA triggers, each of 200-300 nucleotides in length and with a sequence corresponding to (e. g., for anti-sense triggers, complementary to) a fragment of a target gene having a sequence selected from SEQ ID NOs:1-859 are designed so that each trigger's sequence overlaps about 25 nucleotides of the next adjacent trigger's sequence, in such a way that the multiple triggers in combination cover the full length of the target gene. (Sense triggers are designed in an analogous fashion, where the trigger sequence is identical to a fragment of the target gene. Similarly, double-stranded triggers can be designed by providing pairs of sense and anti-sense triggers, each pair of triggers overlapping the next adjacent pair of triggers.)


The polynucleotide triggers are tested by any convenient means for efficacy in silencing the insect target gene. Examples of a suitable test include the bioassays described herein in the working Examples. Another test involves the topical application of the polynucleotide triggers either directly to individual insects or to the surface of a plant to be protected from an insect infestation. One desired result of treatment with a polynucleotide as disclosed herein is prevention or control of an insect infestation, e. g., by inducing in an insect a physiological or behavioural change such as, but not limited to, growth stunting, increased mortality, decrease in reproductive capacity, decrease in or cessation of feeding behavior or movement, or decrease in or cessation of metamorphosis stage development. Another desired result of treatment with a polynucleotide as disclosed herein is provision of a plant that exhibits improved resistance to an insect infestation.


The tiling procedure can be repeated, if desired. A polynucleotide trigger found to provide desired activity can itself be subjected to a tiling procedure. For example, multiple overlapping anti-sense single-stranded RNA triggers are designed, each of 50-60 nucleotides in length and with a sequence corresponding to (e. g., for anti-sense triggers, complementary to) the fragment of a target gene having a sequence selected from SEQ ID NOs:1-859 for which a single polynucleotide trigger of 300 nucleotides was found to be effective. Additional rounds of tiling analysis can be carried out, where triggers as short as 18, 19, 20, or 21 nucleotides are tested.


Effective polynucleotide triggers of any size can be used, alone or in combination, in the various methods disclosed herein. In some embodiments, a single polynucleotide trigger is used to make a composition (e. g., a composition for topical application, or a recombinant DNA construct useful for making a transgenic plant). In other embodiments, a mixture or pool of different polynucleotide triggers is used; in such cases the polynucleotide triggers can be for a single target gene or for multiple target genes. In some embodiments, a polynucleotide trigger is designed to target different regions of the target gene, e. g., a trigger can include multiple segments that correspond to different exon regions of the target gene, and “spacer” nucleotides which do not correspond to a target gene can optionally be used in between or adjacent to the segments.


Thermodynamic Considerations in Selecting Polynucleotide Triggers


Polynucleotide triggers can be designed or their sequence optimised using thermodynamic considerations. For example, polynucleotide triggers can be selected based on the thermodynamics controlling hybridization between one nucleic acid strand (e. g., a polynucleotide trigger or an individual siRNA) and another (e. g., a target gene transcript)


Methods and algorithms to predict nucleotide sequences that are likely to be effective at RNAi-mediated silencing of a target gene are known in the art. Non-limiting examples of such methods and algorithms include “i-score”, described by Ichihara et al. (2007) Nucleic Acids Res., 35(18): 123e; “Oligowalk”, publicly available at rna.urmc.rochester.edu/servers/oligowalk and described by Lu et al. (2008) Nucleic Acids Res., 36:W104-108; and “Reynolds score”, described by Khovorova et al. (2004) Nature Biotechnol., 22:326-330.


Permitted Mismatches


By “essentially identical” or “essentially complementary” is meant that the trigger polynucleotide (or at least one strand of a double-stranded polynucleotide) has sufficient identity or complementarity to the target gene or to the RNA transcribed from a target gene (e. g., the transcript) to suppress expression of a target gene (e. g., to effect a reduction in levels or activity of the target gene transcript and/or encoded protein). Polynucleotides need not have 100 percent identity or complementarity to a target gene or to the RNA transcribed from a target gene to suppress expression of the target gene (e. g., to effect a reduction in levels or activity of the target gene transcript or encoded protein, or to provide control of an insect species). In some embodiments, the polynucleotide or a portion thereof is designed to be essentially identical to, or essentially complementary to, a sequence of at least 18 or 19 contiguous nucleotides in either the target gene or the RNA transcribed from the target gene. In some embodiments, the polynucleotide or a portion thereof is designed to be exactly identical to, or exactly complementary to, a sequence of 21 contiguous nucleotides in either the target gene or the RNA transcribed from the target gene. In certain embodiments, an “essentially identical” polynucleotide has 100 percent sequence identity or at least about 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, or 99 percent sequence identity when compared to the sequence of 18 or more contiguous nucleotides in either the endogenous target gene or to an RNA transcribed from the target gene. In certain embodiments, an “essentially complementary” polynucleotide has 100 percent sequence complementarity or at least about 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, or 99 percent sequence complementarity when compared to the sequence of 18 or more contiguous nucleotides in either the target gene or RNA transcribed from the target gene.


Polynucleotides containing mismatches to the target gene or transcript can be used in certain embodiments of the compositions and methods disclosed herein. In some embodiments, the polynucleotide includes at least 18 or at least 19 contiguous nucleotides that are essentially identical or essentially complementary to a segment of equivalent length in the target gene or target gene's transcript. In certain embodiments, a polynucleotide of 19 contiguous nucleotides that is essentially identical or essentially complementary to a segment of equivalent length in the target gene or target gene's transcript can have 1 or 2 mismatches to the target gene or transcript (i. e., 1 or 2 mismatches between the polynucleotide's 19 contiguous nucleotides and the segment of equivalent length in the target gene or target gene's transcript). In certain embodiments, a polynucleotide of 20 or more nucleotides that contains a contiguous 19 nucleotide span of identity or complementarity to a segment of equivalent length in the target gene or target gene's transcript can have 1 or 2 mismatches to the target gene or transcript. In certain embodiments, a polynucleotide of 21 continuous nucleotides that is essentially identical or essentially complementary to a segment of equivalent length in the target gene or target gene's transcript can have 1, 2, or 3 mismatches to the target gene or transcript. In certain embodiments, a polynucleotide of 22 or more nucleotides that contains a contiguous 21 nucleotide span of identity or complementarity to a segment of equivalent length in the target gene or target gene's transcript can have 1, 2, or 3 mismatches to the target gene or transcript.


In designing polynucleotides with mismatches to an endogenous target gene or to an RNA transcribed from the target gene, mismatches of certain types and at certain positions that are more likely to be tolerated can be used. In certain exemplary embodiments, mismatches formed between adenine and cytosine or guanosine and uracil residues are used as described by Du et al. (2005) Nucleic Acids Res., 33:1671-1677. In some embodiments, mismatches in 19 base-pair overlap regions are located at the low tolerance positions 5, 7, 8 or 11 (from the 5′ end of a 19-nucleotide target), at medium tolerance positions 3, 4, and 12-17(from the 5′ end of a 19-nucleotide target), and/or at the high tolerance positions at either end of the region of complementarity, e. g., positions 1, 2, 18, and 19 (from the 5′ end of a 19-nucleotide target) as described by Du et al. (2005) Nucleic Acids Res., 33:1671-1677. Tolerated mismatches can be empirically determined in routine assays such as those described herein in the working Examples.


In some embodiments, the polynucleotides include additional nucleotides for reasons of stability or for convenience in cloning or synthesis. In one embodiment, the polynucleotide is a dsRNA including an RNA strand with a segment of at least 21 contiguous nucleotides of a sequence selected from the group consisting of SEQ ID NOs:860-1718 and 1722-1724 and further including an additional 5′ G or an additional 3′ C or both, adjacent to the segment. In another embodiment, the polynucleotide is a double-stranded RNA including additional nucleotides to form an overhang, for example, a dsRNA including 2 deoxyribonucleotides to form a 3′ overhang.


Embedding Active Triggers in Neutral Sequence


In an embodiment, a bioactive trigger (i. e., a polynucleotide with a sequence corresponding to the target gene and which is responsible for an observed suppression of the target gene) is embedded in “neutral” sequence, e. g., inserted into additional nucleotides that have no sequence identity or complementarity to the target gene. Neutral sequence can be desirable, e. g., to increase the overall length of a polynucleotide. For example, it can be desirable for a polynucleotide to be of a particular size for reasons of stability, cost-effectiveness in manufacturing, or biological activity.


It has been reported that in another coleopteran species, Diabrotica virgifera, dsRNAs greater than or equal to approximately 60 base-pairs (bp) are required for biological activity in artificial diet bioassays; see Bolognesi et al. (2012) PLoS ONE 7(10): e47534. doi:10.1371/journal.pone.0047534. Thus, in one embodiment, a 21-base-pair dsRNA trigger corresponding to a target gene in Table 1 and found to provide control of an insect infestation is embedded in neutral sequence of an additional 39 base pairs, thus forming a polynucleotide of about 60 base pairs. In another embodiment, a single 21-base-pair trigger is found to be efficacious when embedded in larger sections of neutral sequence, e. g., where the total polynucleotide length is from about 60 to about 300 base pairs. In another embodiment, at least one segment of at least 21 contiguous nucleotides of a sequence selected from the group consisting of SEQ ID NOs:860-1718 and 1722-1724 is embedded in larger sections of neutral sequence to provide an efficacious trigger. In another embodiment, segments from multiple sequences selected from the group consisting of SEQ ID NOs:860-1718 and 1722-1724 are embedded in larger sections of neutral sequence to provide an efficacious trigger.


It is anticipated that the combination of certain recombinant RNAs disclosed herein (e. g., the dsRNA triggers including a sequence selected from the group consisting of SEQ ID NOs:860-1718 and 1722-1724, or active fragments of these triggers) with one or more non-polynucleotide pesticidal agents will result in a synergetic improvement in prevention or control of insect infestations, when compared to the effect obtained with the recombinant RNA alone or the non-polynucleotide pesticidal agent alone. Routine insect bioassays such as the bioassays described herein in the working Examples are useful for defining dose-responses for larval mortality or growth inhibition using combinations of the polynucleotides disclosed herein and one or more non-polynucleotide pesticidal agents (e. g., a patatin, a plant lectin, a phytoecdysteroid, a Bacillus thuringiensis insecticidal protein, a Xenorhabdus insecticidal protein, a Photorhabdus insecticidal protein, a Bacillus laterosporous insecticidal protein, and a Bacillus sphaericus insecticidal protein). One of skill in the art can test combinations of polynucleotides and non-polynucleotide pesticidal agents in routine bioassays to identify combinations of bioactives that are synergistic and desirable for use in protecting plants from insect infestations.


Example 5

This example illustrates non-limiting embodiments of methods of testing the efficacy of dsRNA triggers in flea beetles. More specifically this example illustrates a method including oral delivery of dsRNAs to flea beetles, resulting in stunting or mortality in the flea beetles.



P. cruciferae were collected from a canola field where no pesticides had been applied in the previous 3 months. Three dsRNAs (SEQ ID NOs:1169, 1193, and 1392) targeting Phyllotreta genes and one negative control dsRNA targeting GFP were tested on groups of 30 P. cruciferae. The dsRNAs were resuspended in water and applied to 6 millimeter leaf discs (55±6 milligrams each) at a discriminating dose of 50 nanograms dsRNA/milligram leaf tissue, which were fed to groups of 5 flea beetles. Leaf discs with freshly applied dsRNA were replaced every other day, and the number of surviving individuals was recorded over a 2-week period. A low non-specific mortality rate was observed in the negative-control insect groups (3 out of 30 insects dying over 2 weeks, or 10% non-specific mortality). Mortality was observed beginning at day 4 and continuing through the 2 week period. Specific mortality was observed for all dsRNA treatments (Table 2). Correcting for non-specific mortality (subtracting non-specific mortality rate of 3 insects per group for corrected N=27), the percent mortality observed at the end of the 2-week period was 85% (SEQ ID NO:1169), 0.70% (SEQ ID NO:1193), and 0.63% (SEQ ID NO:1392). These results demonstrated the efficacy of the dsRNA triggers in causing mortality in flea beetles when provided in the flea beetles' diet.









TABLE 2







Cumulative number of dead P. cruciferae (N = 30)












Negative
SEQ ID NO:
SEQ ID NO:
SEQ ID NO:


Day
control
1169
1193
1392














0
0
0
0
0


2
1
2
1
1


4
2
6
2
2


6
2
9
3
3


8
2
13
8
9


10
3
18
16
15


12
3
23
19
18


14
3
26
22
20









In a second series of experiments carried out in a similar manner, several dsRNA triggers were tested at a discriminating dose of 50 nanograms dsRNA/milligram leaf tissue on P. cruciferae; two lower doses (15 nanograms dsRNA/milligram leaf tissue and 2 nanograms dsRNA/milligram leaf tissue) were also tested. Ten beetles were tested at each dose. The negative control (five replicates) used was a dsRNA trigger targetting the bacterial gene uidA encoding beta-glucuronidase (NCBI accession number NC_000913.3). Leaf discs with freshly applied dsRNA were replaced every other day, and mortality was recorded over a 12 day period. The overall mortality rate for the negative controls was ˜4% (likely due to handling injuries) over the 12-day observation period. The observed cumulative mortality (N=10) following 12 days exposure to the dsRNAs are provided in Table 3; the negative control mortality values are given as an average (N=5). Eight of the dsRNA triggers (indicated by a mortality rating of +++) caused 90-100% mortality at the highest dose and were still highly effective (80% or higher mortality) at the lowest dose tested. Some dsRNA triggers (indicated by a mortality rating of ++) induced mortality in a proportion of the insects at the highest dose, but were less effective at lower doses (<20% mortality).












TABLE 3









cumulative mortality (N = 10)
Mortality











Trigger SEQ ID NO:
50 ng/mg
15 ng/mg
2 ng/mg
Rating*














 870
3
1
0



 876
3
1
0



1156
2
0
0



1157
10
3
0



1158
2
0
0



1159
5
2
0



1160
2
0
0



1161
10
3
1



1163
4
4
2



1164
10
8
4
++


1165
8
7
5
++


1166
5
2
2



1167
6
2
0



1168
8
5
0



1169
10
10
8
+++


1170
9
5
3



1171
10
10
6
++


1392
3
2
0



1393
6
1
0



1186
9
7
5



1394
9
9
5



1187
9
9
8
+++


1193
10
10
9
+++


1210
6
3
1



1219
8
3
2



1224
10
9
8
+++


1234
10
7
6
++


1243
5
2
0



1258
9
4
2



1396
9
6
5
++


1397
6
3
0



1398
8
7
7
++


1399
10
10
8
+++


1400
2
1
1



1403
9
6
6



1404
10
7
4



1405
6
6
2



1406
9
9
7
+++


1407
10
9
8
+++


1408
9
9
9
+++


negative control (GFP)
0.6
0.6
0.4



negative control (beta-
0.4
0.6
0.2



glucuronidase)


negative control (water
0.2
0.4
0.6



only)





*+++ rating indicates high (>80%) mortalities for all three doses; ++ rating indicates high mortalities for the highest dose, and within 40 to 70% mortality with the lower two doses.






Other techniques for delivering these or similar dsRNA triggers are contemplated and include applying the dsRNA triggers directly to the insect surface (e. g. by spraying or dusting), or providing the dsRNA triggers to the insect in a diet or bait (e. g., in a bacterial or plant cell expressing a dsRNA trigger such as a hairpin form of a dsRNA trigger, or in an artificial bait containing the dsRNA). In an embodiment, a hairpin version of the Phyllotreta trigger with the sequence SEQ ID NO: 1169 is designed; this hairpin version is encoded by the DNA sequence SEQ ID NO:1722, which contains, in 5′ to 3′ order, anti-sense sequence (nucleotide positions 1-267), loop sequence (nucleotide positions 268-373) which does not contain matches to Phyllotreta sequences, and sense sequence (nucleotide positions 374-640). This DNA sequence is expressed as a single-stranded RNA transcript, wherein the anti-sense and sense regions anneal to form the double-stranded “stem” region of the hairpin. The construct is expressed in a bacterium, such as E. coli; the resulting dsRNA hairpin produced in the bacterium is provided to flea beetles as a crude or purified fermentation product, or in the form of the bacterial cells. Similar constructs are designed encoding dsRNAs having modified stem-loops, such as “stabilized anti-sense” or “stabilized sense” versions, which contain stabilized loops formed by an extended anti-sense or sense sequence, respectively, of trigger sequence corresponding to the intended target gene.


Example 6

This example discloses embodiments related to polynucleotide molecules having a nucleotide sequence containing specific modifications such as nucleotide substitutions. Embodiments of such modifications include modified dsRNA triggers that provide improved sequence discrimination between the intended target gene of the insect pest of interest, and genetic sequences of other, non-target species.


Selected dsRNA triggers identified in Table 1 were screened for unintended sequence matches to a sequence of at least 19 contiguous nucleotides identified in a non-target gene or a non-target organism (NTO, e. g., Apis mellifera, Bombus impatiens and B. terrestris; Coleomegilla spp.; Danaus plexippus; Homo sapiens; Megachile rotundata; Mus musculus; and Brassica rapa). Nucleotide changes are made in an original trigger sequence to eliminate undesirable sequence matches to a non-target gene or non-target organism. Examples of such modified trigger sequences are provided by SEQ ID NO:1723, which corresponds to SEQ ID NO:1393 (which targets the same flea beetle gene as does the trigger SEQ ID NO:1392), and SEQ ID NO:1724, which corresponds to SEQ ID NO:1169. These modified trigger sequences provide improved discrimination between the intended target species and non-target organisms.


Example 7

This example discloses embodiments related to polynucleotide molecules having a nucleotide sequence for silencing a target gene in more than one species. Embodiments include dsRNA sequences of at least 21 contiguous nucleotides identified as having 100% complementarity or identity to more than one species-specific target gene.


Table 4 provides a list of sequences, each at least 21 contiguous nucleotides in length and identified by the sequence's coordinates in a dsRNA trigger for one flea beetle species, wherein the identical sequence is also found in a dsRNA trigger for a different flea beetle species. These sequences are useful as triggers in the multiple species in which the sequence co-occurs. For example, the trigger having the sequence of SEQ ID NO:1186 (targetting a Phyllotreta cruciferae COPI alpha target gene, SEQ ID NO:327) contains five sequences of at least 21 contiguous nucleotides at positions 1-71, 88-116, 136-209, 238-266, and 274-296, all of which match a sequence in the triggers having the sequences of SEQ ID NOs:882 and 888 (targetting a Phyllotreta atra COPI alpha target genes, SEQ ID NOs:23 and 29, respectively); these five sequences are therefore useful in targeting a gene in the two Phyllotreta species.












TABLE 4







QUERY Trigger

QUERY Trigger















SEQ


SUBJECT Trigger
SEQ


SUBJECT Trigger


ID NO:
start
end
SEQ ID NO:
ID NO:
start
end
Trigger SEQ ID NO:

















1186
1
71
882, 888
1333
329
351
1039-1043, 1045, 1594, 1597,









1598


1186
88
116
882, 888
1334
42
98
1039-1043, 1045, 1594, 1597,









1598


1186
136
209
882, 888
1334
109
185
1039-1043, 1045, 1594, 1597,









1598


1186
238
266
882, 888
1334
187
254
1039-1043, 1045, 1594, 1597,









1598


1186
274
296
882, 888
1334
271
302
1039-1043, 1045, 1594, 1597,









1598


1191
51
96
900-908, 910
1335
2
47
1039-1043, 1045, 1594, 1597,









1598


1191
137
177
900-908, 910
1335
49
116
1039-1043, 1045, 1594, 1597,









1598


1191
179
216
900-908, 910
1335
133
164
1039-1043, 1045, 1594, 1597,









1598


1191
218
255
900-908, 910
1335
229
251
1039-1043, 1045, 1594, 1597,









1598


1191
257
342
900-908, 910
1336
34
90
1039-1043, 1045, 1594, 1597,









1598


1192
2
25
900-908, 910
1336
101
177
1039-1043, 1045, 1594, 1597,









1598


1192
66
106
900-908, 910
1336
179
246
1039-1043, 1045, 1594, 1597,









1598


1192
108
145
900-908, 910
1336
263
294
1039-1043, 1045, 1594, 1597,









1598


1192
147
184
900-908, 910
1338
40
96
1039-1043, 1045, 1594, 1597,









1598


1192
186
271
900-908, 910
1338
107
183
1039-1043, 1045, 1594, 1597,









1598


1192
273
298
900-908, 910
1338
185
252
1039-1043, 1045, 1594, 1597,









1598


1192
300
330
900-908, 910
1338
269
300
1039-1043, 1045, 1594, 1597,









1598


1191
58
96
900-908, 910
1328
35
59
1039-1043, 1045, 1594, 1597,









1598


1192
300
336
900-908, 910
1331
60
84
1039-1043, 1045, 1594, 1597,









1598


1191
44
96
900-908, 910
1332
1
26
1039-1043, 1045, 1594, 1597,









1598


1191
179
200
900-908, 910
1333
36
60
1039-1043, 1045, 1594, 1597,









1598


1192
108
129
900-908, 910
1334
74
98
1039-1043, 1045, 1594, 1597,









1598


1191
218
242
900-908, 910
1336
66
90
1039-1043, 1045, 1594, 1597,









1598


1192
147
171
900-908, 910
1338
72
96
1039-1043, 1045, 1594, 1597,









1598


1191
257
277
900-908, 910
1331
1
26
1039-1043, 1045, 1594, 1597,









1598


1192
186
206
900-908, 910
1334
2
40
1039-1043, 1045, 1594, 1597,









1598


1191
257
334
900-908, 910
1336
2
32
1039-1043, 1045, 1594, 1597,









1598


1192
186
263
900-908, 910
1338
2
38
1039-1043, 1045, 1594, 1597,









1598


1191
257
320
900-908, 910
1328
36
59
1039-1043, 1045, 1594, 1597,









1598


1192
186
249
900-908, 910
1331
61
84
1039-1043, 1045, 1594, 1597,









1598


1193
15
101
911, 915, 916, 919
1332
3
26
1039-1043, 1045, 1594, 1597,









1598


1194
6
92
911, 915, 916, 919
1333
37
60
1039-1043, 1045, 1594, 1597,









1598


1195
2
107
911, 915, 916, 919
1334
75
98
1039-1043, 1045, 1594, 1597,









1598


1195
121
207
911, 915, 916, 919
1336
67
90
1039-1043, 1045, 1594, 1597,









1598


1196
2
122
911, 915, 916, 919
1338
73
96
1039-1043, 1045, 1594, 1597,









1598


1196
136
222
911, 915, 916, 919
1329
172
191
1039-1043 1045


1197
2
20
911, 915, 916, 919
1329
265
296
1039-1043 1045


1197
22
42
911, 915, 916, 919
1329
298
317
1039-1043 1045


1197
44
180
911, 915, 916, 919
1329
319
343
1039-1043 1045


1197
194
280
911, 915, 916, 919
1330
181
200
1039-1043 1045


1198
18
38
911, 915, 916, 919
1330
274
305
1039-1043 1045


1198
40
176
911, 915, 916, 919
1330
307
326
1039-1043 1045


1198
190
276
911, 915, 916, 919
1330
328
352
1039-1043 1045


1199
5
25
911, 915, 916, 919
1335
283
302
1039-1043, 1045, 1594, 1597,









1598


1199
27
163
911, 915, 916, 919
1337
1
19
1043, 1045


1199
177
263
911, 915, 916, 919
1337
93
124
1043, 1045


1200
16
152
911, 915, 916, 919
1337
126
145
1043, 1045


1200
166
252
911, 915, 916, 919
1337
147
171
1043, 1045


1201
19
105
911, 915, 916, 919
1329
319
352
1039-1043 1045


1202
2
119
911, 915, 916, 919
1337
147
180
1043, 1045


1202
133
219
911, 915, 916, 919
1386
2
38
1054-1057, 1060, 1496, 1498


1203
14
100
911, 915, 916, 919
1386
40
59
1054-1057, 1060, 1496, 1498


1193
123
189
911, 915, 916, 919
1386
70
95
1054-1057, 1060, 1496, 1498


1194
114
180
911, 915, 916, 919
1386
103
161
1054-1057, 1060, 1496, 1498


1195
229
295
911, 915, 916, 919
1386
196
262
1054-1057, 1060, 1496, 1498


1196
244
310
911, 915, 916, 919
1388
2
51
1054-1057, 1060, 1496, 1498


1197
302
350
911, 915, 916, 919
1388
53
72
1054-1057, 1060, 1496, 1498


1198
298
350
911, 915, 916, 919
1388
83
108
1054-1057, 1060, 1496, 1498


1199
285
352
911, 915, 916, 919
1388
116
174
1054-1057, 1060, 1496, 1498


1200
274
340
911, 915, 916, 919
1388
209
275
1054-1057, 1060, 1496, 1498


1201
127
193
911, 915, 916, 919
1390
88
119
1054-1057, 1060, 1492,









1496-1498


1202
241
307
911, 915, 916, 919
1390
145
194
1054-1057, 1060, 1492,









1496-1498


1203
122
188
911, 915, 916, 919
1390
196
215
1054-1057, 1060, 1492,









1496-1498


1193
123
196
911, 915, 916, 919
1390
226
251
1054-1057, 1060, 1492,









1496-1498


1193
198
230
911, 915, 916, 919
1390
259
317
1054-1057, 1060, 1492,









1496-1498


1194
114
187
911, 915, 916, 919
1391
19
50
1054-1057, 1060, 1492,









1496-1498


1194
189
221
911, 915, 916, 919
1391
76
125
1054-1057, 1060, 1492,









1496-1498


1195
229
302
911, 915, 916, 919
1391
127
146
1054-1057, 1060, 1492,









1496-1498


1195
304
336
911, 915, 916, 919
1391
157
182
1054-1057, 1060, 1492,









1496-1498


1196
1
122
911, 915, 916, 919
1391
190
248
1054-1057, 1060, 1492,









1496-1498


1196
244
317
911, 915, 916, 919
1391
283
349
1054-1057, 1060, 1492,









1496-1498


1196
319
351
911, 915, 916, 919
1384
20
39
1055, 1058, 1059, 1061-1063,









1500


1197
60
180
911, 915, 916, 919
1384
62
84
1055, 1058, 1059, 1061-1063,









1500


1198
56
176
911, 915, 916, 919
1384
134
204
1055, 1058, 1059, 1061-1063,









1500


1199
43
163
911, 915, 916, 919
1384
206
249
1055, 1058, 1059, 1061-1063,









1500


1199
285
351
911, 915, 916, 919
1384
251
270
1055, 1058, 1059, 1061-1063,









1500


1200
32
152
911, 915, 916, 919
1384
284
305
1055, 1058, 1059, 1061-1063,









1500


1200
274
347
911, 915, 916, 919
1385
21
40
1055, 1058, 1059, 1061-1063,









1500


1201
127
200
911, 915, 916, 919
1385
63
85
1055, 1058, 1059, 1061-1063,









1500


1201
202
234
911, 915, 916, 919
1385
135
205
1055, 1058, 1059, 1061-1063,









1500


1202
241
314
911, 915, 916, 919
1385
207
250
1055, 1058, 1059, 1061-1063,









1500


1202
316
348
911, 915, 916, 919
1385
252
271
1055, 1058, 1059, 1061-1063,









1500


1203
122
195
911, 915, 916, 919
1385
285
306
1055, 1058, 1059, 1061-1063,









1500


1203
197
229
911, 915, 916, 919
1387
2
21
1055, 1058, 1059, 1061-1063,









1500, 1057


1204
6
25
920, 921, 922, 923, 924
1387
23
42
1055, 1058, 1059, 1061-1063,









1500, 1057


1204
27
49
920, 921, 922, 923, 924
1387
56
77
1055, 1058, 1059, 1061-1063,









1500, 1057


1204
51
118
920, 921, 922, 923, 924
1389
1
55
1055, 1058, 1059, 1061-1063,









1500


1204
186
214
920, 921, 922, 923, 924
1389
57
100
1055, 1058, 1059, 1061-1063,









1500


1204
219
268
920, 921, 922, 923, 924
1389
102
121
1055, 1058, 1059, 1061-1063,









1500


1204
270
295
920, 921, 922, 923, 924
1389
135
156
1055, 1058, 1059, 1061-1063,









1500


1204
306
351
920, 921, 922, 923, 924
1386
196
255
1054-1057, 1060, 1496, 1498


1205
180
199
920, 921, 922, 923, 924
1388
209
268
1054-1057, 1060, 1496, 1498


1205
201
223
920, 921, 922, 923, 924
1391
283
342
1054-1057, 1060, 1492,









1496-1498


1205
225
292
920, 921, 922, 923, 924
1387
257
321
1055, 1058, 1059, 1061-1063,









1500, 1057


1206
10
29
920, 921, 922, 923, 924
1387
332
351
1055, 1058, 1059, 1061-1063,









1500, 1057


1206
31
53
920, 921, 922, 923, 924
1390
25
56
1054-1057, 1060, 1492,









1496-1498


1206
55
122
920, 921, 922, 923, 924
1384
284
321
1055, 1058, 1059, 1061-1063,









1500


1206
190
218
920, 921, 922, 923, 924
1385
285
322
1055, 1058, 1059, 1061-1063,









1500


1206
223
272
920, 921, 922, 923, 924
1387
56
93
1055, 1058, 1059, 1061-1063,









1500, 1057


1206
274
299
920, 921, 922, 923, 924
1389
135
172
1055, 1058, 1059, 1061-1063,









1500


1206
310
351
920, 921, 922, 923, 924
1386
196
332
1054-1057,1060, 1496, 1498


1207
11
33
920, 921, 922, 923, 924
1388
209
345
1054-1057, 1060, 1496, 1498


1207
35
102
920, 921, 922, 923, 924
1391
283
352
1054-1057, 1060, 1492,









1496-1498


1207
170
198
920, 921, 922, 923, 924
1384
323
348
1055, 1058, 1059, 1061-1063,









1500


1207
203
252
920, 921, 922, 923, 924
1385
324
349
1055, 1058, 1059, 1061-1063,









1500


1207
254
279
920, 921, 922, 923, 924
1387
95
120
1055, 1058, 1059, 1061-1063,









1500, 1057


1207
290
335
920, 921, 922, 923, 924
1387
128
153
1055, 1058, 1059, 1061-1063,









1500, 1057


1208
18
40
920, 921, 922, 923, 924
1387
161
186
1055, 1058, 1059, 1061-1063,









1500, 1057


1208
42
109
920, 921, 922, 923, 924
1387
191
210
1055, 1058, 1059, 1061-1063,









1500, 1057


1208
177
205
920, 921, 922, 923, 924
1389
174
199
1055, 1058, 1059, 1061-1063,









1500


1208
210
259
920, 921, 922, 923, 924
1389
207
232
1055, 1058, 1059, 1061-1063,









1500


1208
261
286
920, 921, 922, 923, 924
1389
240
265
1055, 1058, 1059, 1061-1063,









1500


1208
297
342
920, 921, 922, 923, 924
1389
270
289
1055, 1058, 1059, 1061- 063,









1500


1209
101
120
920, 921, 922, 923, 924
1283
177
208
1064-1070


1209
122
144
920, 921, 922, 923, 924
1284
130
161
1064-1070


1209
146
213
920, 921, 922, 923, 924
1284
301
351
1064-1070


1209
281
309
920, 921, 922, 923, 924
1286
210
241
1064-1070


1209
314
351
920, 921, 922, 923, 924
1287
126
157
1064-1070


1205
2
91
920, 921, 922, 923, 924
1287
297
351
1064-1070


1205
114
142
920, 921, 922, 923, 924
1288
326
351
1064-1070, 1071


1205
144
178
920, 921, 922, 923, 924
1289
41
72
1064-1070


1209
35
63
920, 921, 922, 923, 924
1289
212
288
1064-1070


1209
65
99
920, 921, 922, 923, 924
1289
320
351
1064-1070


1204
306
347
920, 921, 922, 923, 924
1290
178
209
1064-1070


1207
290
331
920, 921, 922, 923, 924
1291
228
259
1064-1070, 1071


1208
297
338
920, 921, 922, 923, 924
1292
43
74
1064-1070


1207
290
352
920, 921, 922, 923, 924
1292
214
290
1064-1070


1208
297
351
920, 921, 922, 923, 924
1292
322
351
1064-1070


1205
18
91
920, 921, 922, 923, 924
1293
330
351
1064-1070, 1071


1224
1
43
947-949, 951-956
1377
37
68
1064-1070


1224
57
95
947-949, 951-956
1377
208
284
1064-1070


1224
97
145
947-949, 951-956
1377
316
348
1064-1070


1224
147
175
947-949, 951-956
1289
212
274
1064-1070


1224
177
208
947-949, 951-956
1292
214
276
1064-1070


1224
210
262
947-949, 951-956
1377
208
270
1064-1070


1224
285
350
947-949, 951-956
1285
123
148
1067, 1069, 1071


1225
150
192
947, 949, 951-956
1288
107
132
1064-1070, 1071


1225
206
244
947, 949, 951-956
1291
9
34
1064-1070, 1071


1225
246
294
947, 949, 951-956
1293
111
136
1064-1070, 1071


1225
296
324
947, 949, 951-956
1287
297
347
1064-1070


1225
326
351
947, 949, 951-956
1289
212
262
1064-1070


1226
258
300
947, 949, 951-955
1292
214
264
1064-1070


1226
314
351
947, 949, 951-955
1377
208
258
1064-1070


1227
253
295
947, 949, 951-955
1287
297
352
1064-1070


1227
309
347
947, 949, 951-955
1289
212
266
1064-1070


1228
206
248
947, 949, 951-956
1292
214
268
1064-1070


1228
262
300
947, 949, 951-956
1377
208
262
1064-1070


1228
302
350
947, 949, 951-956
1285
18
61
1067, 1069, 1071


1229
171
213
947, 949, 951-956
1288
2
45
1064-1070, 1071


1229
227
265
947, 949, 951-956
1293
6
49
1064-1070, 1071


1229
267
315
947, 949, 951- 956
1357
1
40
1079-1082, 1152-1154,









1455, 1457, 1458


1229
317
345
947, 949, 951-956
1357
63
85
1079-1082, 1152-1154,









1455, 1457, 1458


1230
252
294
947, 949, 951-955
1357
102
157
1079-1082, 1152-1154,









1455, 1457, 1458


1230
308
346
947, 949, 951-955
1357
159
189
1079-1082, 1152-1154,









1455, 1457, 1458


1231
191
233
947, 949, 951-956
1357
191
322
1079-1082, 1152-1154,









1455, 1457, 1458


1231
247
285
947, 949, 951-956
1358
25
47
1079- 1082, 1152-1154,









1455, 1457, 1458


1231
287
335
947, 949, 951-956
1358
64
119
1079-1082, 1152-1154,









1455, 1457, 1458


1232
196
238
947, 949, 951-956
1358
121
151
1079-1082, 1152-1154,









1455, 1457, 1458


1232
252
290
947, 949, 951-956
1358
153
284
1079-1082, 1152-1154,









1455, 1457, 1458


1232
292
340
947, 949, 951-956
1359
31
53
1079-1082, 1152-1154,









1455, 1457, 1458


1233
209
251
947, 949, 951-956
1359
70
125
1079-1082, 1152-1154,









1455, 1457, 1458


1233
265
303
947, 949, 951-956
1359
127
157
1079-1082, 1152-1154,









1455, 1457, 1458


1233
305
351
947, 949, 951-956
1359
159
290
1079-1082, 1152-1154,









1455, 1457, 1458


1224
177
202
947-949, 951-956
1360
38
60
1079-1082, 1152-1154,









1455, 1457, 1458


1225
1
72
947, 949, 951-956
1360
77
132
1079-1082, 1152-1154,









1455, 1457, 1458


1225
74
135
947, 949, 951-956
1360
134
164
1079-1082, 1152-1154,









1455, 1457, 1458


1225
137
192
947, 949, 951-956
1360
166
297
1079-1082, 1152-1154,









1455, 1457, 1458


1226
110
180
947, 949, 951-955
1361
1
41
1079-1082, 1152-1154,









1455, 1457, 1458


1226
182
243
947, 949, 951-955
1361
64
86
1079-1082, 1152-1154,









1455, 1457, 1458


1226
245
300
947, 949, 951-955
1361
103
158
1079-1082, 1152-1154,









1455, 1457, 1458


1227
105
175
947, 949, 951-955
1361
160
190
1079-1082, 1152-1154,









1455, 1457, 1458


1227
177
238
947, 949, 951-955
1361
192
323
1079-1082, 1152-1154,









1455, 1457, 1458


1227
240
295
947, 949, 951-955
1362
31
53
1079-1082, 1152-1154,









1455, 1457, 1458


1228
58
128
947, 949, 951-956
1362
70
125
1079-1082, 1152-1154,









1455, 1457, 1458


1228
130
191
947, 949, 951-956
1362
127
157
1079-1082, 1152-1154,









1455, 1457, 1458


1228
193
248
947, 949, 951-956
1362
159
290
1079-1082, 1152-1154,









1455, 1457, 1458


1229
23
93
947, 949, 951-956
1363
33
55
1079-1082, 1152-1154,









1455, 1457, 1458


1229
95
156
947, 949, 951-956
1363
72
127
1079-1082, 1152-1154,









1455, 1457, 1458


1229
158
213
947, 949, 951-956
1363
129
159
1079-1082, 1152-1154,









1455, 1457, 1458


1230
104
174
947, 949, 951-955
1363
161
292
1079-1082, 1152-1154,









1455, 1457, 1458


1230
176
237
947, 949, 951-955
1364
4
59
1079-1082, 1152-1154,









1455, 1457, 1458


1230
239
294
947, 949, 951-955
1364
61
91
1079-1082, 1152-1154,









1455, 1457, 1458


1231
43
113
947, 949, 951-956
1364
93
224
1079-1082, 1152-1154,









1455, 1457, 1458


1231
115
176
947, 949, 951-956
1365
35
57
1079-1082, 1152-1154,









1455, 1457, 1458


1231
178
233
947, 949, 951-956
1365
74
129
1079-1082, 1152-1154,









1455, 1457, 1458


1232
48
118
947, 949, 951-956
1365
131
161
1079-1082, 1152-1154,









1455, 1457, 1458


1232
120
181
947, 949, 951-956
1365
163
294
1079-1082, 1152-1154,









1455, 1457, 1458


1232
183
238
947, 949, 951-956
1366
2
26
1079-1082, 1152-1154,









1455, 1457, 1458


1233
61
131
947, 949, 951-956
1366
28
58
1079-1082, 1152-1154,









1455, 1457, 1458


1233
133
194
947, 949, 951-956
1366
60
191
1079-1082, 1152-1154,









1455, 1457, 1458


1233
196
251
947, 949, 951-956
1367
2
116
1079, 1080, 1081, 1082, 1152,









1153, 1154


1224
227
262
947-949, 951-956
1358
322
345
1079-1082, 1152-1154,









1455, 1457, 1458


1224
57
94
947-949, 951-956
1359
328
350
1079-1082, 1152-1154,









1455, 1457, 1458


1225
2
72
947, 949, 951-956
1362
328
351
1079-1082, 1152-1154,









1455, 1457, 1458


1225
206
243
947, 949, 951-956
1363
330
352
1079-1082, 1152-1154,









1455, 1457, 1458


1226
1
96
947, 949, 951-955
1364
262
285
1079-1082, 1152-1154,









1455, 1457, 1458


1226
98
180
947, 949, 951-955
1365
332
351
1079-1082, 1152-1154,









1455, 1457, 1458


1227
2
91
947, 949, 951-955
1366
229
252
1079-1082, 1152-1154,









1455, 1457, 1458


1227
93
175
947, 949, 951-955
1367
154
177
1079-1082, 1152-1154


1227
309
346
947, 949, 951-955
1358
322
344
1079-1082, 1152-1154,









1455, 1457, 1458


1228
2
44
947, 949, 951-956
1362
328
350
1079-1082, 1152-1154,









1455, 1457, 1458


1228
46
128
947, 949, 951-956
1364
262
284
1079-1082, 1152-1154,









1455, 1457, 1458


1228
262
299
947, 949, 951-956
1366
229
251
1079-1082, 1152-1154,









1455, 1457, 1458


1229
11
93
947, 949, 951-956
1367
154
176
1079-1082, 1152-1154


1229
227
264
947, 949, 951-956
1368
126
145
1083, 1087


1230
2
90
947, 949, 951-955
1368
153
177
1083, 1087


1230
92
174
947, 949, 951-955
1368
186
208
1083, 1087


1230
308
345
947, 949, 951-955
1368
224
253
1083, 1087


1231
2
29
947, 949, 951-956
1369
161
180
1083, 1084, 1089


1231
31
113
947, 949, 951-956
1370
124
143
1083, 1087


1231
247
284
947, 949, 951-956
1370
151
175
1083, 1087


1232
2
34
947, 949, 951-956
1370
184
206
1083, 1087


1232
36
118
947, 949, 951-956
1370
222
251
1083, 1087


1232
252
289
947, 949, 951-956
1369
278
303
1083, 1084, 1089


1233
2
47
947, 949, 951-956
1369
182
201
1083, 1084, 1089


1233
49
131
947, 949, 951-956
1371
1
71
1093-1095, 1098, 1100-1103


1233
265
302
947, 949, 951-956
1371
82
122
1093-1095, 1098, 1100-1103


1226
7
96
947, 949, 951-955
1371
124
180
1093-1095, 1098, 110 -1103


1227
1
91
947, 949, 951-955
1371
182
244
1093-1095, 1098, 1100-1103


1226
8
96
947, 949, 951-955
1372
16
56
1093-1095, 1098, 1100-1103


1227
3
91
947, 949, 951-955
1372
58
114
1093-1095, 1098, 1100-1103


1230
1
90
947, 949, 951-955
1372
116
178
1093-1095, 1098, 1100-1103


1226
54
96
947, 949, 951-955
1373
2
61
1093-1095, 1098, 1100-1103


1227
49
91
947, 949, 951-955
1373
72
112
1093-1095, 1098, 1100-1103


1228
1
44
947, 949, 951-956
1373
114
170
1093-1095, 1098, 1100-1103


1230
48
90
947, 949, 951-955
1373
172
234
1093-1095, 1098, 1100-1103


1233
5
47
947, 949, 951-956
1374
1
68
1093-1095, 1098, 1100-1103


1224
125
145
947-949, 951-956
1374
79
119
1093-1095, 1098, 1100-1103


1225
274
294
947, 949, 951-956
1374
121
177
1093-1095, 1098, 1100-1103


1228
330
350
947, 949, 951-956
1374
179
241
1093-1095, 1098, 1100-1103


1229
295
315
947, 949, 951-956
1375
2
41
1093-1095, 1098, 1100-1103


1231
315
335
947, 949, 951-956
1375
52
92
1093-1095, 1098, 1100-1103


1232
320
340
947, 949, 951-956
1375
94
150
1093-1095, 1098, 1100-1103


1233
333
351
947, 949, 951-956
1375
152
214
1093-1095, 1098, 1100-1103


1234
50
135
960, 964
1376
7
47
1093-1095, 1098, 1100-1103


1234
149
168
960, 964
1376
49
105
1093-1095, 1098, 1100-1103


1234
170
350
960, 964
1376
107
169
1093-1095, 1098, 1100-1103


1235
175
260
960, 963, 964
1371
124
148
1093-1095, 1098, 1100-1103


1235
274
293
960, 963, 964
1372
58
82
1093-1095, 1098, 1100-1103


1235
295
351
960, 963, 964
1373
114
138
1093-1095, 1098, 1100-1103


1236
190
275
960, 963, 964
1374
121
145
1093-1095, 1098, 1100-1103


1236
289
308
960, 963, 964
1375
94
118
1093-1095, 1098, 1100-1103


1236
310
351
960, 963, 964
1376
49
73
1093-1095, 1098, 1100-1103


1237
269
350
960, 963, 964
1371
182
276
1093-1095, 1098, 1100-1103


1238
51
136
960, 964
1371
278
333
1093-1095, 1098, 1100-1103


1238
150
169
960, 964
1372
116
210
1093-1095, 1098, 1100-1103


1238
171
350
960, 964
1372
212
267
1093-1095, 1098, 1100-1103


1239
50
135
960, 964
1372
269
309
1093-1095, 1098, 1100-1103


1239
149
168
960, 964
1372
311
352
1093-1095, 1098, 1100-1103


1239
170
351
960, 964
1373
172
266
1093-1095, 1098, 1100-1103


1240
103
188
960, 963, 964
1373
268
323
1093-1095, 1098, 1100-1103


1240
202
221
960, 963, 964
1373
325
351
1093-1095, 1098, 1100-1103


1240
223
351
960, 963, 964
1374
179
273
1093-1095, 1098, 1100-1103


1241
269
351
960, 963, 964
1374
275
330
1093-1095, 1098, 1100-1103


1242
87
172
960, 963, 964
1374
332
351
1093-1095, 1098, 1100-1103


1242
186
205
960, 963, 964
1375
152
246
1093-1095, 1098, 1100-1103


1242
207
351
960, 963, 964
1375
248
303
1093-1095, 1098, 1100-1103


1235
2
23
960, 963, 964
1375
305
345
1093-1095, 1098, 1100-1103


1235
25
114
960, 963, 964
1376
107
201
1093-1095, 1098, 1100-1103


1236
2
38
960, 963, 964
1376
203
258
1093-1095, 1098, 1100-1103


1236
40
129
960, 963, 964
1376
260
300
1093-1095, 1098, 1100-1103


1237
2
39
960, 963, 964
1376
302
342
1093-1095, 1098, 1100-1103


1237
41
117
960, 963, 964
1371
278
303
1093-1095, 1098, 1100-1103


1237
119
208
960, 963, 964
1372
212
237
1093-1095, 1098, 1100-1103


1240
2
42
960, 963, 964
1373
268
293
1093-1095, 1098, 1100-1103


1241
2
39
960, 963, 964
1374
275
300
1093-1095, 1098, 1100-1103


1241
41
117
960, 963, 964
1375
248
273
1093-1095, 1098, 1100-1103


1241
119
208
960, 963, 964
1376
203
228
1093-1095, 1098, 1100-1103


1242
2
26
960, 963, 964
1371
124
155
1093-1095, 1098, 1100-1103


1234
38
135
960, 964
1372
58
89
1093-1095, 1098, 1100-1103


1234
170
211
960, 964
1373
114
145
1093-1095, 1098, 1100-1103


1235
25
136
960, 963, 964
1374
121
152
1093-1095, 1098, 1100-1103


1235
163
260
960, 963, 964
1375
94
125
1093-1095, 1098, 1100-1103


1235
295
336
960, 963, 964
1376
49
80
1093-1095, 1098, 1100-1103


1236
1
38
960, 963, 964
1371
182
241
1093-1095, 1098, 1100-1103


1236
40
151
960, 963, 964
1372
116
175
1093-1095, 1098, 1100-1103


1236
178
275
960, 963, 964
1373
172
231
1093-1095, 1098, 1100-1103


1237
81
117
960, 963, 964
1374
179
238
1093-1095, 1098, 1100-1103


1237
119
230
960, 963, 964
1375
152
211
1093-1095, 1098, 1100-1103


1237
257
350
960, 963, 964
1376
107
166
1093-1095, 1098, 1100-1103


1238
39
136
960, 964
1371
278
325
1093-1095, 1098, 1100-1103


1238
171
212
960, 964
1372
212
259
1093-1095, 1098, 1100-1103


1239
38
135
960, 964
1373
268
315
1093-1095, 1098, 1100-1103


1239
170
211
960, 964
1374
275
322
1093-1095, 1098, 1100-1103


1240
2
64
960, 963, 964
1375
248
295
1093-1095, 1098, 1100-1103


1240
91
188
960, 963, 964
1376
203
250
1093-1095, 1098, 1100-1103


1240
223
264
960, 963, 964
1309
1
69
1114, 1115


1241
81
117
960, 963, 964
1309
71
96
1114, 1115


1241
119
230
960, 963, 964
1309
98
144
1114, 1115


1241
257
351
960, 963, 964
1309
152
195
1114, 1115


1242
2
48
960, 963, 964
1309
197
237
1114, 1115


1242
75
172
960, 963, 964
1309
254
352
1114, 1115


1242
207
248
960, 963, 964
1310
25
92
1114, 1115


1243
118
158
965, 966, 968, 969
1310
94
119
1114, 1115


1243
283
304
965, 966, 968, 969
1310
121
167
1114, 1115


1243
310
348
965, 966, 968, 969
1310
175
218
1114, 1115


1244
165
205
965, 966, 968, 969
1310
220
260
1114, 1115


1244
330
351
965, 966, 968, 969
1310
277
351
1114, 1115


1246
205
245
965, 966, 967, 968, 969
1311
7
74
1114, 1115


1247
206
246
965, 966, 967, 968, 969
1311
76
101
1114, 1115


1248
163
203
965, 966, 968, 969
1311
103
149
1114, 1115


1248
328
349
965, 966, 968, 969
1311
157
200
1114, 1115


1245
1
20
967
1311
202
242
1114, 1115


1245
22
42
967
1311
259
351
1114, 1115


1245
104
135
967
1312
9
76
1114, 1115


1245
137
155
967
1312
78
103
1114, 1115


1245
187
209
967
1312
105
151
1114, 1115


1246
36
58
965, 966, 967, 968, 969
1312
159
202
1114, 1115


1247
37
59
965, 966, 967, 968, 969
1312
204
244
1114, 1115


1244
330
352
965, 966, 968, 969
1312
261
352
1114, 1115


1249
2
20
970, 973, 974, 978, 979
1309
2
69
1114, 1115


1250
5
84
969-971, 973-979
1309
254
327
1114, 1115


1250
86
270
969-971, 973-979
1310
22
92
1114, 1115


1250
278
306
969-971, 973-979
1310
277
350
1114, 1115


1250
326
351
969-971, 973-979
1311
4
74
1114, 1115


1251
2
52
969-971, 973-979
1311
259
332
1114, 1115


1251
54
238
969-971, 973-979
1312
6
76
1114, 1115


1251
246
274
969-971, 973-979
1312
261
334
1114, 1115


1251
294
322
969-971, 973-979
1315
56
87
1117, 1119-1125


1253
115
194
969-971, 973-979
1315
91
114
1117, 1119-1125


1253
196
351
969-971, 973-979
1315
116
144
1117, 1119-1125


1254
3
31
970, 971, 973, 974,
1315
146
171
1117, 1119-1125





977-979






1254
51
79
970, 971, 973, 974,
1315
185
225
1117, 1119-1125





977-979






1255
282
352
1629
1315
275
294
970, 971, 973-978, 1626,









1117, 1119-1125


1256
1
53
970, 971, 973-978
1315
317
342
1117, 1119-1125


1256
55
239
970, 971, 973-978
1316
22
45
1117, 1119-1125


1256
247
275
970, 971, 973-978
1316
47
75
1117, 1119-1125


1256
295
323
970, 971, 973-978
1316
77
102
1117, 1119-1125


1257
6
85
970, 971, 973-978
1316
116
156
1117, 1119-1125


1257
87
271
970, 971, 973-978
1316
206
225
1117, 1119-1125


1257
279
307
970, 971, 973-978
1316
248
273
1117, 1119-1125


1257
327
351
970, 971, 973-978
1316
275
317
1117, 1119-1125


1250
1
84
969-971, 973-979
1318
144
175
1117, 1119-1125


1250
326
352
969-971, 973-979
1318
179
202
1117, 1119-1125


1251
294
319
969-971, 973-979
1318
204
232
1117, 1119-1125


1253
112
194
969-971, 973-979
1318
234
259
1117, 1119-1125


1254
51
76
970, 971, 973, 974,
1318
273
313
1117, 1119-1125





977-979






1255
279
352
1629
1319
2
20
970, 971, 973-978, 1626,









1117, 1119-1125


1256
295
320
970, 971, 973-978
1319
24
47
1117, 1119-1125


1257
3
85
970, 971, 973-978
1319
49
77
1117, 1119-1125


1252
31
89
972
1319
79
104
1117, 1119-1125


1252
91
236
972
1319
118
158
1117, 1119-1125


1252
238
266
972
1319
208
227
1117, 1119-1125


1252
277
337
972
1319
250
275
1117, 1119-1125


1249
2
23
970, 973, 974, 978, 979
1319
277
319
1117, 1119-1125


1249
25
44
970, 973, 974, 978, 979
1313
17
81
1118, 1125


1250
34
84
969-971, 973-979
1313
92
117
1118, 1125


1251
1
52
969-971, 973-979
1313
137
204
1118, 1125


1251
294
325
969-971, 973-979
1313
215
240
1118, 1125


1251
327
346
969-971, 973-979
1313
242
291
1118, 1125


1253
144
194
969-971, 973-979
1313
293
329
1118, 1125


1254
51
82
970, 971, 973, 974,
1314
22
89
1118-1125





977-979






1254
84
103
970, 971, 973, 974,
1314
100
125
1118-1125





977-979






1255
311
352
1629
1314
127
176
970, 971, 973-978, 1626,









1118-1125


1256
3
53
970, 971, 973-978
1314
178
214
1118-1125


1256
295
326
970, 971, 973-978
1317
25
92
1118, 1120-1122, 1124, 1125


1256
328
347
970, 971, 973-978
1317
103
128
1118, 1120-1122, 1124, 1125


1257
35
85
970, 971, 973-978
1317
130
179
1118, 1120-1122, 1124, 1125


1250
47
84
969-971, 973-979
1317
181
217
1118, 1120-1122, 1124, 1125


1251
15
52
969-971, 973-979
1314
332
351
1118-1125


1253
157
194
969-971, 973-979
1315
27
51
1117, 1119-1125


1255
324
352
1629
1316
275
306
970, 971, 973-978, 1626,









1117, 1119-1125


1256
16
53
970, 971, 973-978
1318
115
139
1117, 1119-1125


1257
48
85
970, 971, 973-978
1319
277
308
1117, 1119-1125


1250
2
84
969-971, 973-979
1314
330
351
1118-1125


1250
86
241
969-971, 973-979
1315
25
51
1117, 1119-1125


1251
54
209
969-971, 973-979
1316
275
303
1117, 1119-1125


1253
1
68
969-971, 973-979
1317
333
351
1118, 1120-1122, 1124, 1125


1253
91
194
969-971, 973-979
1318
113
139
1117, 1119-1125


1253
196
352
969-971, 973-979
1319
277
305
1117, 1119-1125


1255
169
235
1629
1314
262
293
970, 971, 973-978, 1626,









1118-1125


1255
258
352
1629
1314
295
314
970, 971, 973-978, 1626,









1118-1125


1256
55
210
970, 971, 973-978
1314
316
351
1118-1125


1257
1
85
970, 971, 973-978
1315
11
51
1117, 1119-1125


1257
87
242
970, 971, 973-978
1317
265
296
1118, 1120-1122, 1124, 1125


1250
86
110
969-971, 973-979
1317
298
317
1118, 1120-1122, 1124, 1125


1251
54
78
969-971, 973-979
1317
319
351
1118, 1120-1122, 1124, 1125


1253
2
68
969-971, 973-979
1318
45
76
1117, 1119-1125


1253
196
220
969-971, 973-979
1318
78
97
1117, 1119-1125


1255
39
130
1629
1318
99
139
970, 971, 973-978, 1626,









1117, 1119-1125


1255
132
235
1629
1316
275
324
970, 971, 973-978, 1626,









1117, 1119-1125


1256
55
79
970, 971, 973-978
1319
277
326
1117, 1119-1125


1257
87
111
970, 971, 973-978
1299
50
96
1126-1131, 1651-1653


1250
326
350
969-971, 973-979
1300
2
43
1126-1131, 1651-1653


1251
294
318
969-971, 973-979
1300
66
112
1126-1131, 1651-1653


1253
110
194
969-971, 973-979
1300
123
154
1126-1131, 1651-1653


1254
51
75
970, 971, 973, 974,
1300
183
211
1126-1131, 1651-1653





977-979






1255
277
352
1629
1300
213
232
970, 971, 973-978, 1626,









1126-1131, 1651-1653


1256
295
319
970, 971, 973-978
1300
264
310
1126-1131, 1651-1653


1257
327
352
970, 971, 973-978
1301
1
35
1126-1131


1250
32
84
969 - 971, 973-979
1301
37
84
1126-1131


1253
142
194
969 - 971, 973-979
1301
107
153
1126-1131


1255
309
352
1629
1301
164
195
970, 971, 973-978, 1626,









1126-1131


1257
33
85
970, 971, 973-978
1301
224
252
1126-1131


1249
46
68
970, 973, 974, 978, 979
1301
254
273
1126-1131


1250
61
84
969-971, 973-979
1301
305
351
1126-1131


1251
29
52
969-971, 973-979
1302
26
54
1126-1131, 1651-1653


1253
171
194
969-971, 973-979
1302
56
75
1126-1131, 1651-1653


1254
105
127
970, 971, 973, 974,
1302
107
153
1126-1131, 1651-1653





977-979






1256
30
53
970, 971, 973-978
1303
11
39
1126-1131, 1651-1653


1257
62
85
970, 971, 973-978
1303
41
60
1126-1131, 1651-1653


1259
192
226
999-1004
1303
92
138
1126-1131, 1651-1653


1259
249
298
999-1004
1299
50
114
1126-1131, 1651-1653


1259
321
352
999-1004
1299
131
162
1126-1131, 1651-1653


1260
190
224
999-1004
1299
215
236
1126-1131, 1651-1653


1260
247
296
999-1004
1299
248
270
1126-1131, 1651-1653


1260
319
351
999-1004
1299
272
309
1126-1131, 1651-1653


1261
99
133
999-1004
1300
264
328
1126-1131, 1651-1653


1261
156
205
999-1004
1302
107
171
1126-1131, 1651-1653


1261
228
289
999-1004
1302
188
219
1126-1131, 1651-1653


1261
300
334
999-1004
1302
272
293
1126-1131, 1651-1653


1262
82
116
999-1004
1302
305
327
1126-1131, 1651-1653


1262
139
188
999-1004
1302
329
351
1126-1131, 1651-1653


1262
211
272
999-1004
1303
92
156
1126-1131, 1651-1653


1262
283
317
999-1004
1303
173
204
1126-1131, 1651-1653


1262
319
350
999-1004
1303
257
278
1126-1131, 1651-1653


1263
324
351
999-1004
1303
290
312
1126-1131, 1651-1653


1264
191
225
999-1004
1303
314
351
1126-1131, 1651-1653


1264
248
297
999-1004
1299
272
352
1126-1131, 1651-1653


1264
320
351
999-1004
1299
272
344
1126-1131, 1651-1653


1265
98
132
999-1004
1299
272
318
1126-1131, 1651-1653


1265
155
204
999-1004
1299
272
310
1126-1131, 1651-1653


1265
227
288
999-1004
1304
2
25
1132, 1134, 1135, 1136


1265
299
333
999-1004
1304
36
169
1132, 1134, 1135, 1136


1259
95
145
999-1004
1304
186
214
1132, 1134, 1135, 1136


1259
165
226
999-1004
1304
231
250
1132, 1134, 1135, 1136


1260
93
143
999-1004
1304
264
307
1132, 1134, 1135, 1136


1260
163
224
999-1004
1306
2
70
1132, 1134, 1135, 1136


1261
1
52
999-1004
1306
87
115
1132, 1134, 1135, 1136


1261
72
133
999-1004
1306
132
151
1132, 1134, 1135, 1136


1262
1
35
999-1004
1306
165
208
1132, 1134, 1135, 1136


1262
55
116
999-1004
1307
1
27
1132, 1134, 1135, 1136


1263
227
277
999-1004
1307
29
69
1132, 1134, 1135, 1136


1263
297
351
999-1004
1307
80
213
1132, 1134, 1135, 1136


1264
94
144
999-1004
1307
230
258
1132, 1134, 1135, 1136


1264
164
225
999-1004
1307
275
294
1132, 1134, 1135, 1136


1265
2
51
999-1004
1307
308
351
1132, 1134, 1135, 1136


1265
71
132
999-1004
1308
2
33
1132, 1134, 1135, 1136


1259
15
40
999-1004
1308
44
177
1132, 1134, 1135, 1136


1259
42
64
999-1004
1308
194
222
1132, 1134, 1135, 1136


1259
66
88
999-1004
1308
239
258
1132, 1134, 1135, 1136


1259
90
145
999-1004
1308
272
315
1132, 1134, 1135, 1136


1259
165
219
999-1004
1347
2
28
1132, 1134, 1135, 1136


1260
13
38
999-1004
1347
39
172
1132, 1134, 1135, 1136


1260
40
62
999-1004
1347
189
217
1132, 1134, 1135, 1136


1260
64
86
999-1004
1347
234
253
1132, 1134, 1135, 1136


1260
88
143
999-1004
1347
267
310
1132, 1134, 1135, 1136


1260
163
217
999-1004
1305
1
133
1133, 1137, 1138, 1580, 1581,









1583


1261
2
52
999-1004
1305
135
154
1133, 1137, 1138, 1580, 1581,









1583


1261
72
126
999-1004
1305
156
178
1133, 1137, 1138, 1580, 1581,









1583


1262
55
109
999-1004
1305
195
280
1133, 1137, 1138, 1580, 1581,









1583


1263
1
60
999-1004
1305
330
351
1133, 1137, 1138, 1580, 1581,









1583


1263
105
127
999-1004
1344
13
35
1133, 1137, 1138, 1580, 1581,









1583


1263
147
172
999-1004
1344
52
137
1133, 1137, 1138, 1580, 1581,









1583


1263
174
196
999-1004
1344
187
208
1133, 1137, 1138, 1580, 1581,









1583


1263
198
220
999-1004
1345
50
181
1133, 1137, 1138, 1580, 1581,









1583


1263
222
277
999-1004
1345
183
202
1133, 1137, 1138, 1580, 1581,









1583


1263
297
352
999-1004
1345
204
226
1133, 1137, 1138, 1580, 1581,









1583


1264
14
39
999-1004
1345
243
328
1133, 1137, 1138, 1580, 1581,









1583


1264
41
63
999-1004
1346
2
81
1133, 1137, 1138


1264
65
87
999-1004
1346
131
152
1133, 1137, 1138


1264
89
144
999-1004
1304
1
25
1132, 1134, 1135, 1136


1264
164
218
999-1004
1304
264
334
1132, 1134, 1135, 1136


1265
71
125
999-1004
1306
165
235
1132, 1134, 1135, 1136


1259
190
226
999-1004
1307
46
69
1132, 1134, 1135, 1136


1260
188
224
999-1004
1308
10
33
1132, 1134, 1135, 1136


1261
97
133
999-1004
1308
272
342
1132, 1134, 1135, 1136


1262
80
116
999-1004
1347
5
28
1132, 1134, 1135, 1136


1263
322
351
999-1004
1347
267
337
1132, 1134, 1135, 1136


1264
189
225
999-1004
1304
101
169
1132, 1134, 1135, 1136


1265
96
132
999-1004
1306
1
70
1132, 1134, 1135, 1136


1259
96
145
999-1004
1306
237
310
1132, 1134, 1135, 1136


1260
94
143
999-1004
1306
312
352
1132, 1134, 1135, 1136


1261
3
52
999-1004
1307
145
213
1132, 1134, 1135, 1136


1263
228
277
999-1004
1308
109
177
1132, 1134, 1135, 1136


1264
95
144
999-1004
1347
104
172
1132, 1134, 1135, 1136


1265
1
51
999-1004
1307
38
69
1132, 1134, 1135, 1136


1259
165
218
999-1004
1308
1
33
1132, 1134, 1135, 1136


1260
163
216
999-1004
1344
187
239
1133, 1137, 1138, 1580, 1581,









1583


1261
72
125
999-1004
1344
241
272
1133, 1137, 1138, 1580, 1581,









1583


1262
55
108
999-1004
1344
286
308
1133, 1137, 1138, 1580, 1581,









1583


1263
2
60
999-1004
1344
310
329
1133, 1137, 1138, 1580, 1581,









1583


1263
297
350
999-1004
1346
131
183
1133, 1137, 1138


1264
164
217
999-1004
1346
185
216
1133, 1137, 1138


1265
71
124
999-1004
1346
230
252
1133, 1137, 1138


1266
2
39
1016-1023
1346
254
273
1133, 1137, 1138


1266
41
87
1016-1023
1305
227
280
1133, 1137, 1138, 1580, 1581,









1583


1266
89
129
1016-1023
1344
84
137
1133, 1137, 1138, 1580, 1581,









1583


1267
2
74
1016-1023
1345
275
328
1133, 1137, 1138, 1580, 1581,









1583


1267
76
122
1016-1023
1346
28
81
1133, 1137, 1138


1267
124
164
1016-1023
1346
290
351
1133, 1137, 1138


1268
2
53
1016-1023
1348
44
66
1139, 1140, 1141, 1142


1268
55
101
1016-1023
1348
104
129
1139, 1140, 1141, 1142


1268
103
143
1016-1023
1348
131
156
1139, 1140, 1141, 1142


1269
2
72
1016-1023
1348
158
195
1139, 1140, 1141, 1142


1269
74
120
1016-1023
1348
167
189
1139, 1140, 1141, 1142


1269
122
162
1016-1023
1348
197
237
1139, 1140, 1141, 1142


1270
2
107
1016-1023
1348
215
234
1139, 1140, 1141, 1142


1270
109
155
1016-1023
1348
4
49
1139, 1140, 1141, 1142


1270
157
197
1016-1023
1348
4
74
1139, 1140, 1141, 1142


1271
2
62
1016-1023
1348
4
85
1139, 1140, 1141, 1142


1271
64
110
1016-1023
1349
19
90
1143


1271
112
152
1016-1023
1349
146
207
1143


1266
131
177
1016-1023
1349
209
256
1143


1266
179
207
1016-1023
1350
32
51
1144-1151, 1703


1266
209
243
1016-1023
1350
71
90
1144-1151, 1703


1267
166
212
1016-1023
1351
118
137
1144-1151


1267
214
242
1016-1023
1351
157
176
1144-1151


1267
244
278
1016-1023
1353
81
100
1144-1151


1268
145
191
1016-1023
1353
120
139
1144-1151


1268
193
221
1016-1023
1354
1
42
1144-1151


1268
223
257
1016-1023
1354
218
237
1144-1151


1269
164
210
1016-1023
1354
257
276
1144-1151


1269
212
240
1016-1023
1356
43
62
1144-1151


1269
242
276
1016-1023
1356
82
101
1144-1151


1270
199
245
1016-1023
1350
176
201
1144-1151, 1703


1270
247
275
1016-1023
1350
209
231
1144-1151, 1703


1270
277
311
1016-1023
1350
236
267
1144-1151, 1703


1271
154
200
1016-1023
1351
262
287
1144-1151


1271
202
230
1016-1023
1351
295
317
1144-1151


1271
232
266
1016-1023
1351
322
351
1144-1151


1266
209
294
1016-1023
1353
225
250
1144-1151


1266
296
316
1016-1023
1353
258
280
1144-1151


1267
1
74
1016-1023
1353
285
316
1144-1151


1267
244
329
1016-1023
1356
187
212
1144-1151


1267
331
351
1016-1023
1356
220
242
1144-1151


1268
223
308
1016-1023
1356
247
278
1144-1151


1268
310
330
1016-1023
1350
236
265
1144-1151, 1703


1269
242
327
1016-1023
1351
322
352
1144-1151


1269
329
349
1016-1023
1353
285
314
1144-1151


1270
35
107
1016-1023
1356
247
276
1144-1151


1270
277
351
1016-1023
1350
287
306
1144-1151, 1703


1271
232
317
1016-1023
1350
323
348
1144-1151, 1703


1271
319
339
1016-1023
1352
2
21
1147, 1150, 1151, 1703


1266
296
318
1016-1023
1352
38
63
1147, 1150, 1151, 1703


1267
4
74
1016-1023
1355
5
24
1147, 1150, 1151, 1703


1268
310
332
1016-1023
1355
41
66
1147, 1150, 1151, 1703


1269
1
72
1016-1023
1356
298
317
1144-1151


1269
329
351
1016-1023
1358
322
351
1079-1082, 1152-1154,









1455, 1457, 1458


1270
37
107
1016-1023
1364
262
291
1079-1082, 1152-1154,









1455, 1457, 1458


1271
319
341
1016-1023
1366
229
258
1079-1082, 1152-1154,









1455, 1457, 1458


1266
131
157
1016-1023
1367
154
183
1079-1082, 1152-1154


1267
166
192
1016-1023
1361
2
41
1079-1082, 1152-1154,









1455, 1457, 1458


1268
145
171
1016-1023
1210
1
35
1431


1269
164
190
1016-1023
1211
30
63
1431


1270
199
225
1016-1023
1213
15
48
1431


1271
154
180
1016-1023
1217
19
52
1431


1295
113
168
1026, 1027, 1024
1357
162
200
1079-1082, 1152-1154,









1455, 1457, 1458


1295
170
201
1026, 1027, 1024
1358
124
162
1079-1082, 1152-1154,









1455, 1457, 1458


1295
203
233
1026, 1027, 1024
1359
130
168
1079-1082, 1152-1154,









1455, 1457, 1458


1295
236
258
1026, 1027, 1024
1360
137
175
1079-1082, 1152-1154,









1455, 1457, 1458


1297
128
183
1026, 1027, 1024
1361
163
201
1079-1082, 1152-1154,









1455, 1457, 1458


1297
185
216
1026, 1027, 1024
1362
130
168
1079-1082, 1152-1154,









1455, 1457, 1458


1297
218
248
1026, 1027, 1024
1363
132
170
1079-1082, 1152-1154,









1455, 1457, 1458


1296
1
44
1025, 1028, 1029,
1364
64
102
1079-1082, 1152-1154,





1515-1518, 1520



1455, 1457, 1458


1298
7
57
1025, 1028, 1029
1365
134
172
1079-1082, 1152-1154,









1455, 1457, 1458


1298
59
96
1025, 1028, 1029
1366
31
69
1079-1082, 1152-1154,









1455, 1457, 1458


1298
110
132
1025, 1028, 1029
1054
198
244
1492, 1496, 1497, 1498


1298
143
210
1025, 1028, 1029
1054
285
319
1492, 1496, 1497, 1498


1295
17
87
1026, 1027, 1024
1056
191
237
1492, 1496, 1497, 1498


1297
32
102
1026, 1027, 1024
1056
278
312
1492, 1496, 1497, 1498


1294
127
153
1027
1057
14
60
1492, 1496, 1497, 1498


1295
17
46
1026, 1027, 1024
1057
101
135
1492, 1496, 1497, 1498


1297
32
61
1026, 1027, 1024
1057
233
264
1492, 1496, 1497, 1498


1298
5
57
1025, 1028, 1029
1060
269
315
1492, 1496, 1497, 1498


1320
249
268
1033, 1035, 1076
1390
10
50
1054 - 1057, 1060, 1492,









1496-1498


1324
2
23
1036, 1037, 1038
1390
142
173
1054 - 1057, 1060, 1492,









1496-1498


1326
14
38
1036, 1037, 1038
1391
73
104
1054 - 1057, 1060, 1492,









1496-1498


1326
95
117
1036, 1037, 1038
1055
85
131
1493, 1494, 1495, 1499, 1500


1326
152
174
1036, 1037, 1038
1058
117
163
1493, 1494, 1495, 1499, 1500


1326
227
248
1036, 1037, 1038
1059
118
164
1493, 1494, 1495, 1499, 1500


1327
44
65
1036, 1037, 1038
1061
109
155
1493, 1494, 1495, 1499, 1500


1321
65
86
1037
1062
222
268
1493, 1494, 1495, 1499, 1500


1321
88
132
1037
1063
262
308
1493, 1494, 1495, 1499, 1500


1322
2
34
1037
1054
15
64
1492, 1496, 1497, 1498


1322
36
67
1037
1054
165
196
1492, 1496, 1497, 1498


1322
135
156
1037
1056
8
57
1492, 1496, 1497, 1498


1322
158
202
1037
1056
158
189
1492, 1496, 1497, 1498


1323
1
35
1037
1060
86
135
1492, 1496, 1497, 1498


1323
37
68
1037
1060
236
267
1492, 1496, 1497, 1498


1323
136
157
1037
1386
199
248
1054-1057, 1060, 1496, 1498


1323
159
203
1037
1388
212
261
1054-1057, 1060, 1496, 1498


1324
2
51
1036, 1037, 1038
1391
286
335
1054-1057, 1060, 1492,









1496-1498


1324
56
93
1036, 1037, 1038
1384
311
351
1055, 1058, 1059, 1061-1063,









1500


1324
95
126
1036, 1037, 1038
1385
312
351
1055, 1058, 1059, 1061-1063,









1500


1324
194
215
1036, 1037, 1038
1387
83
123
1055, 1058, 1059, 1061-1063,









1500, 1057


1324
217
261
1036, 1037, 1038
1389
162
202
1055, 1058, 1059, 1061-1063,









1500


1325
2
31
1037
1296
69
101
1025, 1028, 1029, 1515, 1516,









1517, 1518, 1520


1325
33
64
1037
909
305
340
1531


1325
132
153
1037
960
70
101
1543, 1551


1325
155
199
1037
964
259
290
1543, 1551


1326
227
276
1036, 1037, 1038
1305
180
226
1133, 1137, 1138, 1580, 1581,









1583


1326
281
318
1036, 1037, 1038
1133
195
226
1580, 1581


1326
320
350
1036, 1037, 1038
1137
52
83
1580, 1581


1327
44
93
1036, 1037, 1038
1344
37
83
1133, 1137, 1138, 1580, 1581,









1583


1327
98
135
1036, 1037, 1038
1345
228
274
1133, 1137, 1138, 1580, 1581,









1583


1327
137
168
1036, 1037, 1038
1305
180
217
1133, 1137, 1138, 1580, 1581,









1583


1327
236
257
1036, 1037, 1038
1344
37
74
1133, 1137, 1138, 1580, 1581,









1583


1327
259
303
1036, 1037, 1038
1345
228
265
1133, 1137, 1138, 1580, 1581,









1583


1324
2
24
1036, 1037, 1038
1039
176
210
1590, 1594, 1597, 1598


1326
227
249
1036, 1037, 1038
1040
142
176
1590, 1594, 1597, 1598


1327
44
66
1036, 1037, 1038
1041
248
282
1590, 1594, 1597, 1598


1328
3
59
1039-1043, 1045, 1594,
1042
141
175
1590, 1594, 1597, 1598





1597, 1598






1328
70
146
1039-1043, 1045, 1594,
1328
175
209
1039-1043, 1045, 1594, 1597,





1597, 1598



1598


1328
148
215
1039-1043, 1045, 1594,
1331
2
54
1039-1043, 1045, 1594, 1597,





1597, 1598



1598


1328
232
263
1039-1043, 1045, 1594,
1331
200
234
1039-1043, 1045, 1594, 1597,





1597, 1598



1598


1328
328
350
1039-1043, 1045, 1594,
1332
142
176
1039-1043, 1045, 1594, 1597,





1597, 1598



1598


1329
22
53
1039-1043 1045
1333
176
210
1039-1043, 1045, 1594, 1597,









1598


1329
118
140
1039-1043 1045
1334
16
68
1039-1043, 1045, 1594, 1597,









1598


1330
31
62
1039-1043 1045
1334
214
248
1039-1043, 1045, 1594, 1597,









1598


1330
127
149
1039-1043 1045
1335
76
110
1039-1043, 1045, 1594, 1597,









1598


1331
28
84
1039-1043, 1045, 1594,
1336
8
60
1039-1043, 1045, 1594, 1597,





1597, 1598



1598


1331
95
171
1039-1043, 1045, 1594,
1336
206
240
1039-1043, 1045, 1594, 1597,





1597, 1598



1598


1331
173
240
1039-1043, 1045, 1594,
1338
14
66
1039-1043, 1045, 1594, 1597,





1597, 1598



1598


1331
257
288
1039-1043, 1045, 1594,
1338
212
246
1039-1043, 1045, 1594, 1597,





1597, 1598



1598


1332
2
26
1039-1043, 1045, 1594,
1255
165
199
970, 971, 973-978, 1626,





1597, 1598



1629


1332
37
113
1039-1043, 1045, 1594,
976
129
163
1626, 1629





1597, 1598






1332
115
182
1039-1043, 1045, 1594,
1299
98
129
1126-1131, 1651-1653





1597, 1598






1332
199
230
1039-1043, 1045, 1594,
1300
312
343
1126-1131, 1651-1653





1597, 1598






1332
295
317
1039-1043, 1045, 1594,
1302
155
186
1126-1131, 1651-1653





1597, 1598






1333
4
60
1039-1043, 1045, 1594,
1303
140
171
1126-1131, 1651-1653





1597, 1598






1333
71
147
1039-1043, 1045, 1594,
1350
314
345
1144-1151, 1703





1597, 1598






1333
149
216
1039-1043, 1045, 1594,
1352
29
60
1147, 1150, 1151, 1703





1597, 1598






1333
233
264
1039-1043, 1045, 1594,
1355
32
63
1147, 1150, 1151, 1703





1597, 1598













All of the materials and methods disclosed and claimed herein can be made and used without undue experimentation as instructed by the above disclosure. Although the materials and methods disclosed herein have been described in terms of preferred embodiments and illustrative examples, it will be apparent to those of skill in the art that variations can be applied to the materials and methods described herein without departing from the concept, spirit and scope of this invention. All such similar substitutes and modifications apparent to those skilled in the art are deemed to be within the spirit, scope and concept of this invention as defined by the appended claims.

Claims
  • 1. A method of causing mortality or stunting in an insect, comprising contacting an insect with at least one recombinant double-stranded RNA (dsRNA) comprising at least one silencing element comprising an RNA strand identical or complementary to 21 or more contiguous nucleotides of an insect target gene sequence that has a DNA sequence of SEQ ID NO: 327, and the complement thereof, wherein said insect is Phylotreta spp., and wherein ingestion of said recombinant dsRNA by said insect results in mortality or stunting in said insect.
  • 2. The method of claim 1, wherein said at least one silencing element comprises an RNA strand having a sequence identical or complementary to 21 or more contiguous nucleotides of SEQ ID NO: 1186.
  • 3. The method of claim 1, wherein said insect is Phyllotreta cruciferae (canola flea beetle).
  • 4. The method of claim 1, wherein said silencing element comprises an RNA strand having a sequence of SEQ ID NO: 1186.
  • 5. The method of claim 1, wherein said recombinant dsRNA is provided in a microbial or plant cell that expresses said recombinant dsRNA, or in a microbial fermentation product, or is chemically synthesized.
  • 6. The method of claim 1, wherein said at least one recombinant dsRNA is provided in a composition comprising said at least one recombinant dsRNA, wherein said composition is applied to a surface of said insect or to a surface of a seed or a plant in need of protection from infestation by said insect.
  • 7. The method of claim 6, wherein said plant is: (a) selected from an ornamental plant or a crop plant;(b) a plant in the family Brassicaceae;(c) a Brassica species selected from the group consisting of B. napus, B, juncea, B. carinata, B. rapa, B. oleracea, B. rupestris, B. septiceps, B. nigra, B. narinosa, B. perviridus, B. tournefortii, and B. fructiculosa; (d) a Brassica plant selected from the group consisting canola, rapeseed, turnips, and field mustard or turnip rape;(e) selected from the group consisting of Glycine max, Linum usitatissimum, Zea mays, Carthamus tinctorius, Helianthus annuus, Nicotiana tabacum, Arabidopsis thaliana, Betholettia excelsa, Ricinus communis, Cocos nucifera, Coriandrum sativum, Gossypium spp., Arachis hypogaea, Simmondsia chinensis, Solanum tuberosum, Elaeis guineensis, Olea europaea, Oryza sativa, Cucurbita maxim, Hordeum vulgare, and Triticum aestivum; or(f) a potato plant and said insect is Epitrix cucumeris (potato flea beetle).
  • 8. The method of claim 6, wherein said contacting comprises: (a) oral delivery to said insect, non-oral delivery to said insect, or a combination of oral and non-oral delivery to said insect;(b) application of a composition comprising said recombinant dsRNA to a surface of said insect or to a surface of said plant infested by said insect;(c) providing said recombinant dsRNA in a composition that further comprises one or more components selected from the group consisting of a carrier agent, a surfactant, an organosilicone, a polynucleotide herbicidal molecule, a non-polynucleotide herbicidal molecule, a non-polynucleotide pesticide, a fungicide, a safener, a fertilizer, a micronutrient, an insect attractant, and an insect growth regulator;(d) providing said recombinant dsRNA in a composition that further comprises at least one pesticidal agent selected from the group consisting of a patatin, a plant lectin, a phytoecdysteroid, a Bacillus thuringiensis insecticidal protein, a Xenorhabdus insecticidal protein, a Photorhabdus insecticidal protein, a Bacillus laterosporous insecticidal protein, a Bacillus sphaericus insecticidal protein, a bacterium that produces an insecticidal protein, an entomicidal bacterial species, Lysinibacillus sphaericus (Bacillus sphaericus), Brevibacillus laterosporus (Bacillus laterosporus), Chromobacterium species, Chromobacterium subtsugae, Paenibacillus species, Paenibacillus lentimorbus, and Paenibacillus popilliae; or(e) providing said recombinant dsRNA in a composition that is ingested by said insect.
  • 9. An insecticidal composition comprising an insecticidally effective amount of a recombinant dsRNA molecule, wherein said recombinant dsRNA molecule comprises an RNA strand complementary to 21 or more contiguous nucleotides of a target gene of an insect that infests a plant, and the complement thereof, wherein said insect is Phylotreta spp., and wherein said target gene has a DNA sequence of SEQ ID NO: 327.
  • 10. The insecticidal composition of claim 9, wherein said recombinant dsRNA molecule: (a) comprises at least one RNA strand having a sequence identical or complementary to 21 or more contiguous nucleotides of SEQ ID NO: 1186;(b) comprises dsRNA of at least 50 base pairs in length;(c) comprises blunt-ended dsRNA;(d) comprises dsRNA with an overhang at at least one terminus;(e) comprises dsRNA comprising at least one stem-loop;(f) comprises dsRNA that is chemically modified;(g) is a dsRNA comprising an RNA strand having a sequence identical or complementary to 21 or more contiguous nucleotides of SEQ ID NO: 1186;(h) is a dsRNA comprising an RNA strand having a sequence of SEQ ID NO: 1186; or(i) is provided in a microbial or plant cell that expresses said recombinant dsRNA, or in a microbial fermentation product; or is chemically synthesized.
  • 11. The insecticidal composition of claim 9, wherein said insecticidal composition: (a) further comprises one or more components selected from the group consisting of a carrier agent, a surfactant, an organosilicone, a polynucleotide herbicidal molecule, a non-polynucleotide herbicidal molecule, a non-polynucleotide pesticide, a fungicide, a safener, a fertilizer, a micronutrient, an insect attractant, and an insect growth regulator;(b) further comprises at least one pesticidal agent selected from the group consisting of a patatin, a plant lectin, a phytoecdysteroid, a Bacillus thuringiensis insecticidal protein, a Xenorhabdus insecticidal protein, a Photorhabdus insecticidal protein, a Bacillus laterosporous insecticidal protein, a Bacillus sphaericus insecticidal protein, a bacterium that produces an insecticidal protein, an entomicidal bacterial species, Lysinibacillus sphaericus (Bacillus sphaericus), Brevibacillus laterosporus (Bacillus laterosporus), Chromobacterium species, Chromobacterium subtsugae, Paenibacillus species, Paenibacillus lentimorbus, and Paenibacillus popilliae; or(c) is in a form selected from the group consisting of a solid, liquid, powder, suspension, emulsion, spray, encapsulation, microbeads, carrier particulates, film, matrix, soil drench, insect diet or insect bait, and seed treatment.
  • 12. A plant treated with the insecticidal composition of claim 9, or a plant grown from seed treated with the insecticidal composition of claim 9, wherein said plant exhibits improved resistance to said insect.
  • 13. A recombinant DNA construct comprising a heterologous promoter operably linked to DNA encoding a dsRNA comprising a sequence identical or complementary to 21 or more contiguous nucleotides of SEQ ID NO: 1186, and the complement thereof.
  • 14. A recombinant vector, plant chromosome or plastid, or transgenic plant cell comprising the recombinant DNA construct of claim 13.
  • 15. A method of providing a plant having improved resistance to a Phylotrera spp. insect, comprising expressing in said plant the recombinant DNA construct of claim 13.
  • 16. A plant having improved resistance to a Phylotrera spp. insect, provided by the method of claim 15, or fruit, seed, or propagatable parts of said plant.
CROSS-REFERENCE TO RELATED APPLICATIONS AND INCORPORATION OF SEQUENCE LISTINGS

This application is a U.S. National Stage of International Application No. PCT/US2015/042415, filed Jul. 28, 2015, which claims priority to U.S. Provisional Patent Application Ser. No. 62/030,430, filed Jul. 29, 2014, which is incorporated by reference in its entirety herein. A sequence listing contained in the file named “P34170US02.txt” which is 2,153,023 bytes in size (measured in MS-Windows®) and created on Jan. 27, 2017, is filed electronically herewith and incorporated by reference in its entirety.

PCT Information
Filing Document Filing Date Country Kind
PCT/US2015/042415 7/28/2015 WO 00
Publishing Document Publishing Date Country Kind
WO2016/018887 2/4/2016 WO A
US Referenced Citations (426)
Number Name Date Kind
3687808 Merigan et al. Aug 1972 A
3791932 Schuurs et al. Feb 1974 A
3839153 Schuurs et al. Oct 1974 A
3850578 McConnell Nov 1974 A
3850752 Schuurs et al. Nov 1974 A
3853987 Dreyer Dec 1974 A
3867517 Ling Feb 1975 A
3879262 Schuurs et al. Apr 1975 A
3901654 Gross Aug 1975 A
3935074 Rubenstein et al. Jan 1976 A
3984533 Uzgiris Oct 1976 A
3996345 Ullman et al. Dec 1976 A
4034074 Miles Jul 1977 A
4098876 Piasio et al. Jul 1978 A
4469863 Ts'o et al. Sep 1984 A
4476301 Imbach et al. Oct 1984 A
4535060 Comai Aug 1985 A
4581847 Hibberd et al. Apr 1986 A
4666828 Gusella May 1987 A
4683202 Mullis Jul 1987 A
4732250 Maucher et al. Mar 1988 A
4761373 Anderson et al. Aug 1988 A
4769061 Comai Sep 1988 A
4801531 Frossard Jan 1989 A
4810648 Stalker Mar 1989 A
4879219 Wands et al. Nov 1989 A
4940835 Shah et al. Jul 1990 A
4971908 Kishore et al. Nov 1990 A
5004863 Umbeck Apr 1991 A
5011771 Bellet et al. Apr 1991 A
5013659 Bedbrook et al. May 1991 A
5015580 Christou et al. May 1991 A
5023243 Tullis Jun 1991 A
5034506 Summerton et al. Jul 1991 A
5094945 Comai Mar 1992 A
5141870 Bedbrook et al. Aug 1992 A
5145783 Kishore et al. Sep 1992 A
5159135 Umbeck Oct 1992 A
5166315 Summerton et al. Nov 1992 A
5177196 Meyer, Jr. et al. Jan 1993 A
5185444 Summerton et al. Feb 1993 A
5188642 Shah et al. Feb 1993 A
5188897 Suhadolnik et al. Feb 1993 A
5192659 Simons Mar 1993 A
5214134 Weis et al. May 1993 A
5216141 Benner Jun 1993 A
5235033 Summerton et al. Aug 1993 A
5264423 Cohen et al. Nov 1993 A
5264562 Matteucci Nov 1993 A
5264564 Matteucci Nov 1993 A
5272057 Smulson et al. Dec 1993 A
5276019 Cohen et al. Jan 1994 A
5278302 Caruthers et al. Jan 1994 A
5281521 Trojanowski et al. Jan 1994 A
5286634 Stadler et al. Feb 1994 A
5286717 Cohen et al. Feb 1994 A
5304732 Anderson et al. Apr 1994 A
5310667 Eichholtz et al. May 1994 A
5312910 Kishore et al. May 1994 A
5321131 Agrawal et al. Jun 1994 A
5331107 Anderson et al. Jul 1994 A
5339107 Henry et al. Aug 1994 A
5346107 Bouix et al. Sep 1994 A
5378824 Bedbrook et al. Jan 1995 A
5390667 Kumakura et al. Feb 1995 A
5392910 Bell et al. Feb 1995 A
5393175 Courville Feb 1995 A
5399676 Froehler Mar 1995 A
5405938 Summerton et al. Apr 1995 A
5405939 Suhadolnik et al. Apr 1995 A
5416011 Hinchee et al. May 1995 A
5453496 Caruthers et al. Sep 1995 A
5455233 Spielvogel et al. Oct 1995 A
5459127 Felgner et al. Oct 1995 A
5460667 Moriyuki et al. Oct 1995 A
5462910 Ito et al. Oct 1995 A
5463174 Moloney et al. Oct 1995 A
5463175 Barry et al. Oct 1995 A
5466677 Baxter et al. Nov 1995 A
5470967 Huie et al. Nov 1995 A
5476925 Letsinger et al. Dec 1995 A
5489520 Adams et al. Feb 1996 A
5489677 Sanghvi et al. Feb 1996 A
5491288 Chaubet et al. Feb 1996 A
5510471 Lebrun et al. Apr 1996 A
5518908 Corbin et al. May 1996 A
5519126 Hecht May 1996 A
5536821 Agrawal et al. Jul 1996 A
5538880 Lundquist et al. Jul 1996 A
5539082 Nielsen et al. Jul 1996 A
5541306 Agrawal et al. Jul 1996 A
5541307 Cook et al. Jul 1996 A
5550111 Suhadolnik et al. Aug 1996 A
5550318 Adams et al. Aug 1996 A
5550398 Kocian et al. Aug 1996 A
5550468 Häberlein et al. Aug 1996 A
5558071 Ward et al. Sep 1996 A
5561225 Maddry et al. Oct 1996 A
5561236 Leemans et al. Oct 1996 A
5563253 Agrawal et al. Oct 1996 A
5569834 Hinchee et al. Oct 1996 A
5571799 Tkachuk et al. Nov 1996 A
5587361 Cook et al. Dec 1996 A
5591616 Hiei et al. Jan 1997 A
5593874 Brown et al. Jan 1997 A
5596086 Matteucci et al. Jan 1997 A
5597717 Guerineau et al. Jan 1997 A
5602240 De Mesmaeker et al. Feb 1997 A
5605011 Bedbrook et al. Feb 1997 A
5608046 Cook et al. Mar 1997 A
5610289 Cook et al. Mar 1997 A
5618704 Sanghvi et al. Apr 1997 A
5623070 Cook et al. Apr 1997 A
5625050 Beaton et al. Apr 1997 A
5627061 Barry et al. May 1997 A
5633360 Bischofberger et al. May 1997 A
5633435 Barry et al. May 1997 A
5633448 Lebrun et al. May 1997 A
5639024 Mueller et al. Jun 1997 A
5646024 Leemans et al. Jul 1997 A
5648477 Leemans et al. Jul 1997 A
5663312 Chaturvedula Sep 1997 A
5677437 Teng et al. Oct 1997 A
5677439 Weis et al. Oct 1997 A
5714331 Buchardt et al. Feb 1998 A
5719046 Guerineau et al. Feb 1998 A
5719262 Buchardt et al. Feb 1998 A
5721138 Lawn Feb 1998 A
5731180 Dietrich Mar 1998 A
5739180 Taylor-Smith Apr 1998 A
5746180 Jefferson et al. May 1998 A
5767361 Dietrich Jun 1998 A
5767373 Ward et al. Jun 1998 A
5780708 Lundquist et al. Jul 1998 A
5804425 Barry et al. Sep 1998 A
5824877 Hinchee et al. Oct 1998 A
5837848 Ely et al. Nov 1998 A
5859347 Brown et al. Jan 1999 A
5866775 Eichholtz et al. Feb 1999 A
5874265 Adams et al. Feb 1999 A
5879903 Strauch et al. Mar 1999 A
5898031 Crooke Apr 1999 A
5914451 Martinell et al. Jun 1999 A
5919675 Adams et al. Jul 1999 A
5928937 Kakefuda et al. Jul 1999 A
5939602 Volrath et al. Aug 1999 A
5969213 Adams et al. Oct 1999 A
5981840 Zhao et al. Nov 1999 A
5985793 Sandbrink et al. Nov 1999 A
RE36449 Lebrun et al. Dec 1999 E
6040497 Spencer et al. Mar 2000 A
6056938 Unger et al. May 2000 A
6069115 Pallett et al. May 2000 A
6084089 Mine et al. Jul 2000 A
6084155 Volrath et al. Jul 2000 A
6107094 Crooke Aug 2000 A
6118047 Anderson et al. Sep 2000 A
6121513 Zhang et al. Sep 2000 A
6130366 Herrera-Estrella et al. Oct 2000 A
6140078 Sanders et al. Oct 2000 A
6153812 Fry et al. Nov 2000 A
6160208 Lundquist et al. Dec 2000 A
6177616 Bartsch et al. Jan 2001 B1
6194636 McElroy et al. Feb 2001 B1
6225105 Sathasivan et al. May 2001 B1
6225114 Eichholtz et al. May 2001 B1
6232526 McElroy et al. May 2001 B1
6232536 McElroy et al. May 2001 B1
6245968 Boudec et al. Jun 2001 B1
6248876 Barry et al. Jun 2001 B1
6252138 Karimi et al. Jun 2001 B1
RE37287 Lebrun et al. Jul 2001 E
6268549 Sailland et al. Jul 2001 B1
6271359 Norris et al. Aug 2001 B1
6282837 Ward et al. Sep 2001 B1
6288306 Ward et al. Sep 2001 B1
6288312 Christou et al. Sep 2001 B1
6294714 Matsunaga et al. Sep 2001 B1
6303374 Zhang et al. Oct 2001 B1
6326193 Liu et al. Dec 2001 B1
6329571 Hiei Dec 2001 B1
6348185 Piwnica-Worms Feb 2002 B1
6365807 Christou et al. Apr 2002 B1
6384301 Martinell et al. May 2002 B1
6385902 Schipper et al. May 2002 B1
6399861 Anderson et al. Jun 2002 B1
6403865 Koziel et al. Jun 2002 B1
6414222 Gengenbach et al. Jul 2002 B1
6421956 Boukens et al. Jul 2002 B1
6426446 McElroy et al. Jul 2002 B1
6433252 Kriz et al. Aug 2002 B1
6437217 McElroy et al. Aug 2002 B1
6453609 Soll et al. Sep 2002 B1
6479291 Kumagai et al. Nov 2002 B2
6506559 Fire et al. Jan 2003 B1
6642435 Rafalski et al. Nov 2003 B1
6644341 Chemo et al. Nov 2003 B1
6645914 Woznica et al. Nov 2003 B1
6768044 Boudec et al. Jul 2004 B1
6843985 Erickson, Jr. et al. Jan 2005 B2
6992237 Habben et al. Jan 2006 B1
7022896 Weeks et al. Apr 2006 B1
7026528 Cheng et al. Apr 2006 B2
7056704 Tuschl et al. Jun 2006 B2
7078196 Tuschl et al. Jul 2006 B2
RE39247 Barry et al. Aug 2006 E
7105724 Weeks et al. Sep 2006 B2
7297541 Moshiri et al. Nov 2007 B2
7304209 Zink et al. Dec 2007 B2
7312379 Andrews et al. Dec 2007 B2
7323310 Peters et al. Jan 2008 B2
7371927 Yao et al. May 2008 B2
7392379 Le Pennec et al. Jun 2008 B2
7405347 Hammer et al. Jul 2008 B2
7406981 Hemo et al. Aug 2008 B2
7462379 Fukuda et al. Dec 2008 B2
7485777 Nakajima et al. Feb 2009 B2
7525013 Hildebrand et al. Apr 2009 B2
7550578 Budworth et al. Jun 2009 B2
7622301 Ren et al. Nov 2009 B2
7657299 Huizenga et al. Feb 2010 B2
7671254 Tranel et al. Mar 2010 B2
7714188 Castle et al. May 2010 B2
7738626 Weese et al. Jun 2010 B2
7807791 Sekar et al. Oct 2010 B2
7838263 Dam et al. Nov 2010 B2
7838733 Wright et al. Nov 2010 B2
7842856 Tranel et al. Nov 2010 B2
7855323 Huang et al. Dec 2010 B2
7884262 Clemente et al. Feb 2011 B2
7910805 Duck et al. Mar 2011 B2
7935869 Pallett et al. May 2011 B2
7943819 Baum et al. May 2011 B2
7973218 McCutchen et al. Jul 2011 B2
8090164 Bullitt et al. Jan 2012 B2
8097712 Paldi et al. Jan 2012 B2
8143480 Axtell et al. Mar 2012 B2
8158414 Rommens et al. Apr 2012 B2
8507457 Paldi et al. Aug 2013 B2
8548778 Hart et al. Oct 2013 B1
8554490 Tang et al. Oct 2013 B2
8598332 Waterhouse et al. Dec 2013 B1
9006414 Huang et al. Apr 2015 B2
9121022 Sammons et al. Sep 2015 B2
9422557 Ader Aug 2016 B2
9445603 Baum et al. Sep 2016 B2
20010006797 Kumagai et al. Jul 2001 A1
20010042257 Connor-Ward et al. Nov 2001 A1
20020069430 Kiaska et al. Jun 2002 A1
20020086356 Tuschl et al. Jul 2002 A1
20020114784 Li et al. Aug 2002 A1
20020123476 Emanuele et al. Sep 2002 A1
20030017068 Larrain et al. Jan 2003 A1
20030044443 Erickson, Jr. et al. Mar 2003 A1
20030092651 Norris et al. May 2003 A1
20030096980 Froehler et al. May 2003 A1
20030140371 Stevens et al. Jul 2003 A1
20030150017 Mesa et al. Aug 2003 A1
20030154508 Stevens et al. Aug 2003 A1
20030167537 Jiang Sep 2003 A1
20030180945 Wang et al. Sep 2003 A1
20040029275 Brown et al. Feb 2004 A1
20040053289 Allen et al. Mar 2004 A1
20040055041 Labate et al. Mar 2004 A1
20040072692 Hoffman et al. Apr 2004 A1
20040082475 Hoffman et al. Apr 2004 A1
20040123347 Hinchey et al. Jun 2004 A1
20040126845 Eenennaam et al. Jul 2004 A1
20040133944 Hake et al. Jul 2004 A1
20040147475 Li et al. Jul 2004 A1
20040177399 Hammer et al. Sep 2004 A1
20040216189 Houmard et al. Oct 2004 A1
20040244075 Cai et al. Dec 2004 A1
20040250310 Shukla et al. Dec 2004 A1
20040259247 Tuschl et al. Dec 2004 A1
20050005319 della-Cioppa et al. Jan 2005 A1
20050044591 Yao et al. Feb 2005 A1
20050080032 Gross et al. Apr 2005 A1
20050095199 Whyard et al. May 2005 A1
20050215435 Menges et al. Sep 2005 A1
20050250647 Hills et al. Nov 2005 A1
20060009358 Kibler et al. Jan 2006 A1
20060021087 Baum et al. Jan 2006 A1
20060040826 Eaton et al. Feb 2006 A1
20060111241 Gerwick, III et al. May 2006 A1
20060130172 Whaley et al. Jun 2006 A1
20060135758 Wu Jun 2006 A1
20060200878 Lutfiyya et al. Sep 2006 A1
20060223708 Hoffman et al. Oct 2006 A1
20060223709 Helmke et al. Oct 2006 A1
20060247197 Van De Craen et al. Nov 2006 A1
20060272049 Waterhouse Nov 2006 A1
20060276339 Windsor et al. Dec 2006 A1
20070011448 Chhabra et al. Jan 2007 A1
20070011775 Allen et al. Jan 2007 A1
20070021360 Nyce et al. Jan 2007 A1
20070050860 Andersen et al. Mar 2007 A1
20070050863 Tranel et al. Mar 2007 A1
20070124836 Baum et al. May 2007 A1
20070199095 Allen et al. Aug 2007 A1
20070219151 Satishchandran et al. Sep 2007 A1
20070232188 Probasco Oct 2007 A1
20070250947 Boukharov et al. Oct 2007 A1
20070259785 Heck et al. Nov 2007 A1
20070269815 Rivory et al. Nov 2007 A1
20070281900 Cui et al. Dec 2007 A1
20070300329 Allen et al. Dec 2007 A1
20080022423 Roberts et al. Jan 2008 A1
20080050342 Fire et al. Feb 2008 A1
20080092256 Kohn Apr 2008 A1
20080113351 Naito et al. May 2008 A1
20080155716 Sonnewald et al. Jun 2008 A1
20080194512 John et al. Aug 2008 A1
20080214443 Baum et al. Sep 2008 A1
20080261303 Kreutzer et al. Oct 2008 A1
20090011934 Zawierucha et al. Jan 2009 A1
20090018016 Duck et al. Jan 2009 A1
20090036311 Witschel et al. Feb 2009 A1
20090054240 Witschel et al. Feb 2009 A1
20090075921 Ikegawa et al. Mar 2009 A1
20090098614 Zamore et al. Apr 2009 A1
20090118214 Paldi et al. May 2009 A1
20090137395 Chicoine et al. May 2009 A1
20090165153 Wang et al. Jun 2009 A1
20090165166 Feng et al. Jun 2009 A1
20090172838 Axtell et al. Jul 2009 A1
20090188005 Boukharov et al. Jul 2009 A1
20090205079 Kumar et al. Aug 2009 A1
20090215628 Witschel et al. Aug 2009 A1
20090285784 Raemaekers et al. Nov 2009 A1
20090293148 Ren et al. Nov 2009 A1
20090298787 Raemaekers et al. Dec 2009 A1
20090306189 Raemaekers et al. Dec 2009 A1
20090307803 Baum et al. Dec 2009 A1
20100005551 Roberts et al. Jan 2010 A1
20100048670 Biard et al. Feb 2010 A1
20100068172 Van De Craen Mar 2010 A1
20100071088 Sela et al. Mar 2010 A1
20100099561 Selby et al. Apr 2010 A1
20100100988 Tranel et al. Apr 2010 A1
20100152443 Hirai et al. Jun 2010 A1
20100154083 Ross et al. Jun 2010 A1
20100192237 Ren et al. Jul 2010 A1
20100247578 Salama Sep 2010 A1
20110015084 Christian et al. Jan 2011 A1
20110015284 Dees et al. Jan 2011 A1
20110028412 Cappello et al. Feb 2011 A1
20110035836 Eudes et al. Feb 2011 A1
20110041400 Trias Vila et al. Feb 2011 A1
20110053226 Rohayem Mar 2011 A1
20110098180 Michel et al. Apr 2011 A1
20110105327 Nelson May 2011 A1
20110105329 Song et al. May 2011 A1
20110112570 Mannava et al. May 2011 A1
20110126310 Feng et al. May 2011 A1
20110126311 Velcheva et al. May 2011 A1
20110152339 Brown et al. Jun 2011 A1
20110152346 Karleson et al. Jun 2011 A1
20110152353 Koizumi et al. Jun 2011 A1
20110160082 Woo et al. Jun 2011 A1
20110166022 Israels et al. Jul 2011 A1
20110166023 Nettleton-Hammond et al. Jul 2011 A1
20110171176 Baas et al. Jul 2011 A1
20110171287 Saarma et al. Jul 2011 A1
20110177949 Krapp et al. Jul 2011 A1
20110185444 Li et al. Jul 2011 A1
20110185445 Bogner et al. Jul 2011 A1
20110191897 Poree et al. Aug 2011 A1
20110201501 Song et al. Aug 2011 A1
20110296555 Ivashuta et al. Dec 2011 A1
20110296556 Sammons et al. Dec 2011 A1
20120036594 Cardoza et al. Feb 2012 A1
20120053231 Paldi et al. Mar 2012 A1
20120107355 Harris et al. May 2012 A1
20120108497 Paldi et al. May 2012 A1
20120128218 Amyot et al. May 2012 A1
20120137387 Baum et al. May 2012 A1
20120150048 Kang et al. Jun 2012 A1
20120156784 Adams, Jr. et al. Jun 2012 A1
20120157512 Ben-Chanoch et al. Jun 2012 A1
20120164205 Baum et al. Jun 2012 A1
20120185967 Sela et al. Jul 2012 A1
20120198586 Narva et al. Aug 2012 A1
20120230565 Steinberg et al. Sep 2012 A1
20120258646 Sela et al. Oct 2012 A1
20120316220 Ward et al. Dec 2012 A1
20130003213 Kabelac et al. Jan 2013 A1
20130041004 Drager et al. Feb 2013 A1
20130047297 Sammons et al. Feb 2013 A1
20130047298 Tang Feb 2013 A1
20130058890 Raemaekers et al. Mar 2013 A1
20130060133 Kassab et al. Mar 2013 A1
20130067618 Ader et al. Mar 2013 A1
20130084243 Goetsch et al. Apr 2013 A1
20130096073 Sidelman Apr 2013 A1
20130097726 Ader et al. Apr 2013 A1
20130212739 Giritch et al. Aug 2013 A1
20130226003 Edic et al. Aug 2013 A1
20130232646 Baum et al. Sep 2013 A1
20130247247 Ader et al. Sep 2013 A1
20130254940 Ader et al. Sep 2013 A1
20130254941 Ader et al. Sep 2013 A1
20130288895 Ader et al. Oct 2013 A1
20130289097 Paldi et al. Oct 2013 A1
20130318657 Avniel et al. Nov 2013 A1
20130318658 Ader et al. Nov 2013 A1
20130324842 Mittal et al. Dec 2013 A1
20130326731 Ader et al. Dec 2013 A1
20140018241 Sammons et al. Jan 2014 A1
20140057789 Sammons et al. Feb 2014 A1
20140109258 Van De Craen et al. Apr 2014 A1
20140230090 Avniel et al. Aug 2014 A1
20140274712 Finnessy et al. Sep 2014 A1
20140275208 Hu et al. Sep 2014 A1
20140296503 Avniel et al. Oct 2014 A1
20140371298 Paldi et al. Dec 2014 A1
20150096079 Avniel et al. Apr 2015 A1
20150143580 Beattie et al. May 2015 A1
20150159156 Inberg et al. Jun 2015 A1
20150203867 Beattie et al. Jul 2015 A1
20150240258 Beattie et al. Aug 2015 A1
20160015035 Tao Jan 2016 A1
20160029644 Tao Feb 2016 A1
20170037407 Gleit-Kielmanowicz et al. Feb 2017 A1
20170088838 Inberg et al. Mar 2017 A1
20170183683 Zheng et al. Jun 2017 A1
Foreign Referenced Citations (267)
Number Date Country
2008325989 May 2009 AU
2008258254 Jul 2014 AU
2806295 Feb 2011 CA
1505504 Jun 2004 CN
101139607 Mar 2008 CN
101279950 Oct 2008 CN
101279951 Oct 2008 CN
101914540 Dec 2010 CN
102822350 Dec 2012 CN
288618 Apr 1991 DE
10000600 Jul 2001 DE
10116399 Oct 2002 DE
10256353 Jun 2003 DE
10256354 Jun 2003 DE
10256367 Jun 2003 DE
10204951 Aug 2003 DE
10234875 Feb 2004 DE
10234876 Feb 2004 DE
102004054666 May 2006 DE
102005014638 Oct 2006 DE
102005014906 Oct 2006 DE
102007012168 Sep 2008 DE
102010042866 May 2011 DE
0 375 408 Jun 1990 EP
0 804 600 Nov 1997 EP
1 157 991 Nov 2001 EP
1 238 586 Sep 2002 EP
1 416 049 May 2004 EP
2 147 919 Jan 2010 EP
2 160 098 Nov 2010 EP
2 530 159 Mar 2011 EP
2 305 813 Apr 2011 EP
2 545 182 Jan 2013 EP
2 703 489 Mar 2014 EP
2 703 490 Mar 2014 EP
2 706 114 Mar 2014 EP
2001253874 Sep 2001 JP
2002080454 Mar 2002 JP
2002138075 May 2002 JP
2002145707 May 2002 JP
2002220389 Aug 2002 JP
2003064059 Mar 2003 JP
2003096059 Apr 2003 JP
2004051628 Feb 2004 JP
2004107228 Apr 2004 JP
2005008583 Jan 2005 JP
2005239675 Sep 2005 JP
2005314407 Nov 2005 JP
2006232824 Sep 2006 JP
2006282552 Oct 2006 JP
2007153847 Jun 2007 JP
2007161701 Jun 2007 JP
2007182404 Jul 2007 JP
2008074840 Apr 2008 JP
2008074841 Apr 2008 JP
2008133207 Jun 2008 JP
2008133218 Jun 2008 JP
2008169121 Jul 2008 JP
2009-508481 Mar 2009 JP
2009067739 Apr 2009 JP
2009114128 May 2009 JP
2009126792 Jun 2009 JP
2009137851 Jun 2009 JP
WO 8911789 Dec 1989 WO
WO 9534659 Dec 1995 WO
WO 9534668 Dec 1995 WO
WO 96005721 Feb 1996 WO
WO 96033270 Oct 1996 WO
WO 96038567 Dec 1996 WO
WO 96040964 Dec 1996 WO
WO 9747193 Dec 1997 WO
WO 9749816 Dec 1997 WO
WO 99024585 May 1999 WO
WO 9926467 Jun 1999 WO
WO 9927116 Jun 1999 WO
WO 9932619 Jul 1999 WO
WO 9961631 Dec 1999 WO
WO 9967367 Dec 1999 WO
WO 0004176 Jan 2000 WO
WO 0032757 Jun 2000 WO
WO 00044914 Aug 2000 WO
WO 0107601 Feb 2001 WO
WO 0134815 May 2001 WO
WO 2001085970 Nov 2001 WO
WO 0214472 Feb 2002 WO
WO 02066660 Aug 2002 WO
WO 03000679 Jan 2003 WO
WO 03004649 Jan 2003 WO
WO 03006422 Jan 2003 WO
WO 03012052 Feb 2003 WO
WO 03013247 Feb 2003 WO
WO 03016308 Feb 2003 WO
WO 2003014357 Feb 2003 WO
WO 03020704 Mar 2003 WO
WO 03022051 Mar 2003 WO
WO 03022831 Mar 2003 WO
WO 03022843 Mar 2003 WO
WO 03029243 Apr 2003 WO
WO 03037085 May 2003 WO
WO 03037878 May 2003 WO
WO 03045878 Jun 2003 WO
WO 03050087 Jun 2003 WO
WO 03051823 Jun 2003 WO
WO 03051824 Jun 2003 WO
WO 03051846 Jun 2003 WO
WO 03064625 Aug 2003 WO
WO 03076409 Sep 2003 WO
WO 03077648 Sep 2003 WO
WO 03087067 Oct 2003 WO
WO 03090539 Nov 2003 WO
WO 03091217 Nov 2003 WO
WO 03093269 Nov 2003 WO
WO 03104206 Dec 2003 WO
WO 2004002947 Jan 2004 WO
WO 2004002981 Jan 2004 WO
WO 2004005485 Jan 2004 WO
WO 2004009761 Jan 2004 WO
WO 2004011429 Feb 2004 WO
WO 2004022771 Mar 2004 WO
WO 2004029060 Apr 2004 WO
WO 2004035545 Apr 2004 WO
WO 2004035563 Apr 2004 WO
WO 2004035564 Apr 2004 WO
WO 2004037787 May 2004 WO
WO 2004049806 Jun 2004 WO
WO 2004062351 Jul 2004 WO
WO 2004067518 Aug 2004 WO
WO 2004067527 Aug 2004 WO
WO 2004074443 Sep 2004 WO
WO 2004077950 Sep 2004 WO
WO 2005000824 Jan 2005 WO
WO 2005003362 Jan 2005 WO
WO 2005007627 Jan 2005 WO
WO 2005007860 Jan 2005 WO
WO 2005040152 May 2005 WO
WO 2005047233 May 2005 WO
WO 2005047281 May 2005 WO
WO 2005061443 Jul 2005 WO
WO 2005061464 Jul 2005 WO
WO 2005068434 Jul 2005 WO
WO 2005070889 Aug 2005 WO
WO 2005089551 Sep 2005 WO
WO 2005095335 Oct 2005 WO
WO 2005107437 Nov 2005 WO
WO 2005110068 Nov 2005 WO
WO 2006006569 Jan 2006 WO
WO 2006024820 Mar 2006 WO
WO 2006029828 Mar 2006 WO
WO 2006029829 Mar 2006 WO
WO 2006037945 Apr 2006 WO
WO 2006050803 May 2006 WO
WO 2006074400 Jul 2006 WO
WO 2006090792 Aug 2006 WO
WO 2006123088 Nov 2006 WO
WO 2006125687 Nov 2006 WO
WO 2006125688 Nov 2006 WO
WO 2006138638 Dec 2006 WO
WO 2007003294 Jan 2007 WO
WO 2007007316 Jan 2007 WO
WO 2007024783 Mar 2007 WO
WO 2007026834 Mar 2007 WO
WO 2007035650 Mar 2007 WO
WO 2007038788 Apr 2007 WO
WO 2007039454 Apr 2007 WO
WO 2007050715 May 2007 WO
WO 2007051462 May 2007 WO
WO 2007070389 Jun 2007 WO
WO 2007071900 Jun 2007 WO
WO 2007074405 Jul 2007 WO
WO 2007074976 Jul 2007 WO
WO 2007077201 Jul 2007 WO
WO 2007077247 Jul 2007 WO
WO 2007080126 Jul 2007 WO
WO 2007080127 Jul 2007 WO
WO 2007083193 Jul 2007 WO
WO 2007096576 Aug 2007 WO
WO 2007051462 Oct 2007 WO
WO 2007119434 Oct 2007 WO
WO 2007134984 Nov 2007 WO
WO 2008007100 Jan 2008 WO
WO 2008009908 Jan 2008 WO
WO 2008029084 Mar 2008 WO
WO 2008042231 Apr 2008 WO
WO 2008059948 May 2008 WO
WO 2008063203 May 2008 WO
WO 2008071918 Jun 2008 WO
WO 2008074991 Jun 2008 WO
WO 2008084073 Jul 2008 WO
WO 2008100426 Aug 2008 WO
WO 2008102908 Aug 2008 WO
WO 2008148223 Dec 2008 WO
WO 2008152072 Dec 2008 WO
WO 2008152073 Dec 2008 WO
WO 2009000757 Dec 2008 WO
WO 2009005297 Jan 2009 WO
WO 2009029690 Mar 2009 WO
WO 2009035150 Mar 2009 WO
WO 2009037329 Mar 2009 WO
WO 2009046384 Apr 2009 WO
WO 2009060429 May 2009 WO
WO 2009063180 May 2009 WO
WO 2009068170 Jun 2009 WO
WO 2009068171 Jun 2009 WO
WO 2009086041 Jul 2009 WO
WO 2009090402 Jul 2009 WO
WO 2009091862 Jul 2009 WO
WO 2009091863 Jul 2009 WO
WO 2009115788 Sep 2009 WO
WO 2009116558 Sep 2009 WO
WO 2009125401 Oct 2009 WO
WO 2009152995 Dec 2009 WO
WO 2009158258 Dec 2009 WO
WO 2010012649 Feb 2010 WO
WO 2010026989 Mar 2010 WO
WO 2010034153 Apr 2010 WO
WO 2010049270 May 2010 WO
WO 2010049369 May 2010 WO
WO 2010049405 May 2010 WO
WO 2010049414 May 2010 WO
WO 2010056519 May 2010 WO
WO 2010063422 Jun 2010 WO
WO 2010069802 Jun 2010 WO
WO 2010078906 Jul 2010 WO
WO 2010078912 Jul 2010 WO
WO 2010093788 Aug 2010 WO
WO 2010104217 Sep 2010 WO
WO 2010108611 Sep 2010 WO
WO 2010112826 Oct 2010 WO
WO 2010116122 Oct 2010 WO
WO 2010119906 Oct 2010 WO
WO 2010128465 Nov 2010 WO
WO 2010130970 Nov 2010 WO
WO 2011001434 Jan 2011 WO
WO 2011003776 Jan 2011 WO
WO 2011021171 Feb 2011 WO
WO 2011035874 Mar 2011 WO
WO 2011045796 Apr 2011 WO
WO 2011065451 Jun 2011 WO
WO 2011067745 Jun 2011 WO
WO 2011075188 Jun 2011 WO
WO 2011080674 Jul 2011 WO
WO 2011112570 Sep 2011 WO
WO 2011132127 Oct 2011 WO
WO 2012001626 Jan 2012 WO
WO 2012056401 May 2012 WO
WO 2012092580 Jul 2012 WO
WO 2012164100 Dec 2012 WO
WO 2013010691 Jan 2013 WO
WO 2013025670 Feb 2013 WO
WO 2013039990 Mar 2013 WO
WO 2013040005 Mar 2013 WO
WO 2013040021 Mar 2013 WO
WO 2013040033 Mar 2013 WO
WO 2013040049 Mar 2013 WO
WO 2013040057 Mar 2013 WO
WO 2013040116 Mar 2013 WO
WO 2013040117 Mar 2013 WO
WO 2013153553 Oct 2013 WO
WO 2013175480 Nov 2013 WO
WO 2014022739 Feb 2014 WO
WO 2014106837 Jul 2014 WO
WO 2014106838 Jul 2014 WO
WO 2014151255 Sep 2014 WO
WO 2014164761 Oct 2014 WO
WO 2014164797 Oct 2014 WO
WO 2015010026 Jan 2015 WO
WO 2016018887 Feb 2016 WO
Non-Patent Literature Citations (571)
Entry
Thomas et al. 2001, The Plant Journal 25(4):417-425.
Yibrah et al. 1993, Hereditas 118:273-2890.
Bachman et al., “Characterization of the spectrum of insecticidal activity of a double-stranded RNA with targeted activity against Western Corn Rootworm (Diabrotica virgifera virgifera LeConte),” Transgenic Res., 22(6):1207-22 (2013).
Chu et al., “Potent RNAi by short RNA triggers,” RNA, 14:1714-1719 (2008).
Advisory Action dated Feb. 22, 2013, in U.S. Appl. No. 13/332,430.
Agricultural Chemical Usage 2006 Vegetables Summary, Agricultural Statistics Board, NASS, USDA, pp. 1-372 (2007).
Agrios, Plant Pathology (Second Edition), 2:466-470 (1978).
Amarzguioui et al., “An algorithm for selection of functional siRNA sequences,” Biochemical and Biophysical Research Communications, 316:1050-1058 (2004).
Amdam et al., Disruption of vitellogenin gene function in adult honeybees by intra-abdominal injection of double-stranded RNA, BMC Biotechnology, 3(1):1-8 (2003).
An et al., “Transient RNAi Induction against Endogenous Genes in Arabidopsis Protoplasts Using in Vitro-Prepared Double-Stranded RNA,” Biosci Biotechnol Biochem, 69(2):415-418 (2005).
Andersen et al., “Delivery of siRNA from lyophilized polymeric surfaces,” Biomaterials, 29:506-512 (2008).
Anonymous, “Agronomy Facts 37: Adjuvants for enhancing herbicide performance,” n.p., 1-8, (Jan. 26, 2000), Web, (Jan. 21, 2014).
Aoki et al., “In Vivo Transfer Efficiency of Antisense Oligonucleotides into the Myocardium Using HVJ—Liposome Method,” Biochem Biophys Res Commun, 231:540-545 (1997).
Arpaia et al., “Production of transgenic eggplant (Solanum melongena L.) resistant to Colorado Potato Beetle (Leptinotarsa decemlineata Say),” (1997) Theor. Appl. Genet., 95:329-334 (1997).
Artymovich, “Using RNA interference to increase crop yield and decrease pest damage,” MMG 445 Basic Biotech., 5(1):7-12 (2009).
Ascencio-Ibanez et al., “DNA abrasion onto plants is an effective method for geminivirus infection and virus-induced gene silencing,” Journal of Virological Methods, 142:198-203 (2007).
Axtell et al., “A Two-Hit Trigger for siRNA Biogenesis in Plants,” Cell, 127:565-577 (2006).
Bachman et al., “Characterization of the spectrum of insecticidal activity of a double-stranded RNA with targeted activity against Western Corn Rootworm (Diabrotica virgifera virgifera LeConte),” Transgenic Res., pp. 1-16 (2013).
Bart et al., “A novel system for gene silencing using siRNAs in rice leaf and stem-derived protoplasts,” Plant Methods, 2(13):1-9 (2006).
Baulcombe, “RNA silencing and heritable epigenetic effects in tomato and Arabidopsis,” Abstract 13th Annual Fall Symposium, Plant Genomes to Phenomes, Donald Danforth Plant Science Center, 28-30 (2011).
Baum et al., “Control of coleopteran insect pests through RNA interference,” Nature Biotechnology, 25(11):1322-1326 (2007).
Baum et al., “Progress Towards RNAi-Mediated Insect Pest Management” Advances in Insect Physiology, 47:249-295 (2014).
Bayer et al., “Programmable ligand-controlled riboregulators of eukaryotic gene expression,” Nature Biotechnol., 23(3):337-343 (2005).
Beal, et al., “Second Structural Motif for Recognition of DNA by Oligonucleotide-Directed Triple-Helix Formation,” Science, 251:1360-1363 (1992).
Becker et al., “Fertile transgenic wheat from microprojectile bombardment of scutellar tissue,” The Plant Journal, 5(2):299-307 (1994).
Bhargava et al., “Long double-stranded RNA-mediated RNA interference as a tool to achieve site-specific silencing of hypothalamic neuropeptides,” Brain Research Protocols, 13:115-125 (2004).
Bhatia et al., “Aphid resistance in Brassica crops: Challenges, biotechnological progress and emerging possibilities,” Biotechnology Advances 29:879-955 (2011).
Boletta et al., “High Efficient Non-Viral Gene Delivery to the Rat Kidney by Novel Polycationic Vectors,” J. Am Soc. Nephrol., 7:1728 (1996).
Bolognesi et al., “Characterizing the Mechanism of Action of Double-Stranded RNA Activity against Western Corn Rootworm(Diabrotica virgifera virgifera LeConte),” PLoS One 7(10):e47534 (2012).
Breaker et al., “A DNA enzyme with Mg2+-dependent RNA phosphoesterase activity,” Chemistry and Biology, 2:655-660 (1995).
Brodersen et al., “The diversity of RNA silencing pathways in plants,” Trends in Genetics, 22(5):268-280 (2006).
Busch et al., “RNAi for discovery of novel crop protection products,” Pflanzenschutz-Nachrichten Bayer, 58(1):34-50 (2005).
Campbell et al., “Gene-knockdown in the honey bee mite Varroa destructor by a non-invasive approach: studies on a glutathione S-transferase,” Parasites & Vectors, 3(1):73, pp. 1-10 (2010).
Carthew, “Gene silencing by double-stranded RNA,” Curr Opin Cell Biol., 13(2):244-248 (2001).
Chabannes et al., “In situ analysis of lignins in transgenic tobacco reveals a differential impact of individual transformations on the spatial patterns of lignin deposition at the cellular and subcellular levels,” The Plant Journal, 28(3):271-282 (2001).
Chabbouh et al., “Cucumber mosaic virus in artichoke,” FAO Plant Protection Bulletin, 38:52-53 (1990).
Chang et al., “Dual-target gene silencing by using long, sythetic siRNA duplexes without triggering antiviral responses,” Molecules and Cells, 27(6) 689-695 (2009).
Chang et al., “Cellular Internalization of Fluorescent Proteins via Arginine-rich Intracellular Delivery Peptide in Plant Cells,” Plant Cell Physiol., 46(3):482-488 (2005).
Chen et al., “Exploring MicroRNA-Like Small RNAs in the Filamentous Fungus Fusarium oxysporum,” PLOS One, 9(8):e104956:1-10 (2014).
Christiaens et al., “The challenge of RNAi-mediated control of hemipterans,” Current Opinion in Insect Science, 6:15-21 (2014).
CN101914540 Patent Diclosure, “Introduction of RNA into plant by interference,” (2010).
Colorado Potato Beetle, Leptinotarsa decemlineata,Transcriptome, PLoS One, 9(1):e86012 (2014).
Communication pursuant to Article 94(3) EPC dated Jan. 14, 2016, in European Patent Application No. 12 832 415.9.
Communication pursuant to Article 94(3) EPC dated Jun. 26, 2015, in European Patent Application No. 11 753 916.3.
Communication pursuant to Article 94(3) EPC dated Mar. 18, 2016, in European Patent Application No. 12 832 160.1.
Communication pursuant to Article 94(3) EPC dated Mar. 24, 2016, in European Patent Application No. 12 831 684.1.
Communication pursuant to Article 94(3) EPC dated Mar. 4, 2016, in European Patent Application No. 12 830 932.5.
Communication pursuant to Article 94(3) EPC dated Mar. 9, 2016, in European Patent Application No. 12 831 166.9.
Communication pursuant to Article 94(3) EPC dated Oct. 23, 2015, in European Patent Application No. 12 831 945.6.
Concise Descriptions of Relevance filed by a third party on Nov. 29, 2012, in U.S. Appl. No. 13/042,856.
Constan et al., “An outer envelope membrane component of the plastid protein import apparatus plays an essential role in Arabidopsis,” The Plant Journal, 38:93-106 (2004).
Cooney et al., “Site-Specific Oligonucleotide Binding Represses Transcription of the Human c-myc Gene in Vitro,” Science,241:456-459 (1988).
Cost Action FA0806 progress report “Plant virus control employing RNA-based vaccines: A novel non-transgenic strategy” (2010).
Cox-Foster et al., “A Metagenomic Survey of Microbes in Honey Bee Colony Collapse Disorder,” Science, 318(5848):283-287 (2007).
Dalakouras et al., “Induction of Silencing in Plants by High-Pressure Spraying of In vitro-Synthesized Small RNAs,” Frontiers in Plant Science, 7(1327):1-5 (2016).
Dalmay et al., “An RNA-Depenedent RNA Polymerase Gene in Arabidopsis Is Required for Posttranscriptional Gene Silencing Mediated by a Transgene but Not by a Virus,” Cell, 101:543-553 (2000).
Davidson et al., “Engineering regulatory RNAs,” Trends in Biotechnology, 23(3):109-112 (2005).
Dawson et al., “cDNA cloning of the complete genome of tobacco mosaic virus and production of infectious transcripts,” Proc. Natl. Acad. Sci. USA, 83:1832-1836 (1986).
De Framond, “MINI-Ti: A New Vector Strategy for Plant Genetic Engineering,” Nature Biotechnology, 1:262-269 (1983).
Desai et al., “Reduction in deformed wing virus infection in larval and adult honey bees (Apis mellifera L.) by double-stranded RNA ingestion,” Insect Molecular Biology, 21(4):446-455 (2012).
Di Prisco et al. “Varroa Destructor Is an Effective Vector of Israeli Acute Paralysis Virus in the Honeybee, Apis mellifera”, Journal of General Virology, 92: 151-155, 2011.
Di Stilio et al., “Virus-Induced Gene Silencing as a Tool for Comparative Functional Studies in Thalictrum,” PLoS One, 5(8):e12064 (2010).
Diallo et al., “Long Endogenous dsRNAs Can Induce Complete Gene Silencing in Mammalian Cells and Primary Cultures,” Oligonucleotides, 13:381-392 (2003).
Dietemann et al, “Varroa destructor: research avenues towards sustainable control,” Journal of Apicultural Research, 51(1):125-132 (2012).
Dietzl et al., “A genome-wide transgenic RNAi library for conditional gene inactivation in Drosophila,” Nature, 448:151-157 (2007).
Du et al., “A systematic analysis of the silencing effects of an active siRNA at all single-nucleotide mismatched target sites,” Nucleic Acids Research, 33(5):1671-1677 (2005).
Dunoyer et al., “Small RNA Duplexes Function as Mobile Silencing Signals Between Plant Cells,” Science, 328:912-916 (2010).
Eamens et al., “RNA Silencing in Plants: Yesterday, Today, and Tomorrow,” Plant Physiology, 147(2):456-468 (2008).
Ellington et al., “In vitro selection of RNA molecules that bind specific ligands,” Nature, 346:818-822 (1990).
Eudes et al., “Cell-penetrating peptides,” Plant Signaling & Behavior, 3(8):549-5550 (2008).
European Cooperation in the field of Scientific and Technical Research—Memorandum of Understanding for COST Action FA0806 (2008).
European Search Report and the European Search Opinion dated Feb. 3, 2014, in European Patent Application No. 13156180.4.
European Search Report and the European Search Opinion dated Feb. 3, 2014, in European Patent Application No. 13156180.5.
European Search Report dated Feb. 3, 2014, in European Patent Application No. 13156180.4.
European Search Report dated Feb. 3, 2014, in European Patent Application No. 13156180.5.
European Search Report dated Feb. 6, 2014, in European Patent Application No. 13156183.9.
European Search Report dated Jun. 29, 2018, in European Patent Application No. 18157745.3.
European Search Report dated Sep. 7, 2017, in European Patent Application No. 17152830.0.
Examination Report dated Mar. 1, 2018, in Australian Patent Application No. 2013264742.
Extended European Search Report dated Feb. 2, 2015, in European Patent Application No. 12 830 932.5.
Extended European Search Report dated Feb. 27, 2015, in European Patent Application No. 12 832 160.1.
Extended European Search Report dated Feb. 3, 2015, in European Patent Application No. 12 831 945.6.
Extended European Search Report dated Feb. 6, 2014, in European Patent Application No. 13156183.9.
Extended European Search Report dated Jan. 20, 2016, in European Patent Application No. 13 794 339.5.
Extended European Search Report dated Jan. 21, 2015, in European Patent Application No. 12 832 415.9.
Extended European Search Report dated Jan. 29, 2015, in European Patent Application No. 12 831 567.8.
Extended European Search Report dated Jun. 29, 2015, in European Patent Application No. 12 831 494.5.
Extended European Search Report dated Mar. 17, 2015, in European Patent Application No. 12 831 684.1.
Extended European Search Report dated Mar. 3, 2015, in European Patent Application No. 12 831 166.9.
Extended European Search Report dated May 23, 2018, in European Patent Application No. 15826865.6.
Extended European Search Report dated Nov. 7, 2017, in European Patent Application No. 15811092.4.
Extended European Search Report dated Nov. 8, 2017, in European Patent Application No. 15737282.2.
Extended European Search Report dated Oct. 8, 2013, in European Patent Application No. 11753916.3.
Extended European Search Report dated Sep. 29, 2016, in European Patent Application No. 14778840.0.
Extended European Search Report dated Apr. 13, 2018, in European Patent Application No. 15812530.0.
Extended European Search Report dated Mar. 15, 2018, in European Patent Application No. 17181861.0.
Fairbairn et al. “Host-Delivered RNAi: An Effective Strategy to Silence Genes in Plant Parasitic Nematodes”, Planta, 226(6):1525-1533 (2007) Abstract.
Fernandez et al., “Uptake of Hydrophilic Solutes Through Plant Leaves: Current State of Knowledge and Perspectives of Foliar Fertilization,” Critical Reviews in Plant Sciences, 28:36-38 (2009).
Fiala et al., “Reversible Downregulation of Protein Kinase a during Olfactory Learning Using Antisense Technique Impairs Long-Term Memory Formation in the Honeybee, Apis mellifera,” J. Neuroscience, 19:10125-10134 (1999).
Final Office Action dated Apr. 7, 2016, in U.S. Appl. No. 13/619,980.
Final Office Action dated Aug. 1, 2013, in U.S. Appl. No. 13/318,636.
Final Office Action dated Dec. 17, 2015, in U.S. Appl. No. 14/335,135.
Final Office Action dated Feb. 17, 2016, in U.S. Appl. No. 13/612,929.
Final Office Action dated Feb. 4, 2016, in U.S. Appl. No. 13/612,936.
Final Office Action dated Jun. 30, 2016, in U.S. Appl. No. 13/901,326.
Final Office Action dated Mar. 18, 2011, in U.S. Appl. No. 12/222,949.
Final Office Action dated Mar. 2, 2016, in U.S. Appl. No. 13/612,995.
Final Office Action dated Mar. 21, 2016, in U.S. Appl. No. 13/612,925.
Final Office Action dated May 26, 2016, in U.S. Appl. No. 14/532,596.
Final Office Action dated Nov. 10, 2015, in U.S. Appl. No. 13/612,985.
Final Office Action dated Nov. 10, 2016, in U.S. Appl. No. 13/583,302.
Final Office Action dated Nov. 19, 2015, in U.S. Appl. No. 13/612,941.
Final Office Action dated Nov. 30, 2015, in U.S. Appl. No. 13/612,948.
Final Office Action dated Nov. 7, 2013, in U.S. Appl. No. 13/042,856.
Final Office Action dated Oct. 15, 2012, in U.S. Appl. No. 13/332,430.
Final Office Action dated Oct. 20, 2016, in U.S. Appl. No. 14/480,199.
Final Office Action dated Oct. 22, 2015, in U.S. Appl. No. 14/608,951.
Final Office Action dated Sep. 9, 2016, in U.S. Appl. No. 13/612,954.
Final Office Action dated Sep. 9, 2016, in U.S. Appl. No. 14/603,347.
Final Office Action dated Sep. 9, 2016, in U.S. Appl. No. 14/608,951.
Fire et al., “Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans,” Nature, 391:806-811 (1998).
First Examination Report dated Apr. 23, 2013, in New Zealand Patent Application No. 601784.
First Examination Report dated Jul. 28, 2014, in New Zealand Patent Application No. 627060.
First Office Action dated Aug. 31, 2015, in Chinese Patent Application No. 201280053985.3.
First Office Action dated Feb. 2, 2016, in Chinese Patent Application No. 201380039346.6.
First Office Action dated Jul. 7, 2015, in Chinese Patent Application No. 201280054820.8.
First Office Action dated Mar. 12, 2015, in Chinese Patent Application No. 201280053984.9.
First Office Action dated Mar. 2, 2015, in Chinese Patent Application No. 201280054819.5.
First Office Action dated May 27, 2015, in Chinese Patent Application No. 201280054179.8.
First Office Action dated Sep. 9, 2015, in Chinese Patent Application No. 201280055409.2.
Foley et al., “The distribution of Aspergillus spp. Opportunistic parasites in hives and their pathogenicity to honey bees,” Veterinary Microbiology, 169:203-210 (2014).
Fraley et al., “Liposome-mediated delivery of tobacco mosaic virus RNA into tobacco protoplasts: A sensitive assay for monitoring liposome-protoplast interactions,” Proc Natl Acad Sci U S A., 79(6):1859-1863 (1982).
Friedberg, “Automated protein function prediction—the genomic challenge,” Briefings in Bioinformatics, 7(3):225-242 (2006).
Fukuhara et al., “Enigmatic Double-Stranded RNA in Japonica Rice,” Plant Molecular Biology, 21:1121-1130 (1993).
Fukuhara et al., “The Unusual Structure of a Novel RNA Replicon in Rice,” The Journal of Biological Chemistry, 270(30):18147-18149 (1995).
Fukuhara et al., “The wide distribution of endornaviruses, large double-stranded RNA replicons with plasmid-like properties,” Archives of Virology, 151:995-1002 (2006).
Fukunaga et al., “dsRNA with 5′ overhangs v contributes to endogenous and antiviral RNA silencing pathways in plants,” The EMBO Journal, 28(5):545-555 (2009).
Further Examination Report dated May 16, 2014, in New Zealand Patent Application No. 601784.
Gallie et al., “Identification of the motifs within the tobacco mosaic virus 5′-leader responsible for enhancing translation,” Nucleic Acids Res., 20(17):4631-4638 (1992).
Gan et al., “Bacterially expressed dsRNA protects maize against SCMV infection,” Plant Cell Rep, 29(11):1261-1268 (2010).
Gao et al., “Down-regulation of acetolactate synthase compromises 01-1-mediated resistance to powdery mildew in tomato,” BMC Plant Biology, 14 (2014).
Gao et al., “Nonviral Methods for siRNA Delivery,” Molecular Pharmaceutics, 6(3):651-658 (2008).
Garbian et al., “Bidirectional Transfer of RNAi between Honey Bee and Varroa destructor: Varroa Gene Silencing Reduces Varroa Population,” 8(12):1-9:e1003035 (2012).
Gaskin et al., “Novel organosillicone adjuvants to reduce agrochemical spray volumes on row crops,” New Zealand Plant Protection, 53:350-354 (2000).
Gill et al. “Stripped-Down DNA Repair in a High Reduced Parasite”, BMC Molecular Biology, 8(24): 1-14, Mar. 20, 2007.
Gomez-Zurita et al., “Recalibrated Tree of Leaf Beetles (Chrysomelidae) Indicates Independent Diversification of Angiosperms and Their Insect Herbivores,” PLoS One, 4(e360):1-8 (2007).
Gong et al., “Silencing of Rieske iron—sulfur protein using chemically synthesised siRNA as a potential biopesticide against Plutella xylostella,” Pest Manag Sci, 67:514-520 (2011).
Gossamer Threads, Compendium of Herbicide Adjuvants: Organo-Silicone Surfactant, p. 1-4 (1998).
Hagio, “Chapter 25: Direct Gene Transfer into Plant Mature Seeds via Electroporation After Vacuum Treatment,” Electroporation and Sonoporation in Developmental Biology, p. 285-293 (2009).
Hamilton et al., “Two classes of short interfering RNA in RNA silencing,” EMBO J., 21(17):4671-4679 (2002).
Han et al., “Molecular Basis for the Recognition of Primary microRNAs by the Drosha-DGCR8 Complex,” Cell, 125(5):887-901 (2006).
Hannon, “RNA interference,” Nature,481:244-251 (2002).
Henderson et al., “U.S. National Bee Colony Loss Survey, www.beesurvey.com, Preliminary Findings With Respect to Colony Collapse Disorder (CCD),” Bee Alert Technology, Inc. (2007).
Heneberg et al., “Assemblage of filamentous fungi associated with aculeate hymenopteran brood in reed galls,” Journal of Invertebrate Pathology, 133:95-106 (2016).
Herman et al., “A three-component dicamba O-demethylase from Pseudomonas maltophilia, strain DI-6: gene isolation, characterization, and heterologous expression,” J. Biol. Chem., 280: 24759-24767 (2005).
Hess, “Surfactants and Additives,” 1999 Proceedings of the California Weed Science Society, 51:156-172 (1999).
Hewezi et al., “Local infiltration of high- and low-molecular-weight RNA from silenced sunflower (Helianthus annuus L.) plants triggers post-transcriptional gene silencing in non-silenced plants,” Plant Biotechnology Journal, 3:81-89 (2005).
Himber et al., “Transitivity-dependant and -independent cell-to-cell movement of RNA silencing,” The EMBO Journal, 22(17):4523-4533 (2003).
Hsieh et al., “A library of siRNA duplexes targeting the phosphoinositide 3-kinase pathway: determinants of gene silencing for use in cell-based screens,” Nucleic Acids Res., 32(3):893-901.
Hu et al., “High efficiency transport of quantum dots into plant roots with the aid of silwet L-77,” Plant Physiology and Biochemistry, 48:703-709 (2010).
Huang et al., “Engineering broad root-know resistance in transgenic plants by RNAi silencing of a conserved and essential root-knot nematode parasitism gene,” Proc. Natl. Acad. Sci. USA, 103(39):14302-14306 (2006).
Huesken et al., “Design of a genome-wide siRNA library using an artificial neural network,” Nature Biotechnology, 23(8): 995-1001 (2005).
Hunter et al., “Large-Scale Field Application of RNAi Technology Reducing Israeli Acute Paralysis Virus Disease in Honey Bees (Apis mellifera, Hymenoptera: Apidae),” PLoS Pathogens, 6(12):e1001160-1-el 001160-10 (2010).
Hunter et al., “RNA Interference Strategy to suppress Psyllids & Leafhoppers,” International Plant and Animal Genome XIX, 15-19 (2011).
Huvenne et al., “Mechanisms of dsRNA uptake in insects and potential of RNAi for pest control: A review,” Journal of Insect Physiology, 56:227-235 (2010).
Ichihara et al., “Thermodynamic instability of siRNA duplex is a prerequisite for dependable prediction of siRNA activities,” Nucleic Acids Res., 35(18):e123 (2007).
International Preliminary Report on Patentability (Chapter II) dated Jul. 24, 2015, in International Application No. PCT/US2014/047204.
International Preliminary Report on Patentability dated Apr. 26, 2012, in International Application No. PCT/IL2010/000844.
International Preliminary Report on Patentability dated Feb. 1, 2010, in International Application No. PCT/IL2008/001440.
International Preliminary Report on Patentability dated Feb. 21, 2012, in International Application No. PCT/IB2010/053776.
International Preliminary Report on Patentability dated Mar. 1, 2010, in International Application No. PCT/IB2010/053776.
International Preliminary Report on Patentability dated Nov. 17, 2011, in International Application No. PCT/IB2010/051980.
International Preliminary Report on Patentability dated Oct. 23, 2014, in International Application No. PCT/IL2013/050321.
International Preliminary Report on Patentability dated Sep. 11, 2012, in International Application No. PCT/US2011/027528.
International Preliminary Report on Patentability dated Sep. 11, 2014, in International Application No. PCT/IL2013/050447.
International Rice Genome Sequencing Project, The map-based sequence of the rice genome, Nature, 436(11):793-800 (2005).
International Search Report and the Written Opinion dated Feb. 25, 2013, in International Application No. PCT/US2012/054883.
International Search Report and the Written Opinion dated Feb. 27, 2013, in International Application No. PCT/US2012/054814.
International Search Report and the Written Opinion dated Feb. 27, 2013, in International Application No. PCT/US2012/054842.
International Search Report and the Written Opinion dated Feb. 27, 2013, in International Application No. PCT/US2012/054862.
International Search Report and the Written Opinion dated Feb. 27, 2013, in International Application No. PCT/US2012/054894.
International Search Report and the Written Opinion dated Feb. 27, 2013, in International Application No. PCT/US2012/054974.
International Search Report and the Written Opinion dated Feb. 27, 2013, in International Application No. PCT/US2012/054980.
International Search Report and the Written Opinion dated Jul. 15, 2014, in International Application No. PCT/US2014/025305.
International Search Report and the Written Opinion dated Jul. 22, 2014, in International Application No. PCT/IL2013/051083.
International Search Report and the Written Opinion dated Jul. 22, 2014, in International Application No. PCT/IL2013/051085.
International Search Report and the Written Opinion dated Jul. 24, 2014, in International Application No. PCT/US2014/026036.
International Search Report and the Written Opinion dated May 10, 2011, in International Application No. PCT/US2011/027528.
International Search Report and the Written Opinion dated Oct. 1, 2013, in International Application No. PCT/IL2013/050447.
International Search Report and Written Opinion dated Dec. 31, 2015, in International Application No. PCT/US2015/042415.
International Search Report and Written Opinion dated Feb. 24, 2011, in International Application No. PCT/IL2010/000844.
International Search Report and Written Opinion dated Jul. 19, 2010, in International Application No. PCT/IB2010/051980.
International Search Report and Written Opinion dated Mar. 26, 2015, in International Application No. PCT/US2014/069535.
International Search Report and Written Opinion dated May 23, 2017, in International Application No. PCT/US2017/015061.
International Search Report and Written Opinion dated Nov. 30, 2010, in International Application No. PCT/IB2010/053776.
International Search Report and Written Opinion dated Oct. 17, 2016, in International Application No. PCT/US2016/030579.
International Search Report and Written Opinion dated Oct. 28, 2013, in International Application No. PCT/IL2013/050321.
International Search Report and Written Opinion dated Aug. 25, 2014, in International Application No. PCT/US2014/023503.
International Search Report and Written Opinion dated Aug. 27, 2014, in International Application No. PCT/US2014/023409.
International Search Report and Written Opinion dated Feb. 23, 2015, in International Application No. PCT/US2014/063832.
International Search Report and Written Opinion dated Jul. 8, 2015, in International Application No. PCT/US2015/011408.
International Search Report and Written Opinion dated Mar. 26, 2015, in International Application No. PCT/US2014/069353.
International Search Report and Written Opinion dated May 26, 2016, in International Application No. PCT/US2016/014344.
International Search Report and Written Opinion dated Nov. 24, 2015, in International Application No. PCT/US2015/037522.
International Search Report and Written Opinion dated Nov. 27, 2015, in International Application No. PCT/US2015/037015.
International Search Report and Written Opinion dated Oct. 1, 2015 in International Application No. PCT/US2015/022985.
International Search Report dated Aug. 13, 2009, in International Application No. PCT/IL2008/001440.
International Search Report dated Mar. 12, 2013, in International Application No. PCT/US2012/054789.
Invitation to Pay Additional Fees dated May 6, 2014, in International Application No. PCT/IL2013/051083.
Invitation to Pay Additional Fees dated May 6, 2014, in International Application No. PCT/IL2013/051085.
Invitation to Pay Additional Fees dated Nov. 25, 2014, in International Application No. PCT/US2014/047204.
Invitation to Pay Additional Fees dated Sep. 8, 2015, in International Application No. PCT/US2015/037015.
Invitation to Pay Additional Fees dated Sep. 9, 2015, in International Application No. PCT/US2015/037522.
Isaacs et al., “Engineered riboregulators enable post-transcriptional control of gene expression,” Nature Biotechnology, 22(7):841-847 (2004).
Jarvis et al, “An Arabidopsis mutant defective in the plastid general protein import apparatus,” Science, 282:100-103 (1998).
Ji et al., “Regulation of small RNA stability: methylation and beyond,” Cell Research, 22:624-636 (2012).
Jin et al., “Posttranslational Elevation of Cell Wall Invertase Activity by Silencing its Inhibitor in Tomato Delays Leaf Senescence and Increases Seed Weight and Fruit Hexose Level,” The Plant Cell, 21:2072-2089 (2009).
Jones-Rhoades et al., “MicroRNAs and Their Regulatory Roles in Plants,” Annu. Rev. Plant Biol., 57:19-53 (2006).
Kam et al., “Nanotube Molecular Transporters: Internalization of Carbon Nanotube—Protein Conjugates into Mammalian Cells,” J. Am. Chem. Soc., 126(22):6850-6851 (2004).
Katoh et al., “Specific residues at every third position of siRNA shape its efficient RNAi activity,” Nucleic Acids Res., 35(4): e27 (2007).
Khodakovskaya et al., “Carbon Nanotubes Are Able to Penetrate Plant Seed Coat and Dramatically Affect Seed Germination and Plant Growth,” ACS Nano, 3(10):3221-3227 (2009).
Khovorova et al., “Rational siRNA design for RNA interference,” Nature Biotechnol., 22 :326-330 (2004).
Kikkert et al., “Stable Transformation of Plant Cells by Particle Bombardment/Biolistics,” Methods in Molecular Biology, 286:61-78 (2005).
Kim et al., “Optimization of Conditions for Transient Agrobacterium-Mediated Gene Expression Assays in Arabidopsis,” Plant Cell Reports, 28:1159-1167 (2009).
Kim et al., “Synthetic dsRNA Dicer substrates enhance RNAi potency and efficacy,” Nature Biotechnology, 23(2):222-226 (2005).
Klahre et al., “High molecular weight RNAs and small interfering RNAs induce systemic posttranscriptional gene silencing in plants,” Proc. Natl. Acad. Sci. USA, PNAS, 99(18):11981-11986 (2002).
Kondylis et al., “The Golgi apparatus: Lessons from Drosophila,” FEBS Letters 583:3827-3838 (2009).
Kronenwett et al., “Oligodeoxyribonucleotide Uptake in Primary Human Hematopoietic Cells Is Enhanced by Cationic Lipids and Depends on the Hematopoietic Cell Subset,” Blood, 91(3):852-862 (1998).
Kumar et al., Sequencing, De Novo Assembly and Annotation of the.
Kusaba, “RNA interference in crop plants,” Curr Opin Biotechnol, 15(2):139-143 (2004).
Lee et al., “A systematic RNAi screen identifies a critical role for mitochondria in C. elegans longevity.” Nature Genetics, 33:40-48 (2003).
Lee et al., “Aptamer Database,” Nucleic Acids Research, 32:D95-D100 (2004).
Li et al, “RNA interference in Nilaparvata lugens (Homoptera:Delphacidae) based on dsRNA ingestion,” Pest Manag. Sci., 67:852-859 (2011).
Li et at., “Long dsRNA but not siRNA initiates RNAi in western corn rootworm larvae and adults,” Journal of Applied Entomology, 139(6):432-445 (2015).
Liu et al., “Prevention of Chinese Sacbrood Virus Infection in Apis Cerana Using RNA Interference,” Current Microbiology, 61(5):422-428 (2010).
Liu et al., “Carbon Nanotubes as Molecular Transporters for Walled Plant Cells,” Nano Letters, 9(3):1007-1010 (2009).
Liu et al., “Comparative study on the interaction of DNA with three different kinds of surfactants and the formation of multilayer films,” Bioelectrochemistry, 70:301-307 (2007).
Liu et al., “DNAzyme-mediated recovery of small recombinant RNAs from a 5S rRNA-derived chimera expressed in Escherichia coli,” BMC Biotechnology, 10:85 (2010).
Liu et al., “RNA interference in Nilaparvata lugens (Homoptera : Delphacidae) based on dsRNA ingestion,” Pest Manag. Sci., 67:852-859 (2011).
Liu, “Influence of Sugars on the Foliar Uptake of Bentazone and Glyphosate,” New Zealand Plant Protection, 55:159-162 (2002).
Liu, “The Transformation of Nucleic Acid Degradants in Plants,” China Organic Fertilizers, Agriculture Press, ISBN: 7-1091634 (with English translation).
Llave et al., “Endogenous and Silencing-Associated Small RNAs in Plants,” The Plant Cell, 14:1605-1619 (2002).
Lu et al., “Oligo Walk: an online siRNA design tool utilizing hybridization thermodynamics,” Nucleic Acids Research, 36:W104-W108 (2008).
Lu et al., “RNA silencing in plants by the expression of siRNA duplexes,” Nucleic Acids Res., 32(21):e171 (2004).
Luft, “Making sense out of antisense oligodeoxynucleotide delivery: getting there is half the fun,” J Mol Med, 76:75-76 (1998).
Luque et al., “Water Permeability of Isolated Cuticular Membranes: A Structural Analysis,” Archives of Biochemistry and Biophysics, 317(2):417-422 (1995).
Maas et al., “Mechanism and optimized conditions for PEG mediated DNA transfection into plant protoplasts,” Plant Cell Reports, 8:148-149 (1989).
MacKenzie et al., “Transgenic Nicotiana debneyii expressing viral coat protein are resistant to potato virus S infection,” Journal of General Virology, 71:2167-2170 (1990).
Maggi et al., “Resistance Phenomena to Amitraz From Population of the Ectoparasitic Mite Varroa Destructor of Argentina,” Parasitology Research, 107(5):1189-1192 (2010).
Maher III et al., “Inhibition of DNA binding proteins by oligonucleotide-directed triple helix formation,” Science, 245(4919):725-730 (1989).
Makkouk et al., “Virus Diseases of Peas, Beans, and Faba Bean in the Mediterranean region,” Adv Virus Res, 84:367-402 (2012).
Manoharan, “Oligonucleotide Conjugates as Potential Antisense Drugs with Improved Uptake, Biodistribution, Targeted Delivery, and Mechanism of Action,” Antisense & Nucleic Acid Drug Development, 12:103-128 (2002).
Mao et al., “Silencing a cotton bollworm P450 monooxygenase gene by plant-mediated RNAi impairs larval tolerance of gossypol.,” Nat Biotechnol, 25(11):1307-13 (2007).
Maori et al., “Isolation and characterization of Israeli acute paralysis virus, a dicistrovirus affecting honeybees in Israel: evidence for diversity due to intra- and inter-species recombination,” Journal of General Virology, 88:3428-3438 (2007).
Maori et al., “Israel Acute Paralysis Virus of Bees, Complete Genome,” GenBank EMBL, EBI Dbfetch, XP002533679, Accession No. EF219380, Nov. 21, 2007.
Maori et al., “Reciprocal sequence exchange between non-retro viruses and hosts leading to the appearance of new host phenotypes,” Virology, 362(2):342-349 (2007).
Maori et al., “IAPV, a bee-affecting virus associated with Colony Collapse Disorder can be silenced by dsRNA ingestion,” Insect Molecular Biology, 18(1):55-60 (2009).
Masoud et al., “Constitutive expression of an inducible β-1,3-glucanase in alfalfa reduces disease severity caused by the oomycete pathogen Phytophthora megasperma f. sp medicaginis, but does not reduce disease severity of chitincontaining fungi,” Transge.
Matveeva et al., “Prediction of antisense oligonucleotide efficacy by in vitro methods,” Nature Biotechnology, 16:1374-1375 (1998).
McGinnis, “RNAi for functional genomics in plants,” Brief Funct Genomics, 9(2):111-7 (2010).
Meins et al., “RNA Silencing Systems and Their Relevance to Plant Development,” Annu. Rev. Cell Dev. Biol., 21:297-318 (2005).
Melnyk et al., “Intercellular and systemic movement of RNA silencing signals,” The EMBO Journal, 30:3553-3563 (2011).
Migge et al., “Greenhouse-grown conditionally lethal tobacco plants obtained by expression of plastidic glutamine synthetase antisense RNA may contribute to biological safety,” Plant Science 153:107-112 (2000).
Molnar et al., “Plant Virus-Derived Small Interfering RNAs Originate redominantly from Highly Structured Single-Stranded Viral RNAs,” Journal of Virology, 79(12):7812-7818 (2005).
Molnar et al., “Small Silencing RNAs in Plants Are Mobile and Direct Epigenetic Modification in Recipient Cells,” Science, 328:872-875 (2010).
Moriyama et al., “Double-stranded RNA in rice: a novel RNA replicon in plants,” Molecular & General Genetics, 248(3):364-369 (1995).
Moriyama et al., “Stringently and developmentally regulated levels of a cytoplasmic double-stranded RNA and its high-efficiency transmission via egg and pollen in rice,” Plant Molecular Biology, 31:713-719 (1996).
Morrissey et al., “Potent and persistent in vivo anti-HBV activity of chemically modified siRNAs,” Nat Biotechnol. 23(8):1002-1007 (2005).
Moser et al., “Sequence-Specific Cleavage of Double Helical DNA by Triple Helix Formation,” Science, 238:645-646 (1987).
Mount et al., “Gene and Metabolite Regulatory Network Analysis of Early Developing Fruit Tissues Highlights New Candidate Genes for the Control of Tomato Fruit Composition and Development,” Plant Physiology, 149:1505-1528 (2009).
Nakayashiki et al. “Evolution and Diversification of RNA Silencing Proteins in Fungi”, Journal of Molecular Evolution, 63(1):127-135 (2006).
Non-Final Office Action dated Apr. 11, 2013, in U.S. Appl. No. 13/042,856.
Non-Final Office Action dated Apr. 15, 2014, in U.S. Appl. No. 13/446,557.
Non-Final Office Action dated Apr. 29, 2016, in U.S. Appl. No. 13/583,302.
Non-Final Office Action dated Aug. 10, 2016, in U.S. Appl. No. 13/612,995.
Non-Final Office Action dated Aug. 12, 2015, in U.S. Appl. No. 13/612,936.
Non-Final Office Action dated Aug. 13, 2015, in U.S. Appl. No. 13/612,929.
Non-Final Office Action dated Aug. 19, 2016, in U.S. Appl. No. 13/612,925.
Non-Final Office Action dated Aug. 19, 2016, in U.S. Appl. No. 13/612,929.
Non-Final Office Action dated Aug. 3, 2016, in U.S. Appl. No. 14/015,715.
Non-Final Office Action dated Aug. 5, 2016, in U.S. Appl. No. 14/015,785.
Non-Final Office Action dated Aug. 8, 2016, in U.S. Appl. No. 13/612,936.
Non-Final Office Action dated Dec. 17, 2015, in U.S. Appl. No. 14/532,596.
Non-Final Office Action dated Feb. 10, 2016, in U.S. Appl. No. 13/901,326.
Non-Final Office Action dated Feb. 23, 2016, in U.S. Appl. No. 14/603,347.
Non-Final Office Action dated Feb. 23, 2016, in U.S. Appl. No. 14/608,951.
Non-Final Office Action dated Feb. 5, 2014, in U.S. Appl. No. 13/446,557.
Non-Final Office Action dated Jan. 7, 2013, in U.S. Appl. No. 13/318,636.
Non-Final Office Action dated Jul. 23, 2015, in U.S. Appl. No. 14/335,135.
Non-Final Office Action dated Jul. 30, 2014, in U.S. Appl. No. 13/042,856.
Non-Final Office Action dated Jun. 5, 2015, in U.S. Appl. No. 13/612,948.
Non-Final Office Action dated Jun. 8, 2015, in U.S. Appl. No. 13/612,941.
Non-Final Office Action dated Mar. 1, 2016, in U.S. Appl. No. 13/612,954.
Non-Final Office Action dated Mar. 21, 2018, in U.S. Appl. No. 13/619,980.
Non-Final Office Action dated Mar. 30, 2015, in U.S. Appl. No. 13/583,302.
Non-Final Office Action dated May 15, 2015, in U.S. Appl. No. 14/608,951
Non-Final Office Action dated May 22, 2015, in U.S. Appl. No. 13/612,985.
Non-Final Office Action dated May 30, 2012, in U.S. Appl. No. 13/332,430.
Non-Final Office Action dated May 4, 2015, in U.S. Appl. No. 13/932,051.
Non-Final Office Action dated Nov. 9, 2016, in U.S. Appl. No. 14/901,003.
Non-Final Office Action dated Oct. 3, 2016, in U.S. Appl. No. 14/403,491.
Non-Final Office Action dated Sep. 1, 2015, in U.S. Appl. No. 13/612,954.
Non-Final Office Action dated Sep. 11, 2015, in U.S. Appl. No. 13/612,925.
Non-Final Office Action dated Sep. 23, 2010, in U.S. Appl. No. 12/222,949.
Non-Final Office Action dated Sep. 4, 2015, in U.S. Appl. No. 13/612,995.
Non-Final Office Action dated Sep. 6, 2016, in U.S. Appl. No. 14/335,135.
Nookaraju et al., “Molecular approaches for enhancing sweetness in fruits and vegetables,” Scientia Horticulture, 127:1-15 (2010).
Nord-Larsen et al., “Cloning, characterization and expression analysis of tonoplast intrinsic proteins and glutamine synthetase in ryegrass (Lolium perenne L.),” Plant Cell Reports, 28(10):1549-1562 (2009).
Nowak et al., “A new and efficient method for inhibition of RNA viruses by DNA interference,” The FEBS Journal, 276:4372-4380 (2009).
Nunes et al., “A non-invasive method for silencing gene transcriptoin in honeybees maintained under natural conditions,” Insect Biochemistry and Molecular Biology, 39:157-160 (2009).
Office Action dated 2015, in Chinese Patent Application No. 201080056585.9.
Office Action dated Apr. 13, 2016, in Chinese Patent Application No. 201280053985.3.
Office Action dated Apr. 15, 2014, in U.S. Appl. No. 13/446,557.
Office Action dated Aug. 1, 2013, in U.S. Appl. No. 13/318,636.
Office Action dated Aug. 1, 2017, in European Patent Application No. 12 830 932.5.
Office Action dated Aug. 14, 2017, in Israeli Patent Application No. 235878.
Office Action dated Aug. 22, 2017, in Korean Patent Application No. 10-2012-7023415.
Office Action dated Aug. 25, 2015, in New Zealand Patent Application No. 700791.
Office Action dated Aug. 25, 2016, in Eurasian Patent Application No. 201201264.
Office Action dated Aug. 28, 2013, in Chinese Patent Application No. 201180012795.2.
Office Action dated Aug. 3, 2015, in Chinese Patent Application No. 201080056585.9 (English translation attached).
Office Action dated Aug. 3, 2017, in Chinese Patent Application No. 201480014392.5 (with English translation).
Office Action dated Aug. 3, 2017, in European Patent Application No. 12 831 684.1.
Office Action dated Aug. 8, 2017, in Chilean Patent Application No. 201501874.
Office Action dated Dec. 13, 2016, in Ukrainian Patent Application No. a 2014 03843.
Office Action dated Dec. 14, 2016, in Ukrainian Patent Application No. a 2014 03850.
Office Action dated Dec. 15, 2016, in Ukrainian Patent Application No. a 2014 03845.
Office Action dated Dec. 15, 2016, in Ukrainian Patent Application No. a 2014 03849.
Office Action dated Dec. 15, 2016, in Ukrainian Patent Application No. a 2014 03852.
Office Action dated Dec. 18, 2014, in Israeli Patent Application No. 216154 (with English translation).
Office Action dated Dec. 21, 2015, in Israeli Patent Application No. 240416 (with English translation).
Office Action dated Dec. 27, 2016, in Ukrainian Patent Application No. a 2012 11548.
Office Action dated Dec. 31, 2014, in Israeli Patent Application No. 205594 (with English translation).
Office Action dated Dec. 5, 2017, in Japanese Patent Application No. 2016-502033.
Office Action dated Feb. 17, 2011, in European Patent Application No. 08847971.2.
Office Action dated Feb. 17, 2014, in European Patent Application No. 08847971.2.
Office Action dated Feb. 17, 2014, in Mexican Patent Application No. MX/a/2012/010479.
Office Action dated Feb. 21, 2018, in Mexican Patent Application No. MX/a/2015/012632 (with English translation).
Office Action dated Feb. 24, 2014, in Eurasian Patent Application No. 201201264.
Office Action dated Feb. 5, 2015, in European Patent Application No. 13156183.9.
Office Action dated Feb. 6, 2015, in European Patent Application No. 10719620.6.
Office Action dated Jan. 19, 2014, in Israeli Patent Application No. 205594 (with English translation).
Office Action dated Jan. 26, 2015, in Israeli Patent Application No. 205594 (with English translation).
Office Action dated Jan. 26, 2015, in Israeli Patent Application No. 219193 (with English translation).
Office Action dated Jan. 30, 2015, in Mexican Patent Application No. MX/a/2012/004378 (with English translation).
Office Action dated Jan. 7, 2013, in U.S. Appl. No. 13/318,636.
Office Action dated Jul. 11, 2017, in Mexican Patent Application No. MX/a/2015/013118 (with English translation).
Office Action dated Jul. 12, 2013, in European Patent Application No. 08847971.2.
Office Action dated Jul. 18, 2016, in Indonesian Patent Application No. W00201203610.
Office Action dated Jul. 2, 2013, in Chinese Patent Application No. 201080056585.9.
Office Action dated Jul. 23, 2015, in Ukrainian Patent Application No. 201211548.
Office Action dated Jul. 3, 2017, in Mexican Patent Application No. MX/a/2015/012632 (with English translation).
Office Action dated Jul. 6, 2017, in Mexican Patent Application No. MX/a/2015/013103 (with English translation).
Office Action dated Jun. 29, 2012, in European Patent Application No. 08847971.2.
Office Action dated Jun. 20, 2016, in Chinese Patent Application No. 201280054819.5.
Office Action dated Jun. 24, 2016, in Chinese Patent Application No. 201280053984.9.
Office Action dated Jun. 28, 2010, in U.S. Appl. No. 12/222,949.
Office Action dated Jun. 8, 2015, in European Patent Application No. 13156185.4.
Office Action dated Mar. 10, 2014, in European Patent Application No. 13156180.4.
Office Action dated Mar. 10, 2014, in European Patent Application No. 13156180.5.
Office Action dated Mar. 16, 2017, in Chinese Patent Application No. 201280054819.5.
Office Action dated Mar. 17, 2014, in European Patent Application No. 13156183.9.
Office Action dated Mar. 18, 2011, in U.S. Appl. No. 12/222,949.
Office Action dated Mar. 19, 2012, in Israeli Patent Application No. 205594 (English Translation attached).
Office Action dated Mar. 19, 2015, in Canadian Patent Application No. 2,704,858.
Office Action dated Mar. 20, 2015, in Indian Patent Application No. 1150/MUMNP/2010.
Office Action dated Mar. 8, 2018 (with English translation), in Chilean Patent Application No. 201403192.
Office Action dated May 12, 2014, in Chinese Patent Application No. 201080056585.9.
Office Action dated May 12, 2014, in Mexican Patent Application No. MX/a/2012/004378 (English Translation attached).
Office Action dated May 29, 2015, in European Patent Application No. 13156180.4.
Office Action dated May 29, 2015, in European Patent Application No. 13156180.5.
Office Action dated May 3, 2016, in Chilean Patent Application No. 201601057.
Office Action dated May 30, 2012, in U.S. Appl. No. 13/332,430.
Office Action dated Nov. 10, 2014, in European Patent Application No. 10779855.5.
Office Action dated Nov. 15, 2016, in Mexican Patent Application No. MX/a/2014/003068 (with English translation).
Office Action dated Nov. 21, 2012, in U.S. Appl. No. 13/318,636.
Office Action dated Nov. 6, 2014, in Australian Patent Application No. 2010244122.
Office Action dated Oct. 15, 2012, in U.S. Appl. No. 13/332,430.
Office Action dated Oct. 21, 2015, in European Patent Application No. 13723252.6.
Office Action dated Oct. 23, 2013, in Australian Patent Application No. 2008325989.
Office Action dated Oct. 31, 2013 , , in Mexican Patent Application No. MX/a/2012/004378 (English Translation attached).
Office Action dated Oct. 31, 2013, in Mexican Patent Application No. MX/a/2012/004378.
Office Action dated Oct. 8, 2013, in European Patent Application No. 10719620.6.
Office Action dated Sep. 29, 2014, European Patent Application No. 13156180.4.
Office Action dated Sep. 29, 2014, in European Patent Application No. 13156180.5.
Office Action dated Sep. 1, 2015, in European Patent Application No. 10779855.5.
Office Action dated Sep. 23, 2010, in U.S. Appl. No. 12/222,949.
Office Action dated Sep. 28, 2015, in U.S. Appl. No. 13/932,051.
Office Action dated Sep. 29, 2014, in European Patent Application No. 13156180.4.
Office Action dated Sep. 4, 2015, in European Patent Application No. 13156183.9.
Office Action dated Sep. 5, 2016, in Ukrainian Patent Application No. a 2014 03846.
Office Action dated Sep. 6, 2017, in Chinese Patent Application No. 2014800154012 (with English translation).
Office Action dated Nov. 3, 2014, in Chinese Patent Application No. 201180012795.2.
Office Action dated Jan. 6, 2015, in Japanese Patent Application No. 2012-557165.
Office Action dated Nov. 19, 2014, in Eurasian Patent Application No. 201201264/28.
Office Action dated Oct. 5, 2015, in Eurasian Patent Application No. 201201264/28.
Ongvarrasopone et al., “A Simple and Cost Effective Method to Generate dsRNA for RNAi Studies in Invertebrates,” Science Asia, 33:35-39 (2007).
Orbović et al., “Foliar-Applied Surfactants and Urea Temporarily Reduce Carbon Assimilation of Grapefruit Leaves,” J. Amer. Soc. Hort. Sci., 126(4):486-490 (2001).
Ouellet et al., “Members of the Acetohydroxyacid Synthase Muligene Family of Brassica napus Have Divergent Patterns of Expression,” The Plant Journal, Blackwell Scientific Publications, Oxford, GB, 2(3):321-330 (1992).
Paddison et al., “Stable suppression of gene expression by RNAi in mammalian cells,” Proc. Natl Acad. Sci. USA, 99(3):1443-1448 (2002).
Palacios et al., “Genetic Analysis of Israel Acute Paralysis Virus: Distinct Clusters Are Circulating in the United States,” Journal of Virology, 82(13):6209-6217 (2008).
Palauqui et al., “Activation of systemic acquired silencing by localised introduction of DNA,” Current Biology, 9:59-66 (1999).
Paldi et al. “Effective Gene Silencing in a Microsporidian Parasite Associated With Honeybee (Apis mellifera) Colony Declines”, Applied and Environmental Microbiology, 760(17):5960-5964 (2010).
Parera et al., “Dehydration Rate after Solid Matrix Priming Alters Seed Performance of Shrunken-2 Corn,” J. Amer. Soc. Hort. Sci., 119(3):629-635 (1994).
Partial European Search Report dated Dec. 6, 2017, in European Patent Application No. 17181861.0.
Partial International Search Report dated Jul. 24, 2013, International Application No. PCT/2013/050321.
Partial International Search Report dated May 13, 2009, in International Application No. PCT/IL2008/001440.
Partial Supplementary European Search Report dated Mar. 2, 2015, in European Patent Application No. 12 831 494.5.
Partial Supplementary European Search Report dated Jan. 11, 2018, in European Patent Application No. 15812530.0.
Patent Examination Report dated Nov. 6, 2014, in Australian Patent Application No. 2010244122.
Patent Examination Report dated Oct. 23, 2013, in Australian Patent Application No. 2008325989.
Patent Examination Report No. 1 dated Feb. 8, 2016, in Australian Patent Application No. 2014262189.
Patent Examination Report No. 1 dated Jun. 17, 2016, in Australian Patent Application No. 2012308659.
Patent Examination Report No. 1 dated Jun. 17, 2016, in Australian Patent Application No. 2012308660.
Patent Examination Report No. 1 dated Jun. 8, 2017, in Australian Patent Application No. 2012308686.
Patent Examination Report No. 1 dated Nov. 11, 2013, in Australian Patent Application No. 2011224570.
Paungfoo-Lonhienne et al., “DNA is Taken up by Root Hairs and Pollen, and Stimulates Root and Pollen Tube Growth,” Plant Physiology, 153:799-805 (2010).
Paungfoo-Lonhienne et al., “DNA uptake by Arabidopsis induces changes in the expression of CLE peptides which control root morphology,” Plant Signaling & Behavior, 5(9):1112-1114 (2010).
Pei et al., “On the art of identifying effective and specific siRNAs,” Nature Methods, 3(9):670-676 (2006).
Peretz et al., “A Universal Expression/Silencing Vector in Plants,” Plant Physiology, 145:1251-1263 (2007).
Pitino et al., “Silencing of Aphid Genes by dsRNA Feeding from Plants,” PLos One, 6:e25709 (2011).
Pornprom et al., “Glutamine synthetase mutation conferring target-site-based resistance to glufosinate in soybean cell selections,” Pest Manag Sci, 2009; 65(2):216-222 (2009).
Powles et al., “Evolution in Action: Plants Resistant to Herbicides,” Annual Review of Plant Biology, 61(1):317-347 (2010).
Pratt et al., “Amaranthus rudis and A. tuberculatus, One Species or Two?,” Journal of the Torrey Botanical Society, 128(3):282-296 (2001).
Preston et al., “Multiple effects of a naturally occurring proline to threonine substitution within acetolactate synthase in two herbicide-resistant populations of Lactuca serriola,” Pesticide Biochem. Physiol., 84(3):227-235 (2006).
Price et al. “RNAi-Mediated Crop Protection Against Insects”, Trends in Biotechnology, XP022757296, 26(7):393-400 (2008).
Pridgeon et al., “Topically Applied AaeIAP1 Double-Stranded RNA Kills Feman Adults of Aedes aegypti,” J. Med. Entomol., 45(3):414-420 (2008).
Rajur et al., “Covalent Protein—Oligonucleotide Conjugates for Efficient Delivery of Antisense Molecules,” Bioconjug Chem., 8:935-940 (1997).
Rakoczy-Trojanowska, “Alternative Methods of Plant Transformation—a short review,” Cellular & Molecular Biology Letters, 7:849-858 (2002).
Reddy et al “Organosilicone Adjuvants Increased the Efficacy of Glyphosate for Control of Weeds in Citrus (Citrus spp.)” HortScience 27(9):1003-1005 (1992).
Reddy et al., “Aminomethylphosphonic Acid Accumulation in Plant Species Treated with Glyphosate,” J. Agric. Food Chem., 56(6):2125-2130 (2008).
Reither et al., “Specificity of DNA triple helix formation analyzed by a FRET assay,” BMC Biochemistry, 3:27 (2002).
Requisition by the Examiner and Examination Search Report dated Mar. 19, 2015, in Canadian Patent Application No. 2,704,858.
Rey et al., “Diversity of Dicotyledenous-Infecting Geminiviruses and Their Associated DNA Molecules in Southern Africa, Including the South-West Indian Ocean Islands,” Viruses, 4:1753-1791 (2012).
Reynolds et al., “Rational siRNA design for RNA interference,” Nature Biotechnology, 22:326-330 (2004).
Richardson et al., “Targeting and assembly of components of the TOC protein import complex at the chloroplast outer envelope membrane,” Frontiers in Plant Science, 5:1-14 (2014).
Riggins et al., “Characterization of de novo transcriptome for waterhemp (Amaranthus tuberculatus) using GS-FLX 454 pyrosequencing and its application for studies of herbicide target-site genes,” Pest Manag. Sci., 66:1042-1052 (2010).
Robalino et al., “Double-Stranded RNA and Antiviral Immunity in Marine Shrimp: Inducible Host Mechanisms and Evidence for the Evolution of Viral Counter-Responses,” Developmental & Comparative Immunology, 31: 539-547 (2007).
Roberts, “Fast-track applications: The potential for direct delivery of proteins and nucleic acids to plant cells for the discovery of gene function,” Plant Methods, 1(12):1-3 (2005).
Rose et al., “Functional polarity is introduced by Dicer processing of short substrate RNAs,” Nucleic Acids Research, 33(13):4140-4156 (2005).
Rothnie et al., Pararetroviruses and Retroviruses: A Comparative Review of Viral Structure and Gene Expression Strategies, Advances in Virus Research, 44:1-67 (1994).
Ryabov et al., “Cell-to-Cell, but Not Long-Distance, Spread of RNA Silencing That Is Induced in Individual Epidermal Cells,” Journal of Virology, 78(6):3149-3154 (2004).
Salanenka et al., “Seedcoat Permeability: Uptake and Post-germination Transport of Applied Model Tracer Compounds,” HortScience, 46(4):622-626 (2011).
Santoro et al., “A general purpose RNA-cleaving DNA enzyme,” Proc. Natl. Acad. Sci. USA, 94:4262-4266 (1997).
Santosh et al., “RNA interference for the control of whiteflies (Bemisia tabaci) by oral route,” Journal of Biosciences, 36(1):153-161 (2011).
Sathasivan et al., “Nucleotide sequence of a mutant acetolactate synthase gene from an imidazolinone-resistant Arabidopsis thaliana var. columbia,” Nucleic Acids Research, 18(8):2188-2193 (1990).
Schönherr, “Water Permeability of Isolated Cuticular Membranes: The Effect of pH and Cations on Diffusion, Hydrodynamic Permeability and Size of Polar Pores in the Cutin Matrix,” Planta, 128:113-126 (1976).
Schwab et al., “RNA silencing amplification in plants: Size matters,” PNAS, 107(34):14945-14946 (2010).
Schweizer et al., “Double-stranded RNA interferes with gene function at the single-cell level in cereals,” The Plant Journal, 24(6):895-903 (2000).
Scott et al., “Towards the elements of successful insect RNAi,” Journal of Insect Physiology, 59(12):1212-1221 (2013).
Scott et al., Botanical Insecticides for Controlling Agricultural Pests: Piperamides and the Colorado Potato Beetle Leptinotarsa decemlineata Say (Coleoptera: Chrysomelidae), Archives of Insect Biochemistry and Physiology, 54:212-225 (2003).
Search Report dated Jul. 24, 2017, in Chinese Patent Application No. 201480014392.5 (with English translation).
Search Report dated Oct. 20, 2017, in Chinese Patent Application No. 201380039346.6.
Second Chinese Office Action dated Jun. 10, 2014, in Chinese Patent Application No. 201180012795.2.
Second Office Action dated Feb. 25, 2016, in Chinese Patent Application No. 201280054179.8.
Second Office Action dated Mar. 4, 2016, in Chinese Patent Application No. 201280054820.8.
Second Office Action dated May 12, 2014, in Chinese Patent Application No. 201080056585.9.
Seidman et al., “The potential for gene repair via triple helix formation,” J Clin Invest., 112(4):487-494 (2003).
Selvarani et al., “Evaluation of seed priming methods to improve seed vigour of onion (Allium cepa cv. Aggregatum) and carrot (Daucus carota),” Journal of Agricultural Technology, 7(3):857-867 (2011).
Senthil-Kumar et al., “A systematic study to determine the extent of gene silencing in Nicotiana benthamiana and other Solanaceae species when heterologous gene sequences are used for virus-induced gene silencing,” New Phytologist, 176:782-791 (2007).
Sharma et al., “A simple and efficient Agrobacterium-mediated procedure for transformation of tomato,” J. Biosci., 34(3):423 433 (2009).
Shen et al., “The Role of Varroa Mites in Infections and Deformed Wing Virus (DWV) in Honey,” Available Online Aug. 18, 2005.
Shintani et al., “Antisense Expression and Overexpression of Biotin Carboxylase in Tobacco Leaves,” Plant Physiol., 114:881-886 (1997).
Showalter, “Structure and Function of Plant Cell Wall Proteins,” The Plant Cell, 5:9-23 (1993).
Sijen et al., “On the Role of RNA Amplification in dsRNA-Triggered Gene Silencing,” Cell, 107:465-476 (2001).
Silwet L-77 Spray Adjuvant for agricultural applications, product description from Momentive Performance Materials, Inc. (2003).
Sindhu et al., “Effective and specific in planta RNAi in cyst nematodes: expression interference of four parasitism genes reduces parasitic success,” J. Exp. Botany, 60:315-324 (2008).
Siomi et al. “On the Road to Reading the RNA-Interference Code”, Nature, 457(7228): 396-404, Jan. 22, 2009. Abstract.
Slamovits et al. “Genome Compaction and Stability in Microsporidian Intracellular Parasites”, Current Biology, 14(10): 891-896, May 25, 2004.
Small, “RNAi for revealing and engineering plant gene functions,” Current Opinion in Biotechnology, 18:148-153 (2007).
Snead et al., “Molecular basis for improved gene silencing by Dicer substrate interfering RNA compared with other siRNA variants,” Nucleic Acids Research, 41(12):6209-6221 (2013).
Soares et al., “Capillary feeding of specific dsRNA induces silencing of the isac gene in nymphal lxodes scapularis ticks,” Insect Mol. Biol., 14(4):443-452 (2005).
Song et al., “Herbicide,” New Heterocyclic Pesticide, Chemical Industry Press, 354-356 (2011).
Standifer et al., “Supplemental Feeding of Honey Bee Colonies,” Agriculture Information Bullentin No. 413, USDA, pp. 1-8 (1977).
Statement of Grounds and Particulars dated Sep. 1, 2017, in Australian Patent No. 2014262189.
Steeves et al., “Transgenic soybeans expressing siRNAs specific to a major sperm protein gene suppress Heterodera glycines reproduction,” Funct. Plant Biol., 33:991-999 (2006).
Stevens et al., “New Formulation Technology—Silwet® Organosilicone Surfactants Have Physical and Physiological Properties Which Enhance the Performance of Sprays,” Proceedings of the 9th Australian Weeds Conference, pp. 327-331 (1990).
Stevens, “Formulation of Sprays to Improve the Efficacy of Foliar Fertilisers,” New Zealand Journal of Forestry Science, 24(1):27-34 (1994).
Stevens, “Organosilicone Surfactants as Adjuvants for Agrochemicals,” Journal of Pesticide Science, 38:103-122 (1993).
Stock et al., “Possible Mechanisms for Surfactant-Induced Foliar Uptake of Agrochemicals,” Pestic. Sci., 38:165-177 (1993).
Strat et al., “Specific and nontoxic silencing in mammalian cells with expressed long dsRNAs,” Nucleic Acids Research, 34(13):3803-3810 (2006).
Street, “Why is DNA (and not RNA) a stable storage form for genetic information?,” Biochemistry Revisited, pp. 1-4 (2008).
Sudarsan et al., “Metabolite-binding RNA domains are present in the genes of eukaryotes,” RNA, 9:644-647 (2003).
Summons to Attend Oral Proceedings Pursuant to Rule 115(1) EPC, dated Aug. 7, 2017, in European Patent Application No. 12832160.1.
Sun, “Characterization of Organosilicone Surfactants and Their Effects on Sulfonylurea Herbicide Activity,” Thesis Submitted to the Faculty of the Virginia Polytechnic Institute and State University dated Apr. 5, 1996.
Supplementary European Search Report dated Jan. 17, 2018, in European Patent Application No. 15773480.7.
Supplementary Partial European Search Report dated Jan. 11, 2018 in European Appln. 15 82 6865.
Supplementary Partial European Search Report dated Oct. 16, 2017, in European Patent Application No. 15773480.7.
Takasaki et al., “An Effective Method for Selecting siRNA Target Sequences in Mammalian Cells,” Cell Cycle, 3:790-795 (2004).
Tang et al., “Efficient delivery of small interfering RNA to plant cells by a nanosecond pulsed laser-induced stress wave for posttranscriptional gene silencing,” Plant Science, 171:375-381 (2006).
Tank Mixing Chemicals Applied to Peanut Crops: Are the Chemicals Compatible?, College of Agriculture & Life Sciences, NC State University, AGW-653, pp. 1-11 (2004).
Templeton et al., “Improved DNA: liposome complexes for increased systemic delivery and gene expression,” Nature Biotechnology, 15:647-652 (1997).
Tenllado et al., “Crude extracts of bacterially expressed dsRNA can be used to protect plants against virus infection,” BMC Biotechnology, 3(3):1-11 (2003).
Tenllado et al, “Double-Stranded RNA-Mediated Interference with Plant Virus Infection,” Journal of Virology, 75(24):12288-12297 (2001).
Tenllado et al., “RNA interference as a new biotechnological tool for the control of virus diseases in plants,” Virus Research, 102:85-96 (2004).
Tepfer, “Risk assessment of virus resistant transgenic plants,” Annual Review of Phytopathology, 40:467-491 (2002).
Terenius et al., RNA interference in Lepidoptera: an overview of successful and unsuccessful studies and implications for experimental design, Journal of Insect Physiology, 57(2):231-245 (2011).
Third Office Action dated Nov. 25, 2014, in Chinese Patent Application No. 201080056585.9.
Third Party Submission filed on Nov. 29, 2012 in U.S. Appl. No. 13/042,856.
Thomas et al., “Size constraints for targeting post-transcriptional gene silencing and for RNA-directed methylation in Nicotiana benthamiana using a potato virus X vector,” The Plant Journal, 25(4):417-425 (2001).
Tian et al., “Developmental Control of a Lepidopteran Pest Spodoptera exigua by Ingestion of Bacteria Expressing dsRNA of a Non-Midgut Gene,” PLoS One, 4:e6225, pp. 1-14 (2009).
Timmons et al., “Specific interference by ingested dsRNA,” Nature, 395:854 (1998).
Tomari et al., “Perspective: machines for RNAi,” Genes & Dev., 19:517-529 (2005).
Töpfer et al., “Uptake and Transient Expression of Chimeric Genes in Seed-Derived Embryos,” Plant Cell, 1:133-139 (1989).
Toriyama et al., “Transgenic Rice Plants After Direct Gene Transfer Into Protoplasts,” Bio/Technology, 6:1072-1074 (1988).
Tran et al., “Control of specific gene expression in mammalian cells by co-expression of long complementary RNAs,” FEBS Lett.;573(1-3):127-134 (2004).
Tranel et al., “Resistance of weeds to ALS-inhibiting herbicides: what have we learned?,” Weed Science, 50:700-712 (2002).
Translation dated Jan. 15, 2015 of Office Action dated Dec. 18, 2014 From the Israel Patent Office Re. Application No. 216154.
Translation dated Jan. 20, 2015 of Office Action dated Dec. 31, 2014 From the Israel Patent Office Re. Application No. 205594.
Translation of Office Action dated Jul. 2, 2013 From the State Intellectual Property Office of the People's Republic of China Re. Application No. 201080056585.9.
Tsugawa et al., “Efficient transformation of rice protoplasts mediated by a synthetic polycationic amino polymer,” Theor Appl Genet, 97:1019-1026 (1998).
Turina et al., “Tospoviruses in the Mediterranean Area,” Advances in Virus Research, 84:403-437 (2012).
Turner et al., “RNA interference in the light brown apple moth, Epiphyas postvittana (Walker) induced by double-stranded RNA feeding,” Insect Mol. Biol., 15(3):383-391 (2006).
Tuschl, “Expanding small RNA interference,” Nature Biotechnol., 20: 446-448 (2002).
Tuschl, “RNA Interference and Small Interfering RNAs,” ChemBiochem. 2(4):239-245 (2001).
Ui-Tei et al., “Guidelines for the selection of highly effective siRNA sequences for mammalian and chick RNA interference,” Nucleic Acids Res., 32(3): 936-948 (2004).
Ullu et al., “RNA Interference in Protozoan Parasites,” Cellular Microbiology, 6(6):509-519 (2004).
Ulrich et al., “Large scale RNAi screen in Tribolium reveals novel target genes for pest control and the proteasome as prime target,” BMC genomics, 16(1):671 (2015).
Unnamalai et al., “Cationic oligopeptide-mediated delivery of dsRNA for post-transcriptional gene silencing in plant cells,” FEBS Letters, 566:307-310 (2004).
Unniraman et al., “Alternate Paradigm for Intrinsic Transcription Termination in Eubacteria,” The Journal of Biological Chemistry, 276(45)(9):41850-41855 (2001).
Unniraman et al., “Conserved Economics of Transcription Termination in Eubacteria,” Nucleic Acids Research, 30(3):675-684 (2002).
Upadhyay et al., RNA interference for the control of whiteflies (Bemisia tabaci) by oral route, J. Biosci., 36(1):153-161 (2011).
Urayama et al., “Knock-down of OsDCL2 in Rice Negatively Affects Maintenance of the Endogenous dsRNA Virus, Oryza sativa Endornavirus,” Plant and Cell Physiology, 51(1):58-67 (2010).
Van de Wetering et al., “Specific inhibition of gene expression using a stably integrated, inducible small-interfering-RNA vector,” EMBO Rep., 4(6):609-615 (2003).
Vasil et al., “Herbicide Resistant Fertile Transgenic Wheat Plants Obtained by Microprojectile Bombardment of Regenerable Embryogenic Callus,” Bio/Technology,10:667-674 (1992).
Vaucheret, “Post-transcriptional small RNA pathways in plants: mechanisms and regulations,” Genes Dev., 20:759-771 (2006).
Vencill et al., “Resistance of Weeds to Herbicides,” Herbicides and Environment, 29:585-594 (2011).
Verma et al., “Modified oligonucleotides: synthesis and strategy for users,” Annu. Rev. Biochem., 67:99-134 (1998).
Vermeulen et al., “The contributions of dsRNA structure to Dicer specificity and efficiency,” RNA, 11(5):674-682 (2005).
Vert et al., “An accurate and interpretable model for siRNA efficacy prediction,” BMC Bioinformatics, 7:520 (2006).
Voinnet et al., “Systemic Spread of Sequence-Specific Transgene RNA Degradation in Plants Is Initiated by Localized Introduction of Ectopic Promoterless DNA,” Cell, 95:177-187 (1998).
Voinnet, “Origin, Biogenesis, and Activity of Plant MicroRNAs,” Cell, 136:669-687 (2009).
Wakelin et al., “A target-site mutation is present in a glyphosate-resistant Lolium rigidum population,” Weed Res. (Oxford), 46(5):432-440 (2006).
Walton et al., “Thermodynamic and Kinetic Characterization of Antisense Oligodeoxynucleotide Binding to a Structured mRNA,” Biophysical Journal, 82:366-377 (2002).
Walton et al., “Prediction of antisense oligonucleotide binding affinity to a structured RNA target,” Biotechnol Bioeng 65(1):1-9 (1999).
Wan et al., “Generation of Large Numbers of Independently Transformed Fertile Barley Plants,” Plant Physiol., 104:37-48 (1994).
Wang et al. “Molecular Characterization of an Arachnid Sodium Channel Gene From the Varroa Mite (Varroa destructor)”, Insect Biochemistry and Molecular Biology, XP002621492, 33(7): 733-739, Jul. 2003. Abstract.
Wang et al. “Tracking Anonymous Peer-to-Peer VoIP Calls on the Internet”, ACM, CCS'05, Alexandria, VA, USA, Nov. 7-11, 2005, 11 P., 2005.
Wang et al., “Foliar uptake of pesticides—Present status and future challenge,” ScienceDirect, 87:1-8 (2007).
Wang et al., “Principle and technology of genetic engineering in plants,” in Plant genetic engineering principles and techniques, Beijing:Science Press, pp. 313-315 (1998).
Wang et al.,“Silkworm Coatomers and Their Role in Tube Expansion of Posterior Silkgland,” PLoS One 5(10): E133252 (2010).
Wardell, “Floral Induction of Vegetative Plants Supplied a Purified Fraction of Deoxyribonucleic Acid from Stems of Flowering Plants,” Plant Physiol, 60:885-891 (1977).
Wardell,“Floral Activity in Solutions of Deoxyribonucleic Acid Extracted from Tobacco Stems,” Plant Physiol, 57:855-861 (1976).
Waterhouse et al., “Virus resistance and gene silencing in plants can be induced by simultaneous expression of sense and antisense RNA,” Proc Natl Acad Sci USA, 95 13959-13964 (1998).
Welch et al., “Expression of ribozymes in gene transfer systems to modulate target RNA levels,” Curr Opin Biotechnol. 9(5):486-496 (1998).
Whyard et al., “Ingested double-stranded RNAs can act as species-specific insecticides,” Insect Biochem. Mol. Biol., 39(11):824-832 (2009).
Widholm et al., “Glyphosate selection of gene amplification in suspension cultures of 3 plant species,” Phyisologia Plantarum, 112:540-545 (2001).
Wiesman et al., “Novel cationic vesicle platform derived from vernonia oil for efficient delivery of DNA through plant cuticle membranes,” Journal of Biotechnology, 130:85-94 (2007).
Wild Carrot, Noxious Weed Control Board (NWCB) of Washington State (2010) <www.nwcb.wa.gov/detail.asp?weed=46>.
Williams “Unique Physiology of Host-Parasite Interactions in Microsporidia Infections,” Cellular Microbiology, 11(11):1551-1560 (2009).
Williams et al., “Genome Sequence Surveys of Brachiola Algerae and Edhazardia Aedis Reveal Micriosporidia With Low Gene Densities,” BMC Genomics, 9(200):1-9 (2008).
Wilson, et al., “Transcription termination at intrinsic terminators: The role of the RNA hairpin,” Proc. Natl. Acad. Sci. USA, 92:8793-8797 (1995).
Winkler et al., “Thiamine derivatives bind messenger RNAs directly to regulate bacterial gene expression,” Nature, 419:952-956 (2002).
Written Opinion dated Apr. 7, 2016, in Singapore Patent Application No. 201206152-9.
Written Opinion dated Aug. 13, 2009, in International Application No. PCT/IL2008/001440.
Written Opinion dated Mar. 6, 2017, in Singaporean Patent Application No. 2012061529.
Written Opinion dated May 8, 2014, in International Application No. PCT/IL2013/050447.
Written Opinion dated Sep. 1, 2014, in Singapore Patent Application No. 201206152-9.
Yadav et al., “Host-Generated Double Stranded RNA Induces RNAi in Plant-Parasitic Nematodes and Protects the Host From Infection,” Molecular & Biochemical Parasitology, 148:219-222 (2006).
Yao et al., “Development of RNAi Methods for Peregrinus maidis, the Corn Planthopper,” PLOS One, 8(8):1-11 (2013).
Yin et al., “Production of double-stranded RNA for interference with TMV infection utilizing a bacterial prokaryotic expression system,” Appl. Microbiol. Biotechnol., 84(2):323-333 (2009).
YouTube video by General Electric Company “Silwet Surfactants,” screen shot taken on Jan. 11, 2012 of video of www.youtube.com/watch?v=WBw7nXMqHk8 (uploaded Jul. 13, 2009).
Zhang et al., “Agrobacterium-mediated transformation of Arabidopsis thaliana using the floral dip method,” Nature Protocols, 1(2):1-6 (2006).
Zhang et al., “Cationic lipids and polymers mediated vectors for delivery of siRNA,” Journal of Controlled Release, 123:1-10 (2007).
Zhang et al., “Transgenic rice plants produced by electroporation-mediated plasmid uptake into protoplasts,” The Plant Cell Rep., 7:379-384 (1988).
Zhang, “Artificial trans-acting small interfering RNA: a tool for plant biology study and crop improvements,” Planta, 239:1139-1146 (2014).
Zhang, Chapter 10: New Characteristics of Pesticide Research & Development, p. 209 (2010).
Zhao et al., “Phyllotreta striolata (Coleoptera: Chrysomelidae):Arginine kinase cloning and RNAi-based pest control,” European Journal of Entomology, 105(5):815-822 (2008).
Zhao et al., “PsOrl, a potential target for RNA interference-based pest management,” Insect Molecular Biology 20(1):97-104 (2011).
Zhu et al., “Ingested RNA interference for managing the populations of the Colorado potato beetle, Leptinotarsa decemlineata,” Pest Manag Sci, 67:175-182 (2010).
Zotti et al., “RNAi technology for insect management and protection of beneficial insects from diseases: lessons, challenges and risk assessments,” Neotropical Entomology, 44(3):197-213 (2015).
Related Publications (1)
Number Date Country
20170260522 A1 Sep 2017 US
Provisional Applications (1)
Number Date Country
62030430 Jul 2014 US